Transcription	B-protein
factor	I-protein
STAT5A	B-protein
is	O
a	O
substrate	O
of	O
Bruton	B-protein
's	I-protein
tyrosine	I-protein
kinase	I-protein
in	O
B	B-cell_type
cells	I-cell_type
.	O

STAT5A	B-protein
is	O
a	O
molecular	O
regulator	O
of	O
proliferation	O
,	O
differentiation	O
,	O
and	O
apoptosis	O
in	O
lymphohematopoietic	B-cell_type
cells	I-cell_type
.	O

Here	O
we	O
show	O
that	O
STAT5A	B-protein
can	O
serve	O
as	O
a	O
functional	O
substrate	O
of	O
Bruton	B-protein
's	I-protein
tyrosine	I-protein
kinase	I-protein
(	O
BTK	B-protein
)	O
.	O

Purified	B-protein
recombinant	I-protein
BTK	I-protein
was	O
capable	O
of	O
directly	O
binding	O
purified	B-protein
recombinant	I-protein
STAT5A	I-protein
with	O
high	O
affinity	O
(	O
K	O
(	O
d	O
)	O
=	O
44	O
nm	O
)	O
,	O
as	O
determined	O
by	O
surface	O
plasmon	O
resonance	O
using	O
a	O
BIAcore	O
biosensor	O
system	O
.	O

BTK	B-protein
was	O
also	O
capable	O
of	O
tyrosine-phosphorylating	O
ectopically	O
expressed	O
recombinant	B-protein
STAT5A	I-protein
on	O
Tyr	O
(	O
694	O
)	O
both	O
in	O
vitro	O
and	O
in	O
vivo	O
in	O
a	O
Janus	B-protein
kinase	I-protein
3	I-protein
-independent	O
fashion	O
.	O

BTK	B-protein
phosphorylated	O
the	O
Y665F	B-protein
,	I-protein
Y668F	I-protein
,	I-protein
and	I-protein
Y682F	I-protein
,	I-protein
Y683F	I-protein
mutants	I-protein
but	O
not	O
the	O
Y694F	B-protein
mutant	I-protein
of	O
STAT5A	B-protein
.	O

STAT5A	O
mutations	O
in	O
the	O
Src	B-protein
homology	I-protein
2	I-protein
(	I-protein
SH2	I-protein
)	I-protein
and	I-protein
SH3	I-protein
domains	I-protein
did	O
not	O
alter	O
the	O
BTK	B-protein
-mediated	O
tyrosine	O
phosphorylation	O
.	O

Recombinant	B-protein
BTK	I-protein
proteins	I-protein
with	O
mutant	O
pleckstrin	O
homology	O
,	O
SH2	B-protein
,	I-protein
or	I-protein
SH3	I-protein
domains	I-protein
were	O
capable	O
of	O
phosphorylating	O
STAT5A	B-protein
,	O
whereas	O
recombinant	B-protein
BTK	I-protein
proteins	I-protein
with	O
SH1/kinase	O
domain	O
mutations	O
were	O
not	O
.	O

In	O
pull-down	O
experiments	O
,	O
only	O
full-length	B-protein
BTK	I-protein
and	O
its	O
SH1/kinase	B-protein
domain	I-protein
(	O
but	O
not	O
the	O
pleckstrin	O
homology	O
,	O
SH2	B-protein
,	I-protein
or	I-protein
SH3	I-protein
domains	I-protein
)	O
were	O
capable	O
of	O
binding	O
STAT5A	B-protein
.	O

Ectopically	O
expressed	O
BTK	B-protein
kinase	I-protein
domain	I-protein
was	O
capable	O
of	O
tyrosine-phosphorylating	O
STAT5A	B-protein
both	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O

BTK	B-protein
-mediated	O
tyrosine	O
phosphorylation	O
of	O
ectopically	O
expressed	O
wild	O
type	O
(	O
but	O
not	O
Tyr	B-protein
(	I-protein
694	I-protein
)	I-protein
mutant	I-protein
)	O
STAT5A	B-protein
enhanced	O
its	O
DNA	O
binding	O
activity	O
.	O

In	O
BTK	B-protein
-competent	O
chicken	O
B	B-cell_type
cells	I-cell_type
,	O
anti-IgM-stimulated	O
tyrosine	O
phosphorylation	O
of	O
STAT5	B-protein
protein	I-protein
was	O
prevented	O
by	O
pretreatment	O
with	O
the	O
BTK	B-protein
inhibitor	O
LFM-A13	O
but	O
not	O
by	O
pretreatment	O
with	O
the	O
JAK3	O
inhibitor	O
HI-P131	O
.	O

B	O
cell	O
antigen	O
receptor	O
ligation	O
resulted	O
in	O
enhanced	O
tyrosine	O
phosphorylation	O
of	O
STAT5	B-protein
in	O
BTK	B-protein
-deficient	O
chicken	O
B	B-cell_type
cells	I-cell_type
reconstituted	O
with	O
wild	B-protein
type	I-protein
human	I-protein
BTK	I-protein
but	O
not	O
in	O
BTK	B-protein
-deficient	O
chicken	O
B	B-cell_type
cells	I-cell_type
reconstituted	O
with	O
kinase-inactive	B-protein
mutant	I-protein
BTK	I-protein
.	O

Similarly	O
,	O
anti-IgM	O
stimulation	O
resulted	O
in	O
enhanced	O
tyrosine	O
phosphorylation	O
of	O
STAT5A	B-protein
in	O
BTK	B-protein
-competent	O
B	B-cell_type
cells	I-cell_type
from	O
wild	O
type	O
mice	O
but	O
not	O
in	O
BTK	B-protein
-deficient	O
B	B-cell_type
cells	I-cell_type
from	O
XID	O
mice	O
.	O

In	O
contrast	O
to	O
B	B-cell_type
cells	I-cell_type
from	O
XID	O
mice	O
,	O
B	B-cell_type
cells	I-cell_type
from	O
JAK3	O
knockout	O
mice	O
showed	O
a	O
normal	O
STAT5A	O
phosphorylation	O
response	O
to	O
anti-IgM	O
stimulation	O
.	O

These	O
findings	O
provide	O
unprecedented	O
experimental	O
evidence	O
that	O
BTK	B-protein
plays	O
a	O
nonredundant	O
and	O
pivotal	O
role	O
in	O
B	O
cell	O
antigen	O
receptor-mediated	O
STAT5A	O
activation	O
in	O
B	B-cell_type
cells	I-cell_type

THE	NULL
JOURNAL	NULL
oF	NULL
BIOLOGICAL	NULL
CHEMISTRY	NULL
©	NULL
2001	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

276	NULL
,	NULL
No	NULL
.	NULL

33	NULL
,	NULL
Issue	NULL
of	NULL
August	NULL
17	NULL
,	NULL
pp	NULL
.	NULL

31216-31228	NULL
,	NULL
2001	NULL
Printed	NULL
in	NULL
U.S.A	NULL
.	NULL

Transcription	NULL
Factor	NULL
STAT5A	NULL
Is	NULL
a	NULL
Substrate	NULL
of	NULL
Bruton	NULL
's	NULL
Tyrosine	NULL
Kinase	NULL
in	NULL
B	NULL
Cells*	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
May	NULL
29	NULL
,	NULL
2001	NULL
Published	NULL
,	NULL
JBC	NULL
Papers	NULL
in	NULL
Press	NULL
,	NULL
June	NULL
18	NULL
,	NULL
2001	NULL
,	NULL
DOI	NULL
10.1074/jbe	NULL
.	NULL

M104874200	NULL
Sandeep	NULL
Mahajant§	NULL
,	NULL
Alexei	NULL
Vassilev	NULL
$	NULL
§	NULL
,	NULL
Nancy	NULL
Sun§	NULL
,	NULL
Zahide	NULL
Ozer1|	NULL
,	NULL
Chen	NULL
Mao**	NULL
,	NULL
and	NULL
Fatih	NULL
M.	NULL
Uckun	NULL
#	NULL
|t	NULL
#	NULL
From	NULL
the	NULL
{	NULL
Molecular	NULL
Signal	NULL
Transduction	NULL
Laboratory	NULL
,	NULL
Parker	NULL
Hughes	NULL
Cancer	NULL
Center	NULL
and	NULL
the	NULL
Departments	NULL
of	NULL
§Biochemistry	NULL
,	NULL
Molecular	NULL
Biology	NULL
,	NULL
|Immunology	NULL
,	NULL
and	NULL
**Structural	NULL
Biology	NULL
,	NULL
Parker	NULL
Hughes	NULL
Institute	NULL
,	NULL
St.	NULL
Paul	NULL
,	NULL
Minnesota	NULL
55113	NULL
STAT5A	NULL
is	NULL
a	NULL
molecular	NULL
regulator	NULL
of	NULL
proliferation	NULL
,	NULL
differentiation	NULL
,	NULL
and	NULL
apoptosis	NULL
in	NULL
lymphohematopoietic	NULL
cells	NULL
.	NULL

Here	NULL
we	NULL
show	NULL
that	NULL
STAT5A	NULL
can	NULL
serve	NULL
as	NULL
a	NULL
functional	NULL
substrate	NULL
of	NULL
Bruton	NULL
's	NULL
tyrosine	NULL
kinase	NULL
(	NULL
BTK	NULL
)	NULL
.	NULL

Purified	NULL
recombinant	NULL
BTK	NULL
was	NULL
capable	NULL
of	NULL
directly	NULL
binding	NULL
purified	NULL
recombinant	NULL
STAT5A	NULL
with	NULL
high	NULL
affinity	NULL
(	NULL
K	NULL
,	NULL
=	NULL
44	NULL
nm	NULL
)	NULL
,	NULL
as	NULL
determined	NULL
by	NULL
surface	NULL
plasmon	NULL
resonance	NULL
using	NULL
a	NULL
BIA-core	NULL
biosensor	NULL
system	NULL
.	NULL

BTK	NULL
was	NULL
also	NULL
capable	NULL
of	NULL
tyrosine-phosphorylating	NULL
ectopically	NULL
expressed	NULL
recombinant	NULL
STAT5A	NULL
on	NULL
Tyr®®*	NULL
both	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
in	NULL
a	NULL
Janus	NULL
kinase	NULL
3-independent	NULL
fashion	NULL
.	NULL

BTK	NULL
phosphorylated	NULL
the	NULL
Y665F	NULL
,	NULL
Y668F	NULL
,	NULL
and	NULL
Y682F	NULL
,	NULL
Y683F	NULL
mutants	NULL
but	NULL
not	NULL
the	NULL
Y694F	NULL
mutant	NULL
of	NULL
STAT5A	NULL
.	NULL

STAT5A	NULL
mutations	NULL
in	NULL
the	NULL
Sre	NULL
homology	NULL
2	NULL
(	NULL
SH2	NULL
)	NULL
and	NULL
SH3	NULL
domains	NULL
did	NULL
not	NULL
alter	NULL
the	NULL
BTK-mediated	NULL
tyrosine	NULL
phosphorylation	NULL
.	NULL

Recombinant	NULL
BTK	NULL
proteins	NULL
with	NULL
mutant	NULL
pleckstrin	NULL
homology	NULL
,	NULL
SH2	NULL
,	NULL
or	NULL
SH3	NULL
domains	NULL
were	NULL
capable	NULL
of	NULL
phosphorylating	NULL
STAT5A	NULL
,	NULL
whereas	NULL
recombinant	NULL
BTK	NULL
proteins	NULL
with	NULL
SH1/kinase	NULL
domain	NULL
mutations	NULL
were	NULL
not	NULL
.	NULL

In	NULL
pull-down	NULL
experiments	NULL
,	NULL
only	NULL
full-length	NULL
BTK	NULL
and	NULL
its	NULL
SH/kinase	NULL
domain	NULL
(	NULL
but	NULL
not	NULL
the	NULL
pleckstrin	NULL
homology	NULL
,	NULL
SH2	NULL
,	NULL
or	NULL
SH3	NULL
domains	NULL
)	NULL
were	NULL
capable	NULL
of	NULL
binding	NULL
STAT5A	NULL
.	NULL

Ectopically	NULL
expressed	NULL
BTK	NULL
kinase	NULL
domain	NULL
was	NULL
capable	NULL
of	NULL
tyrosine-phosphorylating	NULL
STAT5A	NULL
both	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
.	NULL

BTK-mediated	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
ectopically	NULL
expressed	NULL
wild	NULL
type	NULL
(	NULL
but	NULL
not	NULL
Tyr®	NULL
``	NULL
*	NULL
mutant	NULL
)	NULL
STAT5A	NULL
enhanced	NULL
its	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

In	NULL
BTK-competent	NULL
chicken	NULL
B	NULL
cells	NULL
,	NULL
anti-IgM-stimulated	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT5	NULL
protein	NULL
was	NULL
prevented	NULL
by	NULL
pretreatment	NULL
with	NULL
the	NULL
BTK	NULL
inhibitor	NULL
LFM-A13	NULL
but	NULL
not	NULL
by	NULL
pretreatment	NULL
with	NULL
the	NULL
JAK3	NULL
inhibitor	NULL
HI-P131	NULL
.	NULL

B	NULL
cell	NULL
antigen	NULL
receptor	NULL
ligation	NULL
resulted	NULL
in	NULL
enhanced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT5	NULL
in	NULL
BTK-deficient	NULL
chicken	NULL
B	NULL
cells	NULL
reconstituted	NULL
with	NULL
wild	NULL
type	NULL
human	NULL
BTK	NULL
but	NULL
not	NULL
in	NULL
BTK-deficient	NULL
chicken	NULL
B	NULL
cells	NULL
reconstituted	NULL
with	NULL
kinase-inactive	NULL
mutant	NULL
BTK	NULL
.	NULL

Similarly	NULL
,	NULL
anti-IgM	NULL
stimulation	NULL
resulted	NULL
in	NULL
enhanced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT5A	NULL
in	NULL
BTK-competent	NULL
B	NULL
cells	NULL
from	NULL
wild	NULL
type	NULL
mice	NULL
but	NULL
not	NULL
in	NULL
BTK-deficient	NULL
B	NULL
cells	NULL
from	NULL
XID	NULL
mice	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
B	NULL
cells	NULL
from	NULL
XID	NULL
mice	NULL
,	NULL
B	NULL
cells	NULL
from	NULL
JAK3	NULL
knockout	NULL
mice	NULL
showed	NULL
a	NULL
normal	NULL
STAT5A	NULL
phosphorylation	NULL
response	NULL
to	NULL
anti-IgM	NULL
stimulation	NULL
.	NULL

These	NULL
findings	NULL
provide	NULL
unprecedented	NULL
experimental	NULL
evidence	NULL
that	NULL
BTK	NULL
plays	NULL
a	NULL
nonredundant	NULL
and	NULL
pivotal	NULL
role	NULL
in	NULL
B	NULL
cell	NULL
antigen	NULL
receptor-mediated	NULL
STAT5A	NULL
activation	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

*	NULL
The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

+	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
:	NULL
Parker	NULL
Hughes	NULL
Institute	NULL
,	NULL
2665	NULL
Long	NULL
Lake	NULL
Rd	NULL
.	NULL

,	NULL
Suite	NULL
$	NULL
30	NULL
,	NULL
St.	NULL
Paul	NULL
,	NULL
MN	NULL
55113	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
651-697-9228	NULL
(	NULL
ext	NULL
.	NULL

638	NULL
)	NULL
;	NULL
Fax	NULL
:	NULL
651-697-1042	NULL
;	NULL
E-mail	NULL
:	NULL
fatih_uckun	NULL
@	NULL
ih.org	NULL
.	NULL

31216	NULL
Bruton	NULL
's	NULL
tyrosine	NULL
kinase	NULL
(	NULL
BTK	NULL
)	NULL
,	NULL
a	NULL
member	NULL
of	NULL
the	NULL
TEC	NULL
family	NULL
of	NULL
cytoplasmic	NULL
protein-tyrosine	NULL
kinases	NULL
(	NULL
PTKs	NULL
)	NULL
,	NULL
is	NULL
intimately	NULL
involved	NULL
in	NULL
signal	NULL
transduction	NULL
pathways	NULL
regulating	NULL
survival	NULL
,	NULL
activation	NULL
,	NULL
proliferation	NULL
,	NULL
and	NULL
differentiation	NULL
of	NULL
B-lineage	NULL
lymphoid	NULL
cells	NULL
(	NULL
1-5	NULL
)	NULL
.	NULL

BTK	NULL
participates	NULL
in	NULL
signal	NULL
transduction	NULL
pathways	NULL
initiated	NULL
by	NULL
the	NULL
binding	NULL
of	NULL
a	NULL
variety	NULL
of	NULL
extracellular	NULL
ligands	NULL
to	NULL
their	NULL
cell	NULL
surface	NULL
receptors	NULL
(	NULL
2	NULL
)	NULL
.	NULL

Following	NULL
ligation	NULL
of	NULL
B	NULL
cell	NULL
antigen	NULL
receptors	NULL
,	NULL
BTK	NULL
activation	NULL
by	NULL
the	NULL
concerted	NULL
actions	NULL
of	NULL
the	NULL
PTKs	NULL
LYN	NULL
and	NULL
SYK	NULL
is	NULL
required	NULL
for	NULL
induction	NULL
of	NULL
phospholipase	NULL
C-y2-mediated	NULL
calcium	NULL
mobilization	NULL
(	NULL
2	NULL
)	NULL
.	NULL

Mutations	NULL
in	NULL
the	NULL
human	NULL
bitk	NULL
gene	NULL
are	NULL
the	NULL
cause	NULL
of	NULL
X-linked	NULL
agammaglobulinemia	NULL
,	NULL
a	NULL
male	NULL
immune	NULL
deficiency	NULL
disorder	NULL
characterized	NULL
by	NULL
a	NULL
lack	NULL
of	NULL
mature	NULL
,	NULL
immunoglobulin-producing	NULL
,	NULL
peripheral	NULL
B	NULL
cells	NULL
(	NULL
6	NULL
,	NULL
7	NULL
)	NULL
.	NULL

In	NULL
mice	NULL
,	NULL
mutations	NULL
in	NULL
the	NULL
btk	NULL
gene	NULL
have	NULL
been	NULL
identified	NULL
as	NULL
the	NULL
cause	NULL
of	NULL
murine	NULL
X-linked	NULL
immune	NULL
deficiency	NULL
(	NULL
8	NULL
)	NULL
.	NULL

BTK	NULL
has	NULL
an	NULL
N-terminal	NULL
region	NULL
consisting	NULL
of	NULL
a	NULL
pleckstrin	NULL
homology	NULL
(	NULL
PH	NULL
)	NULL
domain	NULL
followed	NULL
by	NULL
a	NULL
proline-rich	NULL
TEC	NULL
homology	NULL
domain	NULL
.	NULL

The	NULL
PH	NULL
domain	NULL
is	NULL
the	NULL
site	NULL
of	NULL
activation	NULL
by	NULL
phos-phatidylinositol	NULL
phosphates	NULL
and	NULL
G-protein	NULL
By	NULL
subunits	NULL
and	NULL
inhibition	NULL
by	NULL
protein	NULL
kinase	NULL
C	NULL
(	NULL
9	NULL
)	NULL
.	NULL

The	NULL
remaining	NULL
portion	NULL
of	NULL
BTK	NULL
contains	NULL
Sre	NULL
homology	NULL
(	NULL
SH	NULL
)	NULL
domain	NULL
SH3	NULL
,	NULL
followed	NULL
by	NULL
SH2	NULL
and	NULL
a	NULL
C-terminal	NULL
SH1/kinase	NULL
domain	NULL
(	NULL
KD	NULL
)	NULL
.	NULL

The	NULL
SH2	NULL
domain	NULL
mediates	NULL
binding	NULL
to	NULL
tyrosine-phosphorylated	NULL
peptide	NULL
motifs	NULL
on	NULL
other	NULL
molecules	NULL
,	NULL
and	NULL
the	NULL
SH3	NULL
domain	NULL
mediates	NULL
binding	NULL
to	NULL
proline-rich	NULL
motifs	NULL
.	NULL

Mutations	NULL
in	NULL
the	NULL
SH1	NULL
domain	NULL
,	NULL
SH2	NULL
domain	NULL
,	NULL
and	NULL
PH	NULL
domain	NULL
of	NULL
human	NULL
BTK	NULL
have	NULL
been	NULL
found	NULL
to	NULL
cause	NULL
maturational	NULL
blocks	NULL
at	NULL
early	NULL
stages	NULL
of	NULL
B	NULL
cell	NULL
ontogeny	NULL
leading	NULL
to	NULL
XLA	NULL
(	NULL
10	NULL
)	NULL
.	NULL

BTK-deficient	NULL
mice	NULL
generated	NULL
by	NULL
introducing	NULL
PH	NULL
domain	NULL
or	NULL
SH1	NULL
domain	NULL
mutations	NULL
in	NULL
embryonic	NULL
stem	NULL
cells	NULL
exhibit	NULL
defective	NULL
B	NULL
cell	NULL
development	NULL
and	NULL
function	NULL
(	NULL
11	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
different	NULL
domains	NULL
of	NULL
BTK	NULL
are	NULL
important	NULL
for	NULL
its	NULL
physiologic	NULL
functions	NULL
.	NULL

Proximal	NULL
events	NULL
involving	NULL
Sre	NULL
family	NULL
PTK	NULL
and	NULL
SYK	NULL
that	NULL
lead	NULL
to	NULL
BTK	NULL
activation	NULL
following	NULL
stimulation	NULL
of	NULL
the	NULL
B	NULL
cell	NULL
antigen	NULL
receptor	NULL
are	NULL
well	NULL
known	NULL
,	NULL
but	NULL
only	NULL
very	NULL
few	NULL
signaling	NULL
molecules	NULL
have	NULL
been	NULL
identified	NULL
as	NULL
downstream	NULL
substrates	NULL
of	NULL
BTK	NULL
(	NULL
2	NULL
,	NULL
12	NULL
)	NULL
.	NULL

Recent	NULL
observations	NULL
suggest	NULL
the	NULL
involvement	NULL
of	NULL
BTK	NULL
in	NULL
signal	NULL
transduction	NULL
pathways	NULL
affecting	NULL
gene	NULL
transcription	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Recent	NULL
studies	NULL
have	NULL
further	NULL
revealed	NULL
a	NULL
nucleocytoplasmic	NULL
shuttling	NULL
system	NULL
for	NULL
BTK	NULL
that	NULL
has	NULL
implications	NULL
regarding	NULL
potential	NULL
*The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
BTK	NULL
,	NULL
Bruton	NULL
's	NULL
tyrosine	NULL
kinase	NULL
;	NULL
PTK	NULL
,	NULL
protein-tyrosine	NULL
kinase	NULL
;	NULL
PH	NULL
,	NULL
pleckstrin	NULL
homology	NULL
;	NULL
SH	NULL
,	NULL
Sre	NULL
homology	NULL
;	NULL
KD	NULL
,	NULL
kinase	NULL
domain	NULL
;	NULL
STAT	NULL
,	NULL
signal	NULL
transducers	NULL
and	NULL
activators	NULL
of	NULL
tran-scription	NULL
;	NULL
PCR	NULL
,	NULL
polymerase	NULL
chain	NULL
reaction	NULL
;	NULL
CNBr	NULL
,	NULL
cyanogen	NULL
bromide	NULL
;	NULL
PFB	NULL
,	NULL
pFastBacl	NULL
;	NULL
PIPES	NULL
,	NULL
1,4-piperazinediethanesulfonic	NULL
acid	NULL
;	NULL
JAK	NULL
,	NULL
Janus	NULL
kinase	NULL
;	NULL
MBP	NULL
,	NULL
maltose-binding	NULL
protein	NULL
;	NULL
GST	NULL
,	NULL
glutathione	NULL
S-trans-ferase	NULL
;	NULL
PAGE	NULL
,	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
;	NULL
DTT	NULL
,	NULL
dithiothreitol	NULL
;	NULL
RU	NULL
,	NULL
response	NULL
unit	NULL
(	NULL
s	NULL
)	NULL
;	NULL
Inr	NULL
,	NULL
initiator	NULL
;	NULL
MOPS	NULL
,	NULL
4-morpholinepropanesulfon-ic	NULL
acid	NULL
.	NULL

This	NULL
paper	NULL
is	NULL
available	NULL
on	NULL
line	NULL
at	NULL
http	NULL
:	NULL
//www.jbc.org	NULL
6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san	NULL
$	NULL
4g	NULL
/310-2q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wou	NULL
;	NULL
papeojumo	NULL
(	NULL
STAT5A	NULL
as	NULL
a	NULL
Substrate	NULL
of	NULL
BTK	NULL
targets	NULL
inside	NULL
the	NULL
nucleus	NULL
,	NULL
which	NULL
may	NULL
be	NULL
critical	NULL
in	NULL
gene	NULL
regulation	NULL
during	NULL
B	NULL
cell	NULL
development	NULL
and	NULL
differentiation	NULL
(	NULL
14	NULL
)	NULL
.	NULL

An	NULL
unresolved	NULL
question	NULL
in	NULL
B	NULL
cell	NULL
immunology	NULL
is	NULL
the	NULL
nature	NULL
of	NULL
the	NULL
molecular	NULL
coupling	NULL
mechanisms	NULL
that	NULL
link	NULL
the	NULL
proximal	NULL
signals	NULL
that	NULL
are	NULL
triggered	NULL
by	NULL
the	NULL
engagement	NULL
of	NULL
the	NULL
B	NULL
cell	NULL
antigen	NULL
receptor	NULL
to	NULL
downstream	NULL
signal	NULL
transduction	NULL
pathways	NULL
affecting	NULL
gene	NULL
transcription	NULL
.	NULL

BCR	NULL
stimulation	NULL
leads	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
transcription	NULL
factor	NULL
NF-KB	NULL
in	NULL
a	NULL
BTK-dependent	NULL
fashion	NULL
,	NULL
which	NULL
in	NULL
turn	NULL
regulates	NULL
genes	NULL
controlling	NULL
B	NULL
cell	NULL
growth	NULL
(	NULL
15	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
the	NULL
BTK	NULL
substrate	NULL
phospholipase	NULL
C-y2	NULL
was	NULL
shown	NULL
to	NULL
couple	NULL
BTK	NULL
to	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
signaling	NULL
pathway	NULL
(	NULL
16	NULL
)	NULL
.	NULL

BTK	NULL
has	NULL
also	NULL
been	NULL
shown	NULL
to	NULL
regulate	NULL
the	NULL
nuclear	NULL
localization	NULL
and	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
multifunctional	NULL
transcription	NULL
factor	NULL
BAP-135/	NULL
TFII-I	NULL
(	NULL
17	NULL
)	NULL
.	NULL

These	NULL
results	NULL
illustrate	NULL
that	NULL
the	NULL
identification	NULL
of	NULL
substrates	NULL
for	NULL
BTK	NULL
in	NULL
B	NULL
cells	NULL
is	NULL
a	NULL
critical	NULL
step	NULL
to	NULL
a	NULL
better	NULL
understanding	NULL
of	NULL
the	NULL
molecular	NULL
mechanism	NULL
(	NULL
s	NULL
)	NULL
of	NULL
lymphocyte	NULL
activation	NULL
through	NULL
the	NULL
antigen	NULL
receptor	NULL
.	NULL

Signal	NULL
transducers	NULL
and	NULL
activators	NULL
of	NULL
transcription	NULL
(	NULL
STAT	NULL
)	NULL
proteins	NULL
are	NULL
a	NULL
family	NULL
of	NULL
DNA-binding	NULL
proteins	NULL
that	NULL
were	NULL
initially	NULL
identified	NULL
during	NULL
a	NULL
search	NULL
for	NULL
interferon-a-	NULL
or	NULL
inter-feron-y-stimulated	NULL
gene	NULL
transcription	NULL
targets	NULL
(	NULL
18-20	NULL
)	NULL
.	NULL

Different	NULL
ligands	NULL
and	NULL
cell	NULL
activators	NULL
employ	NULL
specific	NULL
STAT	NULL
family	NULL
members	NULL
(	NULL
21-23	NULL
)	NULL
.	NULL

The	NULL
basic	NULL
model	NULL
for	NULL
STAT	NULL
activation	NULL
suggests	NULL
that	NULL
in	NULL
unstimulated	NULL
cells	NULL
,	NULL
latent	NULL
forms	NULL
of	NULL
STAT	NULL
's	NULL
are	NULL
predominantly	NULL
localized	NULL
within	NULL
the	NULL
cytoplasm	NULL
.	NULL

Ligand	NULL
binding	NULL
induces	NULL
STAT	NULL
proteins	NULL
to	NULL
associate	NULL
with	NULL
intracellular	NULL
phosphotyrosine	NULL
residues	NULL
of	NULL
transmembrane	NULL
receptors	NULL
(	NULL
24	NULL
,	NULL
25	NULL
)	NULL
.	NULL

Once	NULL
STATs	NULL
are	NULL
bound	NULL
to	NULL
receptors	NULL
,	NULL
they	NULL
are	NULL
phosphorylated	NULL
by	NULL
Janus	NULL
family	NULL
or	NULL
Sre	NULL
family	NULL
PTK	NULL
(	NULL
26	NULL
)	NULL
.	NULL

STAT	NULL
proteins	NULL
then	NULL
dimerize	NULL
through	NULL
specific	NULL
reciprocal	NULL
SH2-phosphotyrosine	NULL
interactions	NULL
(	NULL
27	NULL
)	NULL
and	NULL
may	NULL
form	NULL
complexes	NULL
with	NULL
other	NULL
DNA-binding	NULL
proteins	NULL
(	NULL
28	NULL
)	NULL
.	NULL

STAT	NULL
complexes	NULL
translocate	NULL
to	NULL
the	NULL
nucleus	NULL
and	NULL
interact	NULL
with	NULL
DNA	NULL
response	NULL
elements	NULL
to	NULL
enhance	NULL
transcription	NULL
of	NULL
target	NULL
genes	NULL
(	NULL
29	NULL
)	NULL
.	NULL

STATS5	NULL
is	NULL
a	NULL
molecular	NULL
regulator	NULL
of	NULL
proliferation	NULL
,	NULL
differentiation	NULL
,	NULL
and	NULL
apoptosis	NULL
in	NULL
hematopoietic	NULL
cells	NULL
(	NULL
30	NULL
)	NULL
.	NULL

B	NULL
cells	NULL
abundantly	NULL
express	NULL
STAT5	NULL
,	NULL
and	NULL
engagement	NULL
of	NULL
the	NULL
B	NULL
cell	NULL
antigen-receptor	NULL
results	NULL
in	NULL
activation	NULL
of	NULL
STATS	NULL
(	NULL
31	NULL
)	NULL
.	NULL

B	NULL
cells	NULL
from	NULL
mice	NULL
bearing	NULL
subcutaneous	NULL
mammary	NULL
adeno-carcinoma	NULL
tumors	NULL
are	NULL
severely	NULL
impaired	NULL
in	NULL
their	NULL
ability	NULL
to	NULL
generate	NULL
antigen-specific	NULL
responses	NULL
(	NULL
32	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
purified	NULL
B	NULL
cells	NULL
isolated	NULL
from	NULL
these	NULL
immunocompromised	NULL
tumor-bearing	NULL
mice	NULL
exhibited	NULL
a	NULL
marked	NULL
decrease	NULL
in	NULL
the	NULL
expression	NULL
level	NULL
of	NULL
STAT5	NULL
without	NULL
a	NULL
concomitant	NULL
change	NULL
in	NULL
the	NULL
expression	NULL
levels	NULL
of	NULL
STAT1	NULL
,	NULL
-3	NULL
,	NULL
and	NULL
-6	NULL
(	NULL
32	NULL
)	NULL
.	NULL

The	NULL
observed	NULL
correlation	NULL
of	NULL
the	NULL
loss	NULL
of	NULL
B	NULL
cell	NULL
function	NULL
with	NULL
the	NULL
selective	NULL
decrease	NULL
in	NULL
STAT5	NULL
expression	NULL
suggested	NULL
that	NULL
regulation	NULL
of	NULL
the	NULL
STATS5	NULL
signaling	NULL
pathway	NULL
may	NULL
provide	NULL
a	NULL
molecular	NULL
mechanism	NULL
for	NULL
modulating	NULL
the	NULL
antigen-specific	NULL
B	NULL
cell	NULL
responses	NULL
.	NULL

STAT5A-deficient	NULL
mice	NULL
showed	NULL
decreased	NULL
proliferation	NULL
of	NULL
splenocytes	NULL
to	NULL
interleukin	NULL
(	NULL
IL	NULL
)	NULL
-2	NULL
stimulation	NULL
,	NULL
which	NULL
was	NULL
reported	NULL
to	NULL
result	NULL
from	NULL
defective	NULL
induction	NULL
of	NULL
IL-2	NULL
receptor	NULL
chain	NULL
(	NULL
33	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
STAT5A	NULL
and	NULL
STAT5B	NULL
doubly	NULL
disrupted	NULL
mice	NULL
have	NULL
been	NULL
generated	NULL
(	NULL
34	NULL
)	NULL
,	NULL
and	NULL
Sexl	NULL
et	NULL
al	NULL
.	NULL

reported	NULL
that	NULL
STAT5A/B	NULL
contribute	NULL
to	NULL
interleukin-7-induced	NULL
B	NULL
cell	NULL
precursor	NULL
expansion	NULL
(	NULL
35	NULL
)	NULL
.	NULL

The	NULL
expansion	NULL
of	NULL
B	NULL
cell	NULL
precursors	NULL
is	NULL
disrupted	NULL
at	NULL
the	NULL
level	NULL
of	NULL
late	NULL
pro-B	NULL
and	NULL
pre-B	NULL
cells	NULL
in	NULL
STAT5A/B-deficient	NULL
mice	NULL
(	NULL
35	NULL
)	NULL
.	NULL

These	NULL
mice	NULL
also	NULL
have	NULL
reduced	NULL
numbers	NULL
of	NULL
circulating	NULL
B	NULL
cells	NULL
in	NULL
their	NULL
blood	NULL
(	NULL
85	NULL
)	NULL
.	NULL

Notably	NULL
,	NULL
Bmx/Etk	NULL
,	NULL
another	NULL
member	NULL
of	NULL
the	NULL
TEC	NULL
PTK	NULL
family	NULL
,	NULL
was	NULL
shown	NULL
to	NULL
induce	NULL
activation	NULL
of	NULL
the	NULL
STAT	NULL
signaling	NULL
pathway	NULL
in	NULL
transfected	NULL
COS	NULL
cells	NULL
and	NULL
insect	NULL
ovary	NULL
cells	NULL
(	NULL
36	NULL
)	NULL
.	NULL

More	NULL
recently	NULL
,	NULL
Bmx/Etk	NULL
was	NULL
identified	NULL
as	NULL
a	NULL
critical	NULL
mediator	NULL
of	NULL
Src-induced	NULL
cell	NULL
transformation	NULL
and	NULL
STAT3	NULL
activation	NULL
(	NULL
37	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
Bmx/Etk	NULL
in	NULL
a	NULL
human	NULL
hepatoma	NULL
cell	NULL
line	NULL
Hep3B	NULL
resulted	NULL
in	NULL
a	NULL
significant	NULL
increase	NULL
in	NULL
its	NULL
transforming	NULL
ability	NULL
,	NULL
and	NULL
this	NULL
effect	NULL
was	NULL
abrogated	NULL
by	NULL
dominant	NULL
negative	NULL
inhibition	NULL
of	NULL
STAT3	NULL
(	NULL
37	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
Bmx/Etk	NULL
links	NULL
Sre	NULL
to	NULL
STAT3	NULL
31217	NULL
activation	NULL
and	NULL
that	NULL
Src-Etk-STAT3	NULL
is	NULL
an	NULL
important	NULL
pathway	NULL
in	NULL
cellular	NULL
transformation	NULL
.	NULL

While	NULL
these	NULL
results	NULL
set	NULL
a	NULL
precedent	NULL
for	NULL
activation	NULL
of	NULL
STAT	NULL
proteins	NULL
by	NULL
a	NULL
member	NULL
of	NULL
the	NULL
TEC	NULL
family	NULL
PTK	NULL
,	NULL
the	NULL
significance	NULL
of	NULL
these	NULL
findings	NULL
for	NULL
the	NULL
B	NULL
cell	NULL
physiology	NULL
has	NULL
not	NULL
been	NULL
investigated	NULL
.	NULL

The	NULL
purpose	NULL
of	NULL
the	NULL
present	NULL
study	NULL
was	NULL
to	NULL
examine	NULL
the	NULL
role	NULL
of	NULL
BTK	NULL
in	NULL
STATS	NULL
activation	NULL
in	NULL
B	NULL
cells	NULL
that	NULL
follows	NULL
B	NULL
cell	NULL
antigen	NULL
receptor	NULL
ligation	NULL
.	NULL

Our	NULL
experimental	NULL
data	NULL
presented	NULL
herein	NULL
provide	NULL
unprecedented	NULL
evidence	NULL
that	NULL
STAT5A	NULL
is	NULL
a	NULL
substrate	NULL
of	NULL
BTK	NULL
and	NULL
that	NULL
engagement	NULL
of	NULL
the	NULL
B	NULL
cell	NULL
antigen	NULL
receptor	NULL
activates	NULL
STAT5A	NULL
in	NULL
a	NULL
BTK-dependent	NULL
(	NULL
but	NULL
not	NULL
JAK3-dependent	NULL
)	NULL
fashion	NULL
.	NULL

Thus	NULL
,	NULL
our	NULL
study	NULL
provides	NULL
experimental	NULL
evidence	NULL
that	NULL
BTK	NULL
couples	NULL
the	NULL
STAT	NULL
signaling	NULL
pathway	NULL
to	NULL
the	NULL
B	NULL
cell	NULL
antigen	NULL
receptor	NULL
.	NULL

Our	NULL
findings	NULL
prompt	NULL
the	NULL
hypothesis	NULL
that	NULL
STAT5A	NULL
links	NULL
BTK-mediated	NULL
signaling	NULL
events	NULL
that	NULL
follow	NULL
the	NULL
engagement	NULL
of	NULL
the	NULL
B	NULL
cell	NULL
antigen	NULL
receptor	NULL
to	NULL
downstream	NULL
gene	NULL
activation	NULL
.	NULL

A	NULL
compromised	NULL
coupling	NULL
between	NULL
BTK	NULL
and	NULL
STAT5A	NULL
might	NULL
lead	NULL
to	NULL
aberrant	NULL
expression	NULL
of	NULL
the	NULL
STAT5A-responsive	NULL
genes	NULL
and	NULL
might	NULL
contribute	NULL
to	NULL
the	NULL
XLA	NULL
and	NULL
XID	NULL
phenotypes	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Mice	NULL
,	NULL
Cell	NULL
Lines	NULL
,	NULL
Reagents	NULL
,	NULL
and	NULL
Biochemical	NULL
Assays-Control	NULL
,	NULL
XID	NULL
,	NULL
and	NULL
JAK3	NULL
knockout	NULL
mice	NULL
were	NULL
purchased	NULL
from	NULL
Jackson	NULL
Laboratories	NULL
.	NULL

Mouse	NULL
splenocytes	NULL
were	NULL
isolated	NULL
,	NULL
starved	NULL
in	NULL
RPMI	NULL
at	NULL
a	NULL
density	NULL
of	NULL
10	NULL
x	NULL
10°	NULL
cells/ml	NULL
for	NULL
2	NULL
h	NULL
,	NULL
and	NULL
then	NULL
stimulated	NULL
either	NULL
with	NULL
murine	NULL
anti-u	NULL
antibodies	NULL
(	NULL
10	NULL
ug/ml	NULL
;	NULL
Sigma	NULL
)	NULL
or	NULL
recombinant	NULL
IL-2	NULL
(	NULL
20	NULL
ng/ml	NULL
;	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
)	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
.	NULL

KL-2	NULL
is	NULL
an	NULL
Epstein-Barr	NULL
virus-transformed	NULL
human	NULL
lymphoblastoid	NULL
cell	NULL
line	NULL
(	NULL
4	NULL
)	NULL
.	NULL

The	NULL
Sf21	NULL
(	NULL
IPLB-Sf21-AE	NULL
)	NULL
insect	NULL
cell	NULL
line	NULL
(	NULL
Invitrogen	NULL
)	NULL
derived	NULL
from	NULL
Spodoptera	NULL
frugiperda	NULL
ovarian	NULL
cells	NULL
was	NULL
used	NULL
to	NULL
isolate	NULL
and	NULL
propagate	NULL
recombinant	NULL
viral	NULL
stocks	NULL
and	NULL
produce	NULL
recombinant	NULL
proteins	NULL
of	NULL
interest	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
maintained	NULL
at	NULL
26-28	NULL
°C	NULL
in	NULL
Grace	NULL
's	NULL
insect	NULL
cell	NULL
medium	NULL
containing	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
and	NULL
1	NULL
%	NULL
antibiotic/antimy-cotic	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
)	NULL
.	NULL

Stock	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
suspension	NULL
at	NULL
0.2-1.6	NULL
X	NULL
10°/ml	NULL
in	NULL
600	NULL
ml	NULL
of	NULL
total	NULL
culture	NULL
volume	NULL
in	NULL
l-liter	NULL
Bellco	NULL
spinner	NULL
flasks	NULL
at	NULL
60-90	NULL
rpm	NULL
.	NULL

Cell	NULL
viability	NULL
was	NULL
maintained	NULL
at	NULL
>	NULL
95	NULL
%	NULL
as	NULL
determined	NULL
by	NULL
trypan	NULL
blue	NULL
dye	NULL
exclusion	NULL
.	NULL

The	NULL
establishment	NULL
of	NULL
BTK-deficient	NULL
DT-40	NULL
lymphoma	NULL
B	NULL
cell	NULL
clones	NULL
has	NULL
been	NULL
previously	NULL
described	NULL
(	NULL
88	NULL
)	NULL
.	NULL

Lack	NULL
of	NULL
BTK	NULL
expression	NULL
in	NULL
BTK-deficient	NULL
DT-40	NULL
cells	NULL
was	NULL
confirmed	NULL
by	NULL
both	NULL
immune	NULL
complex	NULL
kinase	NULL
assays	NULL
and	NULL
Western	NULL
blot	NULL
analysis	NULL
(	NULL
88	NULL
)	NULL
.	NULL

Mutations	NULL
in	NULL
the	NULL
human	NULL
btk	NULL
cDNA	NULL
were	NULL
introduced	NULL
by	NULL
PCR	NULL
using	NULL
Pfu	NULL
polymerase	NULL
(	NULL
Stratagene	NULL
)	NULL
and	NULL
confirmed	NULL
by	NULL
sequencing	NULL
.	NULL

Wild	NULL
type	NULL
and	NULL
catalytic	NULL
domain	NULL
mutant	NULL
bik	NULL
cDNAs	NULL
were	NULL
subcloned	NULL
into	NULL
pApuro	NULL
expression	NULL
vector	NULL
and	NULL
electroporated	NULL
into	NULL
BTK-deficient	NULL
cells	NULL
.	NULL

The	NULL
PTK	NULL
activity	NULL
of	NULL
BTK	NULL
immune	NULL
complexes	NULL
,	NULL
as	NULL
measured	NULL
by	NULL
in	NULL
vitro	NULL
autophosphorylation	NULL
,	NULL
was	NULL
abrogated	NULL
by	NULL
the	NULL
catalytic	NULL
domain	NULL
mutation	NULL
.	NULL

Equal	NULL
amounts	NULL
of	NULL
BTK	NULL
proteins	NULL
were	NULL
detected	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
in	NULL
all	NULL
of	NULL
the	NULL
BTK-deficient	NULL
DT-40	NULL
clones	NULL
transfected	NULL
with	NULL
wild	NULL
type	NULL
or	NULL
mutated	NULL
human	NULL
btk	NULL
genes	NULL
,	NULL
but	NULL
no	NULL
BTK	NULL
protein	NULL
was	NULL
detectable	NULL
in	NULL
the	NULL
untransfected	NULL
BTK-deficient	NULL
DT-40	NULL
cells	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
starved	NULL
in	NULL
serum-free	NULL
medium	NULL
at	NULL
a	NULL
density	NULL
of	NULL
10	NULL
X	NULL
10°	NULL
cells/ml	NULL
for	NULL
2	NULL
h	NULL
and	NULL
then	NULL
stimulated	NULL
with	NULL
an	NULL
anti-chicken	NULL
IgM	NULL
antibody	NULL
(	NULL
M4	NULL
antibody	NULL
,	NULL
Southern	NULL
Biotechnology	NULL
,	NULL
Inc.	NULL
;	NULL
10	NULL
ug/ml	NULL
)	NULL
.	NULL

STAT5A	NULL
and	NULL
TEC	NULL
antibodies	NULL
were	NULL
obtained	NULL
from	NULL
Transduction	NULL
Laboratories	NULL
,	NULL
Inc.	NULL
;	NULL
JAK3	NULL
antibodies	NULL
were	NULL
from	NULL
Upstate	NULL
Biotechnology	NULL
,	NULL
Inc.	NULL
;	NULL
and	NULL
anti-BTK	NULL
antibodies	NULL
were	NULL
produced	NULL
as	NULL
described	NULL
(	NULL
89	NULL
)	NULL
.	NULL

The	NULL
structure-based	NULL
design	NULL
,	NULL
synthesis	NULL
,	NULL
and	NULL
characterization	NULL
of	NULL
the	NULL
JAK3	NULL
inhibitory	NULL
dimethoxyquinazoline	NULL
compound	NULL
HI-P131	NULL
(	NULL
40	NULL
)	NULL
(	NULL
Calbiochem	NULL
catalog	NULL
no	NULL
.	NULL

420101	NULL
)	NULL
and	NULL
BTK	NULL
inhibitory	NULL
leflunomide	NULL
metabolite	NULL
analogue	NULL
LFM-A13	NULL
(	NULL
5	NULL
)	NULL
(	NULL
Calbiochem	NULL
catalog	NULL
no	NULL
.	NULL

435300	NULL
)	NULL
were	NULL
previously	NULL
described	NULL
in	NULL
detail	NULL
(	NULL
5	NULL
,	NULL
40	NULL
)	NULL
.	NULL

Immunoprecipitations	NULL
,	NULL
immune	NULL
complex	NULL
protein	NULL
kinase	NULL
assays	NULL
,	NULL
and	NULL
immunoblotting	NULL
using	NULL
the	NULL
ECL	NULL
detection	NULL
system	NULL
(	NULL
Amersham	NULL
Pharmacia	NULL
Biotech	NULL
)	NULL
were	NULL
conducted	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
3-5	NULL
,	NULL
38-40	NULL
)	NULL
.	NULL

Phosphoamino	NULL
acid	NULL
analysis	NULL
(	NULL
41	NULL
)	NULL
,	NULL
phosphotryptic	NULL
peptide	NULL
mapping	NULL
(	NULL
41	NULL
)	NULL
,	NULL
and	NULL
cyanogen	NULL
bromide	NULL
(	NULL
CNBr	NULL
)	NULL
peptide	NULL
analysis	NULL
(	NULL
42	NULL
)	NULL
have	NULL
been	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
.	NULL

For	NULL
two-dimensional	NULL
phosphotryptic	NULL
peptide	NULL
map-ping	NULL
,	NULL
°°P-labeled	NULL
protein	NULL
bands	NULL
were	NULL
excised	NULL
and	NULL
subjected	NULL
to	NULL
enzymatic	NULL
digestion	NULL
with	NULL
100	NULL
ug/ml	NULL
trypsin	NULL
(	NULL
Sigma	NULL
)	NULL
overnight	NULL
in	NULL
50	NULL
mM	NULL
ammo-nium	NULL
bicarbonate	NULL
.	NULL

Supernatants	NULL
were	NULL
dried	NULL
by	NULL
centrifugal	NULL
evaporation	NULL
,	NULL
and	NULL
dried	NULL
samples	NULL
were	NULL
resuspended	NULL
in	NULL
4	NULL
pl	NULL
of	NULL
a	NULL
buffer	NULL
containing	NULL
7.8	NULL
%	NULL
glacial	NULL
acetic	NULL
acid	NULL
and	NULL
2.5	NULL
%	NULL
formic	NULL
acid	NULL
.	NULL

Labeled	NULL
peptides	NULL
were	NULL
separated	NULL
on	NULL
thin	NULL
layer	NULL
phosphocellulose	NULL
plates	NULL
(	NULL
Eastman	NULL
Kodak	NULL
Co.	NULL
)	NULL
by	NULL
electrophoresis	NULL
at	NULL
pH	NULL
1.9	NULL
for	NULL
30	NULL
min	NULL
at	NULL
1000	NULL
V	NULL
,	NULL
followed	NULL
by	NULL
ascending	NULL
chromatography	NULL
in	NULL
a	NULL
buffer	NULL
containing	NULL
37.5	NULL
%	NULL
n-butanol	NULL
,	NULL
7.5	NULL
%	NULL
glacial	NULL
acetic	NULL
acid	NULL
,	NULL
and	NULL
25	NULL
%	NULL
pyridine	NULL
.	NULL

Subsequently	NULL
,	NULL
air-dried	NULL
plates	NULL
were	NULL
ex	NULL
6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san	NULL
$	NULL
4g	NULL
/310-2q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wou	NULL
;	NULL
papeojumo	NULL
(	NULL
31218	NULL
posed	NULL
to	NULL
Kodak	NULL
XAR-5	NULL
film	NULL
.	NULL

For	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
,	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
according	NULL
to	NULL
the	NULL
previously	NULL
published	NULL
method	NULL
(	NULL
43	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
cells	NULL
were	NULL
lysed	NULL
in	NULL
WCE	NULL
lysis	NULL
buffer	NULL
(	NULL
50	NULL
mM	NULL
Tris	NULL
,	NULL
pH	NULL
8.0	NULL
,	NULL
150	NULL
mM	NULL
NaCl	NULL
,	NULL
1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
0.5	NULL
mM	NULL
Na	NULL
,	NULL
VO	NULL
,	NULL
,	NULL
and	NULL
protease	NULL
inhibitors	NULL
)	NULL
.	NULL

An	NULL
annealed	NULL
oligonucleotide	NULL
corresponding	NULL
to	NULL
the	NULL
GAS-like	NULL
STATS5	NULL
binding	NULL
site	NULL
in	NULL
the	NULL
B-casein	NULL
gene	NULL
promoter	NULL
(	NULL
5'-AGATTTCTA	NULL
GGAATTCAAATC-3	NULL
'	NULL
)	NULL
purchased	NULL
from	NULL
New	NULL
England	NULL
Biolabs	NULL
was	NULL
end-labeled	NULL
with	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
using	NULL
(	NULL
Amersham	NULL
Pharmacia	NULL
Biotech	NULL
)	NULL
.	NULL

A	NULL
total	NULL
of	NULL
10	NULL
ug	NULL
of	NULL
cell	NULL
extract	NULL
and	NULL
0.5	NULL
ng	NULL
of	NULL
labeled	NULL
oligonucleotide	NULL
were	NULL
used	NULL
per	NULL
reaction	NULL
.	NULL

The	NULL
cell	NULL
extract	NULL
and	NULL
200	NULL
ng	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
(	NULL
Amersham	NULL
Pharmacia	NULL
Biotech	NULL
)	NULL
were	NULL
first	NULL
incubated	NULL
on	NULL
ice	NULL
for	NULL
15	NULL
min	NULL
followed	NULL
by	NULL
another	NULL
15-min	NULL
incubation	NULL
on	NULL
ice	NULL
after	NULL
adding	NULL
the	NULL
labeled	NULL
oligonucleotide	NULL
.	NULL

The	NULL
reaction	NULL
products	NULL
were	NULL
run	NULL
on	NULL
a	NULL
5	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
in	NULL
0.5	NULL
%	NULL
Tris	NULL
borate-EDTA	NULL
buffer	NULL
and	NULL
visualized	NULL
by	NULL
autoradiography	NULL
.	NULL

Recombinant	NULL
Baculovirus	NULL
Expression	NULL
System-The	NULL
murine	NULL
wild	NULL
type	NULL
STAT5A	NULL
gene	NULL
in	NULL
pBluescript	NULL
SKII+	NULL
vector	NULL
was	NULL
a	NULL
kind	NULL
gift	NULL
from	NULL
J.	NULL
N.	NULL
Thle	NULL
(	NULL
St.	NULL
Jude	NULL
Children	NULL
's	NULL
Hospital	NULL
,	NULL
Memphis	NULL
,	NULL
TN	NULL
)	NULL
.	NULL

The	NULL
STAT5A	NULL
gene	NULL
was	NULL
excised	NULL
from	NULL
this	NULL
plasmid	NULL
by	NULL
EcoRI	NULL
digestion	NULL
and	NULL
cloned	NULL
into	NULL
pFastBacl	NULL
(	NULL
PFB	NULL
)	NULL
donor	NULL
vector	NULL
(	NULL
Life	NULL
Technologies	NULL
)	NULL
.	NULL

The	NULL
resulting	NULL
pFast-bac-stat5a	NULL
recombinant	NULL
plasmid	NULL
(	NULL
PFB-stat5a	NULL
)	NULL
was	NULL
then	NULL
used	NULL
to	NULL
generate	NULL
the	NULL
recombinant	NULL
baculovirus	NULL
by	NULL
site-specific	NULL
transposition	NULL
in	NULL
Escherichia	NULL
coli	NULL
DH1OBac	NULL
competent	NULL
cells	NULL
(	NULL
Life	NULL
Technologies	NULL
)	NULL
,	NULL
which	NULL
harbor	NULL
a	NULL
baculovirus	NULL
shuttle	NULL
vector	NULL
(	NULL
bacmid	NULL
)	NULL
,	NULL
bMON14272	NULL
with	NULL
a	NULL
mini-attT	NULL
'	NULL
n	NULL
?	NULL

7	NULL
target	NULL
site	NULL
for	NULL
site-specific	NULL
transposition	NULL
.	NULL

The	NULL
bacterial	NULL
colonies	NULL
containing	NULL
recombinant	NULL
bacmids	NULL
were	NULL
identified	NULL
by	NULL
disruption	NULL
of	NULL
the	NULL
lacZa	NULL
gene	NULL
.	NULL

High	NULL
molecular	NULL
weight	NULL
miniprep	NULL
DNA	NULL
was	NULL
prepared	NULL
from	NULL
selected	NULL
E.	NULL
coli	NULL
clones	NULL
containing	NULL
recombinant	NULL
bacmid	NULL
and	NULL
transfected	NULL
into	NULL
Sf21	NULL
cells	NULL
using	NULL
Cellfectin	NULL
reagent	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
)	NULL
in	NULL
a	NULL
60-mm	NULL
dish	NULL
(	NULL
1.5	NULL
x	NULL
10°	NULL
cells/dish	NULL
)	NULL
.	NULL

On	NULL
day	NULL
5	NULL
after	NULL
transfection	NULL
,	NULL
the	NULL
supernatants	NULL
from	NULL
each	NULL
dish	NULL
were	NULL
collected	NULL
and	NULL
saved	NULL
for	NULL
subsequent	NULL
infections	NULL
and	NULL
plaque	NULL
purification	NULL
.	NULL

Similarly	NULL
,	NULL
the	NULL
genes	NULL
encoding	NULL
Y694F	NULL
mutant	NULL
STAT5A	NULL
,	NULL
Y694F-Y	NULL
STAT5A	NULL
,	NULL
wild	NULL
type	NULL
BTK	NULL
,	NULL
TEC	NULL
,	NULL
and	NULL
JAK3	NULL
were	NULL
excised	NULL
from	NULL
pBluescript	NULL
plasmid	NULL
,	NULL
cloned	NULL
into	NULL
PFB	NULL
vector	NULL
and	NULL
processed	NULL
as	NULL
described	NULL
above	NULL
for	NULL
expression	NULL
in	NULL
Sf21	NULL
cells	NULL
.	NULL

The	NULL
BTK	NULL
kinase	NULL
domain	NULL
(	NULL
BTK-KD	NULL
)	NULL
gene	NULL
was	NULL
amplified	NULL
from	NULL
wild	NULL
type	NULL
BTK	NULL
by	NULL
PCR	NULL
using	NULL
5'-primer	NULL
(	NULL
AGCCATGGGAattgatccaaaggaectcac	NULL
)	NULL
with	NULL
a	NULL
Neo	NULL
!	NULL

site	NULL
and	NULL
3'-primer	NULL
(	NULL
ATAAGCTTtcaggattcttcatccatcaca	NULL
)	NULL
with	NULL
a	NULL
HindIII	NULL
site	NULL
.	NULL

The	NULL
PCR	NULL
used	NULL
Taq	NULL
polymerase	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
)	NULL
and	NULL
conditions	NULL
of	NULL
95	NULL
°C	NULL
denaturing	NULL
for	NULL
3	NULL
min	NULL
,	NULL
followed	NULL
by	NULL
30	NULL
cycles	NULL
of	NULL
94	NULL
°C	NULL
denaturing	NULL
for	NULL
1	NULL
min	NULL
,	NULL
60	NULL
°C	NULL
annealing	NULL
for	NULL
1	NULL
min	NULL
,	NULL
72	NULL
°C	NULL
extension	NULL
for	NULL
2	NULL
min	NULL
,	NULL
and	NULL
then	NULL
running	NULL
for	NULL
an	NULL
additional	NULL
10	NULL
min	NULL
at	NULL
72	NULL
°C	NULL
.	NULL

The	NULL
PCR	NULL
product	NULL
was	NULL
cloned	NULL
into	NULL
the	NULL
PCR2.1	NULL
vector	NULL
(	NULL
BTKKD/PCR2.1	NULL
)	NULL
using	NULL
the	NULL
Invitrogen	NULL
TA	NULL
cloning	NULL
technique	NULL
.	NULL

The	NULL
identity	NULL
of	NULL
the	NULL
insert	NULL
was	NULL
confirmed	NULL
by	NULL
DNA	NULL
sequencing	NULL
.	NULL

Subsequently	NULL
,	NULL
the	NULL
BTKKD/PCR2.1	NULL
was	NULL
completely	NULL
digested	NULL
with	NULL
Nco	NULL
!	NULL

and	NULL
HindIII	NULL
.	NULL

The	NULL
800-base	NULL
pair	NULL
fragment	NULL
was	NULL
purified	NULL
on	NULL
a	NULL
0.8	NULL
%	NULL
agarose	NULL
gel	NULL
(	NULL
Qiagene	NULL
kit	NULL
)	NULL
and	NULL
ligated	NULL
to	NULL
the	NULL
pFastBac	NULL
HTh	NULL
donor	NULL
plasmid	NULL
(	NULL
Life	NULL
Technologies	NULL
)	NULL
,	NULL
followed	NULL
by	NULL
digestion	NULL
with	NULL
Nco	NULL
!	NULL

and	NULL
HindIII	NULL
to	NULL
generate	NULL
pFastBac	NULL
HTh	NULL
:	NULL
BTKKD	NULL
.	NULL

Recombinant	NULL
viral	NULL
clones	NULL
were	NULL
identified	NULL
visually	NULL
and	NULL
purified	NULL
from	NULL
plaque	NULL
assay	NULL
plates	NULL
containing	NULL
1.5	NULL
%	NULL
SeaPlaque	NULL
GTG	NULL
agarose	NULL
(	NULL
FMC	NULL
Bioproducts	NULL
)	NULL
after	NULL
5-6	NULL
days	NULL
at	NULL
28	NULL
°C	NULL
.	NULL

Recombinant	NULL
viral	NULL
clones	NULL
were	NULL
then	NULL
amplified	NULL
in	NULL
T-25	NULL
flask	NULL
cultures	NULL
(	NULL
4.0	NULL
x	NULL
10°®/flask	NULL
on	NULL
day	NULL
0	NULL
)	NULL
for	NULL
3	NULL
days	NULL
;	NULL
infected	NULL
cells	NULL
were	NULL
identified	NULL
morphologically	NULL
and	NULL
then	NULL
screened	NULL
for	NULL
production	NULL
of	NULL
the	NULL
respective	NULL
recombinant	NULL
proteins	NULL
by	NULL
SDS-PAGE	NULL
on	NULL
10	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
stained	NULL
with	NULL
Coomassie	NULL
Brilliant	NULL
Blue	NULL
R.	NULL
The	NULL
various	NULL
recombinant	NULL
baculoviruses	NULL
were	NULL
inoculated	NULL
into	NULL
25	NULL
X	NULL
10°	NULL
Sf21	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
cells	NULL
were	NULL
harvested	NULL
48	NULL
h	NULL
later	NULL
as	NULL
detailed	NULL
earlier	NULL
(	NULL
44	NULL
)	NULL
.	NULL

When	NULL
coexpression	NULL
experiments	NULL
were	NULL
performed	NULL
,	NULL
the	NULL
amounts	NULL
of	NULL
different	NULL
viruses	NULL
were	NULL
adjusted	NULL
following	NULL
preliminary	NULL
experiments	NULL
to	NULL
yield	NULL
equivalent	NULL
expression	NULL
of	NULL
the	NULL
necessary	NULL
proteins	NULL
.	NULL

For	NULL
large	NULL
scale	NULL
production	NULL
of	NULL
wild	NULL
type	NULL
or	NULL
mutant	NULL
forms	NULL
of	NULL
STAT5A	NULL
and	NULL
BTK	NULL
,	NULL
1-liter	NULL
cultures	NULL
of	NULL
Sf21	NULL
cells	NULL
in	NULL
3-liter	NULL
Bellco	NULL
spinner	NULL
flasks	NULL
(	NULL
1.0-1.2	NULL
x	NULL
10°	NULL
cells/ml	NULL
)	NULL
were	NULL
infected	NULL
with	NULL
the	NULL
recombinant	NULL
plasmids	NULL
PFB-stat5a	NULL
or	NULL
PFB-btk	NULL
during	NULL
logarithmic	NULL
growth	NULL
with	NULL
25	NULL
ml	NULL
of	NULL
viral	NULL
stock	NULL
solution	NULL
(	NULL
~2.5	NULL
X	NULL
10°	NULL
plaque-forming	NULL
units/ml	NULL
)	NULL
.	NULL

This	NULL
infection	NULL
protocol	NULL
results	NULL
in	NULL
a	NULL
multiplicity	NULL
of	NULL
infection	NULL
of	NULL
~6	NULL
.	NULL

The	NULL
viral	NULL
stock	NULL
solutions	NULL
were	NULL
passaged	NULL
no	NULL
more	NULL
than	NULL
three	NULL
times	NULL
following	NULL
plaque	NULL
purification	NULL
prior	NULL
to	NULL
use	NULL
in	NULL
these	NULL
large	NULL
scale	NULL
infections	NULL
in	NULL
order	NULL
to	NULL
minimize	NULL
the	NULL
presence	NULL
of	NULL
defective	NULL
interfering	NULL
particles	NULL
.	NULL

Cultures	NULL
were	NULL
incubated	NULL
at	NULL
28	NULL
°C	NULL
and	NULL
stirred	NULL
at	NULL
80-100	NULL
rpm	NULL
using	NULL
a	NULL
magnetic	NULL
stirrer	NULL
(	NULL
Bellco	NULL
Glass	NULL
Inc.	NULL
,	NULL
Vineland	NULL
,	NULL
NJ	NULL
)	NULL
for	NULL
48	NULL
h.	NULL
Infected	NULL
cells	NULL
were	NULL
harvested	NULL
by	NULL
gentle	NULL
centrifugation	NULL
in	NULL
a	NULL
Beckman	NULL
GS-6	NULL
centrifuge	NULL
at	NULL
500	NULL
x	NULL
g	NULL
for	NULL
7	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Cells	NULL
from	NULL
1-liter	NULL
cultures	NULL
were	NULL
divided	NULL
into	NULL
two	NULL
aliquots	NULL
(	NULL
~4	NULL
g	NULL
of	NULL
wet	NULL
cell	NULL
paste	NULL
)	NULL
and	NULL
immediately	NULL
flash-frozen	NULL
at	NULL
-80	NULL
°C	NULL
and	NULL
stored	NULL
at	NULL
-80	NULL
°C	NULL
until	NULL
purification	NULL
of	NULL
the	NULL
recombinant	NULL
proteins	NULL
.	NULL

Gel	NULL
Filtration	NULL
Analysis-Sf21	NULL
insect	NULL
cells	NULL
coexpressing	NULL
STATS5	NULL
and	NULL
STAT5A	NULL
as	NULL
a	NULL
Substrate	NULL
of	NULL
BTK	NULL
BTK	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
assembly	NULL
buffer	NULL
(	NULL
10	NULL
mM	NULL
PIPES	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
pH	NULL
7.2	NULL
)	NULL
and	NULL
lysed	NULL
in	NULL
lysis	NULL
buffer	NULL
(	NULL
0.01	NULL
M	NULL
Tris-Cl	NULL
,	NULL
pH	NULL
8.2	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
0.15	NULL
M	NULL
NaCl	NULL
,	NULL
1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
2	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
,	NULL
1	NULL
ug/ml	NULL
leupeptin	NULL
,	NULL
1	NULL
ug/ml	NULL
pepstatin	NULL
,	NULL
and	NULL
1	NULL
mM	NULL
Na	NULL
,	NULL
VO	NULL
,	NULL
)	NULL
for	NULL
2	NULL
h	NULL
on	NULL
ice	NULL
.	NULL

Cytosolic	NULL
fractions	NULL
were	NULL
recovered	NULL
after	NULL
centrifugation	NULL
at	NULL
18,000	NULL
x	NULL
g	NULL
for	NULL
15	NULL
min	NULL
.	NULL

Supernatants	NULL
were	NULL
analyzed	NULL
with	NULL
fast	NULL
protein	NULL
liquid	NULL
chromatography	NULL
on	NULL
a	NULL
Superdex	NULL
200	NULL
HR	NULL
10/30	NULL
column	NULL
(	NULL
Amersham	NULL
Pharmacia	NULL
Biotech	NULL
)	NULL
at	NULL
a	NULL
flow	NULL
rate	NULL
of	NULL
0.5	NULL
ml/min	NULL
.	NULL

0.5-ml	NULL
fractions	NULL
were	NULL
collected	NULL
and	NULL
subjected	NULL
to	NULL
Western	NULL
blot	NULL
analysis	NULL
to	NULL
determine	NULL
the	NULL
elution	NULL
patterns	NULL
and	NULL
tyrosine	NULL
phosphorylation	NULL
status	NULL
of	NULL
STAT5	NULL
and	NULL
BTK	NULL
proteins	NULL
,	NULL
as	NULL
described	NULL
above	NULL
.	NULL

STAT5A	NULL
Homology	NULL
Model-A	NULL
molecular	NULL
model	NULL
of	NULL
STAT5A	NULL
from	NULL
residue	NULL
210	NULL
to	NULL
687	NULL
was	NULL
initially	NULL
constructed	NULL
based	NULL
on	NULL
its	NULL
homology	NULL
with	NULL
both	NULL
STAT1	NULL
and	NULL
STAT3	NULL
$	NULL
using	NULL
the	NULL
Swiss-Model	NULL
program	NULL
(	NULL
45	NULL
)	NULL
.	NULL

Subsequently	NULL
,	NULL
the	NULL
model	NULL
was	NULL
extended	NULL
to	NULL
include	NULL
all	NULL
coordinates	NULL
from	NULL
residue	NULL
163	NULL
to	NULL
710	NULL
and	NULL
then	NULL
refined	NULL
using	NULL
the	NULL
Homology	NULL
module	NULL
of	NULL
the	NULL
InsightII	NULL
program	NULL
(	NULL
MSI	NULL
,	NULL
San	NULL
Diego	NULL
)	NULL
and	NULL
a	NULL
Silicon	NULL
Graphics	NULL
INDIGO2	NULL
computer	NULL
(	NULL
Silicon	NULL
Graphics	NULL
,	NULL
Mountain	NULL
View	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Specifically	NULL
,	NULL
the	NULL
homology	NULL
modeling	NULL
of	NULL
STAT5A	NULL
was	NULL
carried	NULL
out	NULL
in	NULL
two	NULL
steps	NULL
as	NULL
follows	NULL
.	NULL

1	NULL
)	NULL
The	NULL
most	NULL
reasonable	NULL
sequence	NULL
alignment	NULL
between	NULL
STAT5A	NULL
and	NULL
a	NULL
coordinate	NULL
template	NULL
based	NULL
on	NULL
the	NULL
STAT1	NULL
and	NULL
STATS3B	NULL
crystal	NULL
structures	NULL
was	NULL
deter-mined	NULL
.	NULL

2	NULL
)	NULL
New	NULL
coordinates	NULL
were	NULL
assigned	NULL
to	NULL
the	NULL
STAT5A	NULL
residues	NULL
according	NULL
to	NULL
the	NULL
template	NULL
coordinates	NULL
(	NULL
based	NULL
on	NULL
the	NULL
sequence	NULL
align-ment	NULL
)	NULL
,	NULL
followed	NULL
by	NULL
the	NULL
determination	NULL
of	NULL
the	NULL
loop	NULL
coordinates	NULL
and	NULL
an	NULL
energy	NULL
minimization	NULL
of	NULL
the	NULL
entire	NULL
structure	NULL
.	NULL

Finally	NULL
,	NULL
the	NULL
constructed	NULL
model	NULL
of	NULL
STAT5A	NULL
was	NULL
subjected	NULL
to	NULL
visual	NULL
inspection	NULL
in	NULL
CHAIN	NULL
(	NULL
46	NULL
)	NULL
and	NULL
energy	NULL
minimization	NULL
using	NULL
the	NULL
X-plor	NULL
program	NULL
(	NULL
version	NULL
3.1	NULL
,	NULL
A.	NULL
T.	NULL
Brunger	NULL
,	NULL
Yale	NULL
University	NULL
Press	NULL
)	NULL
.	NULL

The	NULL
coordinates	NULL
of	NULL
the	NULL
BTK	NULL
kinase	NULL
domain	NULL
have	NULL
been	NULL
experimentally	NULL
determined	NULL
and	NULL
will	NULL
be	NULL
published	NULL
elsewhere	NULL
.	NULL

The	NULL
model	NULL
of	NULL
the	NULL
BTK	NULL
kinase	NULL
domain	NULL
complexed	NULL
with	NULL
the	NULL
tail	NULL
segment	NULL
of	NULL
STAT5A	NULL
was	NULL
based	NULL
on	NULL
the	NULL
ternary	NULL
structure	NULL
of	NULL
the	NULL
insulin	NULL
receptor	NULL
kinase	NULL
domain	NULL
and	NULL
a	NULL
peptide	NULL
substrate	NULL
.	NULL

Site-directed	NULL
Mutagenesis-Point	NULL
mutations	NULL
were	NULL
introduced	NULL
into	NULL
the	NULL
statba	NULL
cDNA	NULL
by	NULL
PCR	NULL
(	NULL
47	NULL
)	NULL
.	NULL

The	NULL
codon	NULL
for	NULL
arginine	NULL
618	NULL
within	NULL
the	NULL
SH2	NULL
domain	NULL
was	NULL
mutated	NULL
to	NULL
a	NULL
codon	NULL
for	NULL
lysine	NULL
.	NULL

The	NULL
codons	NULL
for	NULL
the	NULL
conserved	NULL
tryptophans	NULL
at	NULL
positions	NULL
571	NULL
and	NULL
573	NULL
within	NULL
the	NULL
SH3	NULL
domain	NULL
were	NULL
mutated	NULL
to	NULL
leucine	NULL
.	NULL

The	NULL
codon	NULL
for	NULL
tyrosine	NULL
694	NULL
that	NULL
is	NULL
the	NULL
equivalent	NULL
of	NULL
tyrosine	NULL
701	NULL
in	NULL
murine	NULL
STAT1	NULL
,	NULL
a	NULL
previously	NULL
known	NULL
phosphorylation	NULL
site	NULL
by	NULL
JAK	NULL
kinases	NULL
(	NULL
48	NULL
)	NULL
,	NULL
was	NULL
mutated	NULL
to	NULL
a	NULL
codon	NULL
for	NULL
phenylalanine	NULL
.	NULL

The	NULL
codons	NULL
for	NULL
the	NULL
tyrosine	NULL
residues	NULL
665	NULL
,	NULL
668	NULL
,	NULL
682	NULL
,	NULL
and	NULL
683	NULL
that	NULL
flank	NULL
tyrosine	NULL
694	NULL
and	NULL
appear	NULL
to	NULL
be	NULL
potential	NULL
phosphorylation	NULL
sites	NULL
were	NULL
also	NULL
mutated	NULL
to	NULL
a	NULL
codon	NULL
for	NULL
phenylalanine	NULL
.	NULL

All	NULL
mutations	NULL
were	NULL
confirmed	NULL
by	NULL
sequence	NULL
analysis	NULL
.	NULL

Point	NULL
mutations	NULL
introduced	NULL
into	NULL
the	NULL
btk	NULL
gene	NULL
(	NULL
39	NULL
)	NULL
have	NULL
been	NULL
reported	NULL
earlier	NULL
.	NULL

Expression	NULL
and	NULL
Purification	NULL
of	NULL
MBP-BTK	NULL
and	NULL
GST-BTK	NULL
Fusion	NULL
Proteins-cDNAs	NULL
encoding	NULL
full-length	NULL
BTK	NULL
and	NULL
its	NULL
kinase	NULL
or	NULL
PH	NULL
domains	NULL
with	NULL
PCR-generated	NULL
5	NULL
'	NULL
and	NULL
3	NULL
'	NULL
BamHI	NULL
sites	NULL
were	NULL
cloned	NULL
into	NULL
the	NULL
E.	NULL
coli	NULL
expression	NULL
vector	NULL
pMAL-C2	NULL
with	NULL
the	NULL
isopropyl-1-thio-B-D-galactopyranoside-inducible	NULL
Ptac	NULL
promoter	NULL
to	NULL
create	NULL
an	NULL
in	NULL
frame	NULL
fusion	NULL
between	NULL
these	NULL
coding	NULL
sequences	NULL
and	NULL
the	NULL
3'-end	NULL
of	NULL
the	NULL
E.	NULL
coli	NULL
malE	NULL
gene	NULL
,	NULL
which	NULL
codes	NULL
for	NULL
maltose-binding	NULL
protein	NULL
(	NULL
MBP	NULL
)	NULL
.	NULL

cDNAs	NULL
encoding	NULL
the	NULL
SH2	NULL
,	NULL
SH3	NULL
,	NULL
or	NULL
SH2	NULL
+	NULL
SH3	NULL
domains	NULL
with	NULL
PCR-generated	NULL
5	NULL
'	NULL
and	NULL
3	NULL
'	NULL
BamHI	NULL
sites	NULL
were	NULL
cloned	NULL
into	NULL
the	NULL
E.	NULL
coli	NULL
expression	NULL
vector	NULL
pGEX-2T	NULL
with	NULL
the	NULL
isopropyl-1-thio-B-D-galactopyranoside-inducible	NULL
Ptac	NULL
promoter	NULL
to	NULL
create	NULL
an	NULL
in	NULL
frame	NULL
fusion	NULL
between	NULL
these	NULL
coding	NULL
sequences	NULL
and	NULL
the	NULL
3'-end	NULL
of	NULL
the	NULL
E.	NULL
coli	NULL
glutathione	NULL
S-transferase	NULL
(	NULL
GST	NULL
)	NULL
gene	NULL
.	NULL

The	NULL
generated	NULL
recombinant	NULL
plasmids	NULL
were	NULL
transformed	NULL
into	NULL
the	NULL
E.	NULL
coli	NULL
strain	NULL
DHS5	NULL
«	NULL
.	NULL

Single	NULL
transformants	NULL
were	NULL
expanded	NULL
in	NULL
5	NULL
ml	NULL
of	NULL
LB	NULL
medium	NULL
(	NULL
1	NULL
%	NULL
tryptone	NULL
,	NULL
1	NULL
%	NULL
NaCl	NULL
,	NULL
0.5	NULL
%	NULL
yeast	NULL
extract	NULL
)	NULL
containing	NULL
ampicillin	NULL
(	NULL
100	NULL
ug/ml	NULL
)	NULL
by	NULL
overnight	NULL
culture	NULL
at	NULL
37°C	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
fusion	NULL
proteins	NULL
was	NULL
induced	NULL
with	NULL
10	NULL
mM	NULL
isopropyl-1-thi0-B-D-galactopyrano-side	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
harvested	NULL
by	NULL
centrifugation	NULL
at	NULL
4500	NULL
x	NULL
g	NULL
in	NULL
a	NULL
Sorvall	NULL
RC5B	NULL
centrifuge	NULL
for	NULL
10	NULL
min	NULL
at	NULL
4	NULL
°C	NULL
,	NULL
lysed	NULL
in	NULL
sucrose-lysozyme	NULL
buffer	NULL
(	NULL
20	NULL
mM	NULL
Tris	NULL
,	NULL
pH	NULL
8.0	NULL
,	NULL
150	NULL
mM	NULL
NaCl	NULL
,	NULL
10	NULL
%	NULL
sucrose	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
20	NULL
mM	NULL
lysozyme	NULL
)	NULL
,	NULL
and	NULL
further	NULL
disrupted	NULL
by	NULL
sonication	NULL
.	NULL

After	NULL
removal	NULL
of	NULL
the	NULL
cell	NULL
pellets	NULL
by	NULL
centrifugation	NULL
at	NULL
35,000	NULL
x	NULL
g	NULL
for	NULL
1	NULL
h	NULL
at	NULL
4	NULL
°C	NULL
,	NULL
GST-BTK	NULL
fusion	NULL
proteins	NULL
were	NULL
purified	NULL
by	NULL
glutathione-Sepharose	NULL
chromatography	NULL
,	NULL
whereas	NULL
MBP-BTK	NULL
fusion	NULL
proteins	NULL
were	NULL
purified	NULL
from	NULL
the	NULL
culture	NULL
supernatants	NULL
by	NULL
amylose	NULL
affinity	NULL
chromatography	NULL
(	NULL
4	NULL
)	NULL
.	NULL

Pull-down	NULL
Assays	NULL
with	NULL
MBP-BTK	NULL
and	NULL
GST-BTK	NULL
Fusion	NULL
Proteins-GST-BTK	NULL
fusion	NULL
proteins	NULL
were	NULL
noncovalently	NULL
bound	NULL
to	NULL
glutathione-agarose	NULL
beads	NULL
(	NULL
Sigma	NULL
)	NULL
and	NULL
MBP-BTK	NULL
fusion	NULL
proteins	NULL
were	NULL
noncovalently	NULL
bound	NULL
to	NULL
amylose	NULL
beads	NULL
under	NULL
conditions	NULL
of	NULL
saturating	NULL
protein	NULL
,	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
4	NULL
)	NULL
.	NULL

In	NULL
brief	NULL
,	NULL
50	NULL
ug	NULL
of	NULL
each	NULL
protein	NULL
was	NULL
incubated	NULL
with	NULL
50	NULL
ul	NULL
of	NULL
the	NULL
beads	NULL
for	NULL
2	NULL
h	NULL
at	NULL
4°C	NULL
.	NULL

The	NULL
beads	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
buffer	NULL
.	NULL

Nonidet	NULL
P-40	NULL
lysates	NULL
of	NULL
KL2	NULL
human	NULL
Epstein-Barr	NULL
virus-transformed	NULL
lymphoblastoid	NULL
cells	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
(	NULL
4	NULL
)	NULL
,	NULL
and	NULL
500	NULL
ug	NULL
of	NULL
the	NULL
lysate	NULL
was	NULL
incubated	NULL
with	NULL
50	NULL
ul	NULL
of	NULL
6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san	NULL
$	NULL
4g	NULL
/310-2q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wou	NULL
;	NULL
papeojumo	NULL
(	NULL
STAT5A	NULL
as	NULL
a	NULL
Substrate	NULL
of	NULL
BTK	NULL
fusion	NULL
protein-coupled	NULL
beads	NULL
for	NULL
2	NULL
h	NULL
on	NULL
ice	NULL
.	NULL

The	NULL
fusion	NULL
protein	NULL
adsorbates	NULL
were	NULL
washed	NULL
with	NULL
ice-cold	NULL
1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
buffer	NULL
and	NULL
resuspended	NULL
in	NULL
reducing	NULL
SDS	NULL
sample	NULL
buffer	NULL
.	NULL

Samples	NULL
were	NULL
boiled	NULL
for	NULL
5	NULL
min	NULL
and	NULL
then	NULL
fractionated	NULL
on	NULL
SDS-PAGE	NULL
.	NULL

Proteins	NULL
were	NULL
transferred	NULL
to	NULL
Immobilon-P	NULL
(	NULL
Millipore	NULL
Corp.	NULL
)	NULL
membranes	NULL
,	NULL
and	NULL
membranes	NULL
were	NULL
immunoblotted	NULL
with	NULL
anti-STAT5A	NULL
antibody	NULL
(	NULL
Transduction	NULL
Laboratories	NULL
)	NULL
,	NULL
according	NULL
to	NULL
previously	NULL
described	NULL
procedures	NULL
(	NULL
38-5	NULL
,	NULL
38-40	NULL
)	NULL
.	NULL

Purification	NULL
of	NULL
STAT5A	NULL
and	NULL
BTK	NULL
Proteins-Frozen	NULL
Sf21	NULL
insect	NULL
cells	NULL
previously	NULL
infected	NULL
with	NULL
PFB-btk	NULL
(	NULL
~24	NULL
g	NULL
of	NULL
cell	NULL
paste	NULL
;	NULL
3	NULL
liters	NULL
of	NULL
culture	NULL
)	NULL
were	NULL
resuspended	NULL
in	NULL
100	NULL
ml	NULL
of	NULL
extraction	NULL
buffer	NULL
(	NULL
20	NULL
mM	NULL
sodium	NULL
phosphate	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
100	NULL
mM	NULL
NaCl	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
EGTA	NULL
,	NULL
1	NULL
my	NULL
DTT	NULL
,	NULL
0.1	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
and	NULL
1	NULL
%	NULL
Complete	NULL
``	NULL
protease	NULL
inhibitors	NULL
(	NULL
Roche	NULL
Molecular	NULL
Biochemicals	NULL
)	NULL
)	NULL
,	NULL
incubated	NULL
on	NULL
ice	NULL
for	NULL
15	NULL
min	NULL
,	NULL
and	NULL
then	NULL
sonicated	NULL
three	NULL
times	NULL
for	NULL
30	NULL
s	NULL
each	NULL
time	NULL
using	NULL
a	NULL
Branson	NULL
sonifier	NULL
250	NULL
at	NULL
50	NULL
%	NULL
duty	NULL
cycle	NULL
,	NULL
30	NULL
%	NULL
output	NULL
while	NULL
on	NULL
ice	NULL
.	NULL

All	NULL
subsequent	NULL
steps	NULL
were	NULL
performed	NULL
at	NULL
4	NULL
°C	NULL
unless	NULL
otherwise	NULL
noted	NULL
.	NULL

The	NULL
extract	NULL
was	NULL
then	NULL
centrifuged	NULL
at	NULL
100,000	NULL
x	NULL
g	NULL
for	NULL
1	NULL
h	NULL
in	NULL
a	NULL
Beckman	NULL
Optima	NULL
LE-80K	NULL
ultracentrifuge	NULL
using	NULL
a	NULL
70Ti	NULL
rotor	NULL
.	NULL

Following	NULL
centrifugation	NULL
,	NULL
the	NULL
supernatant	NULL
was	NULL
filtered	NULL
through	NULL
a	NULL
0.22-um	NULL
membrane	NULL
filter	NULL
(	NULL
$	NULL
100	NULL
)	NULL
and	NULL
applied	NULL
to	NULL
a	NULL
5	NULL
X	NULL
13.5-cm	NULL
Heparin-Toyopearl	NULL
(	NULL
Sigma	NULL
)	NULL
affinity	NULL
column	NULL
(	NULL
column	NULL
volume	NULL
250	NULL
ml	NULL
)	NULL
which	NULL
had	NULL
been	NULL
equilibrated	NULL
with	NULL
buffer	NULL
A	NULL
(	NULL
20	NULL
mM	NULL
sodium	NULL
phosphate	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
EGTA	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
)	NULL
.	NULL

Following	NULL
application	NULL
of	NULL
the	NULL
filtered	NULL
soluble	NULL
cell	NULL
extract	NULL
,	NULL
the	NULL
column	NULL
was	NULL
washed	NULL
with	NULL
500	NULL
ml	NULL
of	NULL
buffer	NULL
A	NULL
plus	NULL
200	NULL
mM	NULL
NaCl	NULL
.	NULL

Protein	NULL
was	NULL
then	NULL
eluted	NULL
from	NULL
the	NULL
column	NULL
with	NULL
a	NULL
1000-ml	NULL
linear	NULL
gradient	NULL
from	NULL
0.2	NULL
to	NULL
1.0	NULL
M	NULL
NaCl	NULL
in	NULL
buffer	NULL
A	NULL
,	NULL
at	NULL
a	NULL
flow	NULL
rate	NULL
of	NULL
2.5	NULL
ml/min	NULL
,	NULL
and	NULL
15-ml	NULL
fractions	NULL
were	NULL
collected	NULL
.	NULL

Eluted	NULL
fractions	NULL
were	NULL
analyzed	NULL
using	NULL
SDS-PAGE	NULL
and	NULL
immunoblotting	NULL
.	NULL

Fractions	NULL
containing	NULL
anti-BTK	NULL
immunoreactive	NULL
material	NULL
were	NULL
pooled	NULL
(	NULL
~80	NULL
ml	NULL
)	NULL
and	NULL
dialyzed	NULL
twice	NULL
against	NULL
2	NULL
liters	NULL
of	NULL
buffer	NULL
A	NULL
to	NULL
remove	NULL
NaCl	NULL
and	NULL
then	NULL
applied	NULL
to	NULL
a	NULL
Sepharose	NULL
Q	NULL
HP26/10	NULL
ion	NULL
exchange	NULL
column	NULL
(	NULL
column	NULL
volume	NULL
50	NULL
ml	NULL
;	NULL
Amersham	NULL
Pharmacia	NULL
Biotech	NULL
)	NULL
that	NULL
had	NULL
been	NULL
equilibrated	NULL
with	NULL
buffer	NULL
A	NULL
.	NULL

Protein	NULL
was	NULL
eluted	NULL
from	NULL
the	NULL
Sepharose	NULL
Q	NULL
column	NULL
using	NULL
a	NULL
250-ml	NULL
linear	NULL
gradient	NULL
from	NULL
0	NULL
to	NULL
0.5	NULL
M	NULL
NaCl	NULL
in	NULL
buffer	NULL
A	NULL
,	NULL
at	NULL
a	NULL
flow	NULL
rate	NULL
of	NULL
2	NULL
ml/min	NULL
,	NULL
and	NULL
4-ml	NULL
fractions	NULL
were	NULL
collected	NULL
.	NULL

Eluted	NULL
fractions	NULL
were	NULL
again	NULL
analyzed	NULL
using	NULL
SDS-PAGE	NULL
and	NULL
immunoblotting	NULL
.	NULL

Fractions	NULL
containing	NULL
anti-BTK	NULL
immunoreactive	NULL
material	NULL
were	NULL
pooled	NULL
and	NULL
dialyzed	NULL
twice	NULL
against	NULL
2	NULL
liters	NULL
of	NULL
buffer	NULL
A	NULL
to	NULL
remove	NULL
NaCl	NULL
and	NULL
then	NULL
applied	NULL
to	NULL
a	NULL
Mono	NULL
S	NULL
HR	NULL
5/5	NULL
ion	NULL
exchange	NULL
column	NULL
(	NULL
column	NULL
volume	NULL
1	NULL
ml	NULL
;	NULL
Amersham	NULL
Pharmacia	NULL
Biotech	NULL
)	NULL
.	NULL

Protein	NULL
was	NULL
eluted	NULL
from	NULL
the	NULL
Mono	NULL
S	NULL
column	NULL
with	NULL
a	NULL
40-ml	NULL
linear	NULL
gradient	NULL
from	NULL
0	NULL
to	NULL
0.4	NULL
M	NULL
NaCl	NULL
in	NULL
buffer	NULL
A	NULL
at	NULL
a	NULL
flow	NULL
rate	NULL
of	NULL
0.5	NULL
ml/min	NULL
,	NULL
and	NULL
1-ml	NULL
fractions	NULL
were	NULL
collected	NULL
.	NULL

BTK	NULL
was	NULL
eluted	NULL
at	NULL
~0.25	NULL
M	NULL
NaCl	NULL
.	NULL

Fractions	NULL
containing	NULL
BTK	NULL
were	NULL
then	NULL
concentrated	NULL
individually	NULL
to	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
~2	NULL
mg/ml	NULL
of	NULL
>	NULL
95	NULL
%	NULL
protein	NULL
with	NULL
a	NULL
total	NULL
recovery	NULL
of	NULL
1	NULL
mg	NULL
from	NULL
4	NULL
liters	NULL
of	NULL
Sf21	NULL
cell	NULL
culture	NULL
fluid	NULL
.	NULL

Similarly	NULL
,	NULL
frozen	NULL
Sf21	NULL
insect	NULL
cells	NULL
previously	NULL
infected	NULL
with	NULL
PFB-statba	NULL
,	NULL
PFB-statba-	NULL
[	NULL
Y694F	NULL
]	NULL
,	NULL
or	NULL
PFB-statba-	NULL
[	NULL
Y694F-Y	NULL
]	NULL
(	NULL
~24	NULL
g	NULL
of	NULL
cell	NULL
paste	NULL
;	NULL
3-liter	NULL
culture	NULL
)	NULL
were	NULL
resuspended	NULL
in	NULL
100	NULL
ml	NULL
of	NULL
extraction	NULL
buffer	NULL
(	NULL
10	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
EGTA	NULL
,	NULL
2	NULL
mm	NULL
DTT	NULL
,	NULL
0.1	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
and	NULL
1	NULL
%	NULL
Complete	NULL
``	NULL
protease	NULL
inhibitors	NULL
(	NULL
Roche	NULL
Molecular	NULL
Biochemicals	NULL
)	NULL
,	NULL
incubated	NULL
on	NULL
ice	NULL
for	NULL
15	NULL
min	NULL
,	NULL
and	NULL
then	NULL
sonicated	NULL
three	NULL
times	NULL
for	NULL
30	NULL
s	NULL
each	NULL
.	NULL

The	NULL
extract	NULL
was	NULL
then	NULL
centrifuged	NULL
at	NULL
100,000	NULL
x	NULL
g	NULL
for	NULL
1	NULL
h	NULL
,	NULL
and	NULL
the	NULL
supernatant	NULL
was	NULL
filtered	NULL
through	NULL
a	NULL
0.22-um	NULL
membrane	NULL
filter	NULL
(	NULL
$	NULL
100	NULL
)	NULL
and	NULL
applied	NULL
to	NULL
a	NULL
2.5	NULL
X	NULL
15-cm	NULL
Q	NULL
Sepharose	NULL
High	NULL
Performance	NULL
(	NULL
Amersham	NULL
Pharmacia	NULL
Biotech	NULL
)	NULL
column	NULL
.	NULL

Following	NULL
application	NULL
of	NULL
the	NULL
filtered	NULL
soluble	NULL
cell	NULL
extract	NULL
,	NULL
the	NULL
column	NULL
was	NULL
washed	NULL
with	NULL
200	NULL
ml	NULL
of	NULL
Hepes	NULL
buffer	NULL
(	NULL
10	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
EGTA	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
)	NULL
plus	NULL
0.1	NULL
M	NULL
NaCl	NULL
.	NULL

Protein	NULL
was	NULL
then	NULL
eluted	NULL
from	NULL
the	NULL
column	NULL
with	NULL
a	NULL
400-m1	NULL
linear	NULL
gradient	NULL
from	NULL
0.18	NULL
to	NULL
0.3	NULL
M	NULL
NaCl	NULL
in	NULL
Hepes	NULL
buffer	NULL
,	NULL
at	NULL
a	NULL
flow	NULL
rate	NULL
of	NULL
1	NULL
ml/min	NULL
,	NULL
and	NULL
8-ml	NULL
fractions	NULL
were	NULL
collected	NULL
.	NULL

Eluted	NULL
fractions	NULL
were	NULL
analyzed	NULL
using	NULL
SDS-PAGE	NULL
and	NULL
immunoblotting	NULL
.	NULL

Fractions	NULL
containing	NULL
anti-STAT5A	NULL
immunoreactive	NULL
material	NULL
were	NULL
pooled	NULL
and	NULL
dialyzed	NULL
twice	NULL
against	NULL
2	NULL
liters	NULL
of	NULL
Hepes	NULL
buffer	NULL
and	NULL
then	NULL
applied	NULL
to	NULL
a	NULL
2	NULL
X	NULL
10-cm	NULL
Heparin-Toyopearl	NULL
(	NULL
Sigma	NULL
)	NULL
affinity	NULL
column	NULL
that	NULL
had	NULL
been	NULL
equilibrated	NULL
with	NULL
Hepes	NULL
buffer	NULL
.	NULL

Elution	NULL
of	NULL
protein	NULL
was	NULL
performed	NULL
with	NULL
a	NULL
linear	NULL
gradient	NULL
of	NULL
0.05-0.32	NULL
M	NULL
NaCl	NULL
in	NULL
buffer	NULL
A	NULL
at	NULL
a	NULL
flow	NULL
rate	NULL
of	NULL
1	NULL
ml/min	NULL
,	NULL
and	NULL
4-ml	NULL
fractions	NULL
were	NULL
collected	NULL
.	NULL

Eluted	NULL
fractions	NULL
were	NULL
analyzed	NULL
using	NULL
SDS-PAGE	NULL
and	NULL
immunoblotting	NULL
.	NULL

Fractions	NULL
containing	NULL
STAT5A	NULL
(	NULL
or	NULL
mutant	NULL
STAT5A	NULL
)	NULL
were	NULL
combined	NULL
,	NULL
concentrated	NULL
using	NULL
Centriprep	NULL
30	NULL
(	NULL
Millipore	NULL
Corp.	NULL
)	NULL
to	NULL
~2	NULL
ml	NULL
,	NULL
and	NULL
then	NULL
applied	NULL
to	NULL
a	NULL
HiLoad	NULL
26/60	NULL
Superdex	NULL
200	NULL
size	NULL
exclusion	NULL
column	NULL
(	NULL
Amersham	NULL
Pharmacia	NULL
Biotech	NULL
)	NULL
preequilibrated	NULL
with	NULL
10	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
.	NULL

STAT5A	NULL
(	NULL
or	NULL
mutant	NULL
STAT5A	NULL
)	NULL
was	NULL
eluted	NULL
with	NULL
~350	NULL
ml	NULL
of	NULL
10	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
and	NULL
concentrated	NULL
using	NULL
Centriprep	NULL
30	NULL
to	NULL
a	NULL
protein	NULL
concentration	NULL
of	NULL
10	NULL
mg/ml	NULL
.	NULL

For	NULL
purification	NULL
of	NULL
the	NULL
BTK-KD	NULL
,	NULL
frozen	NULL
Sf21	NULL
cells	NULL
expressing	NULL
this	NULL
protein	NULL
were	NULL
thawed	NULL
in	NULL
a	NULL
37	NULL
°C	NULL
water	NULL
bath	NULL
,	NULL
resuspended	NULL
in	NULL
5	NULL
volumes	NULL
of	NULL
the	NULL
lysis	NULL
buffer	NULL
(	NULL
50	NULL
mM	NULL
Tris/HCl	NULL
,	NULL
pH	NULL
8.5	NULL
,	NULL
100	NULL
mM	NULL
KCI	NULL
,	NULL
2	NULL
mM	NULL
DTT	NULL
,	NULL
and	NULL
1	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
)	NULL
,	NULL
sonicated	NULL
for	NULL
1	NULL
min	NULL
,	NULL
and	NULL
centri-	NULL
31219	NULL
fuged	NULL
at	NULL
30,000	NULL
x	NULL
g	NULL
for	NULL
45	NULL
min	NULL
.	NULL

The	NULL
supernatant	NULL
was	NULL
loaded	NULL
on	NULL
a	NULL
nickel	NULL
column	NULL
,	NULL
which	NULL
was	NULL
equilibrated	NULL
with	NULL
a	NULL
solution	NULL
containing	NULL
10	NULL
mM	NULL
Tris/HC	NULL
]	NULL
buffer	NULL
at	NULL
pH	NULL
8.0	NULL
,	NULL
500	NULL
mM	NULL
KCI	NULL
,	NULL
and	NULL
0.5	NULL
mM	NULL
DTT	NULL
at	NULL
a	NULL
flow	NULL
rate	NULL
of	NULL
0.75-0.5	NULL
ml/min	NULL
.	NULL

The	NULL
column	NULL
was	NULL
washed	NULL
with	NULL
20	NULL
bed	NULL
volumes	NULL
of	NULL
buffer	NULL
B	NULL
(	NULL
20	NULL
mM	NULL
Tris/HCl	NULL
,	NULL
pH	NULL
8.5	NULL
,	NULL
500	NULL
mM	NULL
KCl	NULL
,	NULL
15-20	NULL
mM	NULL
imidazole	NULL
,	NULL
and	NULL
2	NULL
mM	NULL
DTT	NULL
)	NULL
and	NULL
then	NULL
washed	NULL
with	NULL
10	NULL
bed	NULL
volumes	NULL
of	NULL
buffer	NULL
C	NULL
(	NULL
20	NULL
mM	NULL
Tris/HCl	NULL
,	NULL
pH	NULL
8.5	NULL
,	NULL
1	NULL
M	NULL
KCl	NULL
,	NULL
and	NULL
2	NULL
mM	NULL
DTT	NULL
)	NULL
.	NULL

Subsequently	NULL
,	NULL
it	NULL
was	NULL
washed	NULL
again	NULL
with	NULL
2	NULL
bed	NULL
volumes	NULL
of	NULL
buffer	NULL
B	NULL
.	NULL

The	NULL
protein	NULL
was	NULL
eluted	NULL
with	NULL
buffer	NULL
D	NULL
(	NULL
20	NULL
mM	NULL
Tris/HCl	NULL
,	NULL
100	NULL
mM	NULL
KCl	NULL
,	NULL
150	NULL
mM	NULL
imidazole	NULL
,	NULL
and	NULL
2	NULL
mM	NULL
DTT	NULL
)	NULL
.	NULL

The	NULL
fractions	NULL
that	NULL
contained	NULL
BTK-KD	NULL
were	NULL
pooled	NULL
together	NULL
and	NULL
dialyzed	NULL
against	NULL
a	NULL
solution	NULL
that	NULL
contained	NULL
20	NULL
mM	NULL
Tris/HC1	NULL
,	NULL
100	NULL
mM	NULL
NaCl	NULL
,	NULL
2	NULL
mM	NULL
DTT	NULL
,	NULL
and	NULL
1	NULL
mM	NULL
EDTA	NULL
.	NULL

Then	NULL
the	NULL
protein	NULL
was	NULL
concentrated	NULL
to	NULL
5	NULL
mg/ml	NULL
,	NULL
digested	NULL
with	NULL
rTEV	NULL
protease	NULL
of	NULL
6	NULL
ug/mg	NULL
at	NULL
4	NULL
°C	NULL
overnight	NULL
,	NULL
and	NULL
then	NULL
concentrated	NULL
to	NULL
3	NULL
ml	NULL
,	NULL
which	NULL
was	NULL
then	NULL
loaded	NULL
on	NULL
a	NULL
Superdex	NULL
200	NULL
column	NULL
(	NULL
26/60	NULL
)	NULL
,	NULL
which	NULL
was	NULL
equilibrated	NULL
with	NULL
a	NULL
solution	NULL
of	NULL
20	NULL
mM	NULL
Tris/HCl	NULL
,	NULL
pH	NULL
8.5	NULL
,	NULL
50	NULL
mM	NULL
NaCl	NULL
,	NULL
and	NULL
2	NULL
mM	NULL
DTT	NULL
at	NULL
a	NULL
flow	NULL
rate	NULL
of	NULL
0.3	NULL
ml/min	NULL
.	NULL

Monitoring	NULL
of	NULL
Binding	NULL
Interactions	NULL
Using	NULL
Surface	NULL
Plasmon	NULL
Resonance	NULL
Technology-A	NULL
BlAcore	NULL
2000	NULL
surface	NULL
plasmon	NULL
resonance-based	NULL
biosensor	NULL
system	NULL
(	NULL
Amersham	NULL
Pharmacia	NULL
Biotech	NULL
Biosensor	NULL
AB	NULL
)	NULL
was	NULL
used	NULL
to	NULL
measure	NULL
the	NULL
kinetic	NULL
parameters	NULL
for	NULL
the	NULL
interactions	NULL
between	NULL
soluble	NULL
recombinant	NULL
STAT5A	NULL
protein	NULL
(	NULL
analyte	NULL
)	NULL
and	NULL
the	NULL
immobilized	NULL
recombinant	NULL
BTK	NULL
protein	NULL
(	NULL
ligand	NULL
)	NULL
.	NULL

BTK	NULL
or	NULL
bovine	NULL
serum	NULL
albumin	NULL
(	NULL
con-trol	NULL
protein	NULL
)	NULL
was	NULL
covalently	NULL
linked	NULL
to	NULL
the	NULL
dextran	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
research	NULL
grade	NULL
CMS5	NULL
sensor	NULL
chips	NULL
via	NULL
primary	NULL
amino	NULL
groups	NULL
using	NULL
the	NULL
amine	NULL
coupling	NULL
kit	NULL
from	NULL
Amersham	NULL
Pharmacia	NULL
Biotech	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
(	NULL
Amersham	NULL
Pharmacia	NULL
Biotech	NULL
)	NULL
,	NULL
yielding	NULL
a	NULL
resonance	NULL
signal	NULL
of	NULL
2700	NULL
resonance	NULL
units	NULL
(	NULL
RU	NULL
)	NULL
(	NULL
1	NULL
RU	NULL
corresponds	NULL
to	NULL
an	NULL
immobilized	NULL
protein	NULL
amount	NULL
of	NULL
1	NULL
pg/mm	NULL
``	NULL
surface	NULL
)	NULL
.	NULL

Unreacted	NULL
moieties	NULL
on	NULL
the	NULL
surface	NULL
were	NULL
blocked	NULL
with	NULL
ethanolamine	NULL
.	NULL

The	NULL
STAT5A	NULL
protein	NULL
samples	NULL
were	NULL
diluted	NULL
in	NULL
PBS	NULL
buffer	NULL
(	NULL
1	NULL
mM	NULL
KH	NULL
,	NULL
PO	NULL
,	NULL
,	NULL
10	NULL
mM	NULL
Na	NULL
,	NULL
HPO	NULL
,	NULL
,	NULL
0.137	NULL
m	NULL
NaCl	NULL
,	NULL
2.7	NULL
mM	NULL
KCI	NULL
,	NULL
0.005	NULL
%	NULL
Tween	NULL
P-20	NULL
,	NULL
pH	NULL
7.4	NULL
)	NULL
to	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
50	NULL
nM	NULL
before	NULL
the	NULL
injection	NULL
.	NULL

Purified	NULL
STAT5A	NULL
protein	NULL
samples	NULL
in	NULL
HBS-EP	NULL
buffer	NULL
(	NULL
0.01	NULL
Hepes	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
0.15	NULL
M	NULL
sodium	NULL
chloride	NULL
,	NULL
3	NULL
mM	NULL
EDTA	NULL
,	NULL
0.005	NULL
%	NULL
polysorbate	NULL
20	NULL
(	NULL
v/v	NULL
)	NULL
)	NULL
was	NULL
injected	NULL
in	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
75	NULL
ul	NULL
containing	NULL
20-80	NULL
ug	NULL
of	NULL
purified	NULL
protein	NULL
.	NULL

Samples	NULL
were	NULL
injected	NULL
at	NULL
25	NULL
°C	NULL
at	NULL
a	NULL
flow	NULL
rate	NULL
of	NULL
15	NULL
ul/min	NULL
onto	NULL
the	NULL
sensor	NULL
chip	NULL
surface	NULL
on	NULL
which	NULL
the	NULL
BTK	NULL
protein	NULL
had	NULL
been	NULL
immobilized	NULL
or	NULL
onto	NULL
a	NULL
control	NULL
surface	NULL
on	NULL
which	NULL
bovine	NULL
serum	NULL
albumin	NULL
had	NULL
been	NULL
immobilized	NULL
.	NULL

Binding	NULL
surface	NULL
was	NULL
regenerated	NULL
by	NULL
washing	NULL
with	NULL
2	NULL
M	NULL
NaCl	NULL
.	NULL

The	NULL
primary	NULL
data	NULL
were	NULL
analyzed	NULL
using	NULL
the	NULL
BlAevaluation	NULL
software	NULL
(	NULL
version	NULL
3.0	NULL
)	NULL
supplied	NULL
with	NULL
the	NULL
instrument	NULL
(	NULL
Biacore	NULL
,	NULL
Inc.	NULL
)	NULL
.	NULL

To	NULL
prepare	NULL
the	NULL
data	NULL
for	NULL
analysis	NULL
,	NULL
base	NULL
lines	NULL
were	NULL
adjusted	NULL
to	NULL
zero	NULL
for	NULL
all	NULL
curves	NULL
,	NULL
and	NULL
injection	NULL
start	NULL
times	NULL
were	NULL
aligned	NULL
.	NULL

Background	NULL
sensorgrams	NULL
were	NULL
then	NULL
subtracted	NULL
from	NULL
the	NULL
experimental	NULL
sensorgrams	NULL
to	NULL
yield	NULL
curves	NULL
representing	NULL
specific	NULL
binding	NULL
.	NULL

All	NULL
of	NULL
the	NULL
kinetic	NULL
data	NULL
were	NULL
fit	NULL
most	NULL
adequately	NULL
by	NULL
assuming	NULL
a	NULL
simple	NULL
bimolecular	NULL
reaction	NULL
model	NULL
for	NULL
interaction	NULL
between	NULL
soluble	NULL
analyte	NULL
and	NULL
immobilized	NULL
ligand	NULL
,	NULL
equivalent	NULL
to	NULL
the	NULL
Langmuir	NULL
isotherm	NULL
for	NULL
adsorption	NULL
to	NULL
a	NULL
surface	NULL
.	NULL

For	NULL
determination	NULL
of	NULL
k	NULL
,	NULL
,	NULL
,	NULL
only	NULL
the	NULL
middle	NULL
portion	NULL
of	NULL
the	NULL
association	NULL
curve	NULL
was	NULL
used	NULL
for	NULL
fitting	NULL
.	NULL

For	NULL
determination	NULL
of	NULL
A	NULL
,	NULL
,	NULL
,	NULL
,	NULL
only	NULL
the	NULL
initial	NULL
portion	NULL
of	NULL
the	NULL
curve	NULL
encompassing	NULL
the	NULL
fast	NULL
dissociation	NULL
phase	NULL
was	NULL
used	NULL
for	NULL
fitting	NULL
.	NULL

The	NULL
goodness	NULL
of	NULL
fit	NULL
was	NULL
assessed	NULL
by	NULL
inspecting	NULL
the	NULL
statistical	NULL
value	NULL
y	NULL
``	NULL
and	NULL
the	NULL
residuals	NULL
(	NULL
ob-served	NULL
-	NULL
calculated	NULL
)	NULL
.	NULL

The	NULL
y	NULL
``	NULL
values	NULL
were	NULL
low	NULL
(	NULL
<	NULL
2	NULL
)	NULL
,	NULL
and	NULL
the	NULL
residuals	NULL
randomly	NULL
distributed	NULL
about	NULL
zero	NULL
.	NULL

RESULTS	NULL
AND	NULL
DISCUSSION	NULL
Physical	NULL
Interactions	NULL
between	NULL
STAT5SA	NULL
and	NULL
BTK-In	NULL
co-im-	NULL
munoprecipitation	NULL
experiments	NULL
using	NULL
Triton	NULL
X-100	NULL
whole	NULL
cell	NULL
lysates	NULL
from	NULL
KL-2	NULL
human	NULL
B	NULL
cells	NULL
,	NULL
we	NULL
discovered	NULL
that	NULL
BTK	NULL
immune	NULL
complexes	NULL
contain	NULL
STAT5A	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
;	NULL
see	NULL
A.2	NULL
,	NULL
first	NULL
lane	NULL
)	NULL
and	NULL
STAT5A	NULL
immune	NULL
complexes	NULL
contain	NULL
BTK	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
;	NULL
see	NULL
B.1	NULL
,	NULL
first	NULL
lane	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicated	NULL
that	NULL
BTK	NULL
is	NULL
consti-tutively	NULL
associated	NULL
with	NULL
STAT5A	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

Interestingly	NULL
,	NULL
this	NULL
physical	NULL
association	NULL
appeared	NULL
to	NULL
be	NULL
markedly	NULL
reduced	NULL
after	NULL
engagement	NULL
of	NULL
the	NULL
B	NULL
cell	NULL
antigen	NULL
receptor	NULL
.	NULL

No	NULL
STAT5A	NULL
was	NULL
detected	NULL
in	NULL
the	NULL
BTK	NULL
immune	NULL
complexes	NULL
from	NULL
whole	NULL
cell	NULL
lysates	NULL
prepared	NULL
after	NULL
20	NULL
min	NULL
of	NULL
stimulation	NULL
with	NULL
an	NULL
anti-IgM	NULL
antibody	NULL
(	NULL
Fig	NULL
.	NULL

14.2	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
although	NULL
there	NULL
was	NULL
as	NULL
much	NULL
BTK	NULL
in	NULL
these	NULL
immune	NULL
complexes	NULL
as	NULL
in	NULL
those	NULL
prepared	NULL
before	NULL
anti-IgM	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

14.1	NULL
)	NULL
,	NULL
and	NULL
the	NULL
Western	NULL
blot	NULL
analysis	NULL
of	NULL
the	NULL
whole	NULL
cell	NULL
lysates	NULL
with	NULL
the	NULL
same	NULL
anti-STAT5A	NULL
antibodies	NULL
did	NULL
not	NULL
indicate	NULL
any	NULL
change	NULL
in	NULL
the	NULL
amount	NULL
of	NULL
cellular	NULL
STAT5A	NULL
(	NULL
Fig	NULL
.	NULL

1A.3	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
virtually	NULL
no	NULL
BTK	NULL
was	NULL
detected	NULL
in	NULL
the	NULL
STAT5A	NULL
immune	NULL
complexes	NULL
from	NULL
whole	NULL
cell	NULL
lysates	NULL
prepared	NULL
after	NULL
anti	NULL
6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san	NULL
$	NULL
4g	NULL
/310-2q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wou	NULL
;	NULL
papeojumo	NULL
(	NULL
31220	NULL
STAT5A	NULL
as	NULL
a	NULL
Substrate	NULL
of	NULL
BTK	NULL
8	NULL
(	NULL
3	NULL
Ses	NULL
Ad	NULL
8	NULL
®	NULL
B.j	NULL
jag	NULL
3®	NULL
D.1	NULL
20	NULL
210	NULL
220	NULL
23	NULL
s	NULL
k	NULL
®	NULL
STAT5-_-v——J	NULL
BTK	NULL
-	NULL
Ls	NULL
we	NULL
Btk	NULL
»	NULL
as	NULL
1	NULL
BTK	NULL
IP	NULL
-	NULL
>	NULL
BTK	NULL
WB	NULL
STATSA	NULL
IP	NULL
-	NULL
>	NULL
BTK	NULL
WB	NULL
woes	NULL
cues	NULL
P4	NULL
25	NULL
26	NULL
27	NULL
-	NULL
28	NULL
29	NULL
STAT5A	NULL
»	NULL
STATSA—	NULL
STATS	NULL
-	NULL
e®	NULL
i	NULL
~	NULL
a	NULL
“	NULL
BTK	NULL
-	NULL
~~	NULL
se-	NULL
»	NULL
axe	NULL
CHP	NULL
CHP	NULL
BTK	NULL
IP	NULL
-	NULL
>	NULL
STATSA	NULL
WB	NULL
STAT5A	NULL
IP	NULL
-	NULL
>	NULL
STATSA	NULL
WB	NULL
8	NULL
&	NULL
&	NULL
&	NULL
&	NULL
STAT5£Ur	NULL
cuse	NULL
come	NULL
BTK-	NULL
we	NULL
mgs	NULL
E4	NULL
WCL	NULL
-	NULL
>	NULL
STATSA	NULL
WB	NULL
WCL	NULL
-	NULL
>	NULL
BTK	NULL
WB	NULL
-	NULL
-	NULL
‘	NULL
STATSA	NULL
STATSA	NULL
WB	NULL
C	NULL
P	NULL
&	NULL
a	NULL
_C	NULL
_£	NULL
E.2	NULL
wath	NULL
some	NULL
-BTK	NULL
'	NULL
C	NULL
®	NULL
€	NULL
(	NULL
&	NULL
“	NULL
$	NULL
9	NULL
BTK	NULL
WB	NULL
C	NULL
¥	NULL
4	NULL
A4	NULL
&	NULL
``	NULL
a	NULL
y	NULL
o	NULL
CC	NULL
FC	NULL
C	NULL
C	NULL
3°	NULL
STATSA	NULL
-	NULL
<	NULL
p	NULL
«	NULL
=-	NULL
w*	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

A	NULL
and	NULL
B	NULL
,	NULL
constitutive	NULL
association	NULL
of	NULL
BTK	NULL
with	NULL
STAT5A	NULL
.	NULL

A	NULL
,	NULL
detection	NULL
of	NULL
STAT5A	NULL
in	NULL
BTK	NULL
immune	NULL
complexes	NULL
.	NULL

BTK	NULL
was	NULL
immunoprecipitated	NULL
from	NULL
TX-100	NULL
lysates	NULL
of	NULL
KL-2	NULL
human	NULL
B	NULL
cells	NULL
before	NULL
(	NULL
-algM	NULL
)	NULL
or	NULL
20	NULL
min	NULL
after	NULL
(	NULL
+	NULL
«	NULL
algM	NULL
)	NULL
stimulation	NULL
with	NULL
an	NULL
anti-IgM	NULL
antibody	NULL
and	NULL
subjected	NULL
to	NULL
immunoblotting	NULL
with	NULL
anti-BTK	NULL
(	NULL
4.1	NULL
)	NULL
and	NULL
anti-STAT5A	NULL
(	NULL
4.2	NULL
)	NULL
antibodies	NULL
.	NULL

B	NULL
,	NULL
detection	NULL
of	NULL
BTK	NULL
in	NULL
STAT5A	NULL
immune	NULL
complexes	NULL
.	NULL

STAT5A	NULL
was	NULL
immunoprecipitated	NULL
from	NULL
TX-100	NULL
lysates	NULL
of	NULL
KL-2	NULL
human	NULL
B	NULL
cells	NULL
before	NULL
(	NULL
-algM	NULL
)	NULL
or	NULL
20	NULL
min	NULL
after	NULL
(	NULL
+aIgM	NULL
)	NULL
stimulation	NULL
with	NULL
an	NULL
anti-IgM	NULL
antibody	NULL
and	NULL
subjected	NULL
to	NULL
immunoblotting	NULL
with	NULL
anti-BTK	NULL
(	NULL
B.1	NULL
)	NULL
and	NULL
anti-STAT5A	NULL
(	NULL
B.2	NULL
)	NULL
antibodies	NULL
.	NULL

Whole	NULL
cell	NULL
lysate	NULL
proteins	NULL
were	NULL
also	NULL
subjected	NULL
to	NULL
immunoblotting	NULL
with	NULL
anti-STAT5A	NULL
(	NULL
4.3	NULL
)	NULL
and	NULL
anti-BTK	NULL
(	NULL
B.3	NULL
)	NULL
antibodies	NULL
.	NULL

C	NULL
,	NULL
binding	NULL
of	NULL
BTK	NULL
fusion	NULL
proteins	NULL
to	NULL
STAT5A	NULL
protein	NULL
in	NULL
human	NULL
B	NULL
cells	NULL
.	NULL

BTK-	NULL
(	NULL
1-659	NULL
)	NULL
(	NULL
full-length	NULL
protein	NULL
)	NULL
,	NULL
BTK-	NULL
(	NULL
408-659	NULL
)	NULL
(	NULL
kinase	NULL
domain	NULL
)	NULL
,	NULL
and	NULL
BTK-	NULL
(	NULL
2-137	NULL
)	NULL
(	NULL
PH	NULL
domain	NULL
)	NULL
were	NULL
fused	NULL
to	NULL
MBP	NULL
.	NULL

BTK-	NULL
(	NULL
219-268	NULL
)	NULL
(	NULL
SH3	NULL
domain	NULL
)	NULL
and	NULL
BTK-	NULL
(	NULL
281-377	NULL
)	NULL
(	NULL
SH2	NULL
domain	NULL
)	NULL
were	NULL
fused	NULL
to	NULL
GST	NULL
.	NULL

B	NULL
,	NULL
MBP-BTK	NULL
and	NULL
GST-BTK	NULL
fusion	NULL
proteins	NULL
were	NULL
used	NULL
in	NULL
pull-down	NULL
binding	NULL
assays	NULL
to	NULL
examine	NULL
their	NULL
ability	NULL
to	NULL
interact	NULL
with	NULL
STAT5A	NULL
protein	NULL
in	NULL
lysates	NULL
of	NULL
KL2	NULL
human	NULL
Epstein-Barr	NULL
virus-transformed	NULL
B	NULL
lymphoblastoid	NULL
cells	NULL
,	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

Fusion	NULL
protein	NULL
adsorbates	NULL
and	NULL
control	NULL
samples	NULL
(	NULL
CON	NULL
(	NULL
1	NULL
)	NULL
,	NULL
cell	NULL
lysate	NULL
+	NULL
amylose	NULL
beads	NULL
with	NULL
no	NULL
fusion	NULL
protein	NULL
added	NULL
;	NULL
CON	NULL
(	NULL
2	NULL
)	NULL
,	NULL
cell	NULL
lysate	NULL
+	NULL
glutathione-agarose	NULL
beads	NULL
,	NULL
no	NULL
fusion	NULL
protein	NULL
added	NULL
)	NULL
as	NULL
well	NULL
as	NULL
a	NULL
KL2	NULL
whole	NULL
cell	NULL
lysate	NULL
sample	NULL
were	NULL
resolved	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
immunoblotted	NULL
with	NULL
anti-STAT5A	NULL
antibody	NULL
,	NULL
and	NULL
developed	NULL
with	NULL
ECL	NULL
.	NULL

D	NULL
and	NULL
E	NULL
,	NULL
physical	NULL
association	NULL
between	NULL
ectopically	NULL
expressed	NULL
BTK	NULL
and	NULL
STAT5A	NULL
in	NULL
Sf21	NULL
cells	NULL
.	NULL

D	NULL
,	NULL
gel	NULL
filtration	NULL
analysis	NULL
.	NULL

Sf21	NULL
cells	NULL
coexpressing	NULL
BTK	NULL
and	NULL
STAT5A	NULL
were	NULL
lysed	NULL
and	NULL
cytosolic	NULL
fractions	NULL
were	NULL
recovered	NULL
then	NULL
analyzed	NULL
using	NULL
fast	NULL
protein	NULL
liquid	NULL
chromatography	NULL
at	NULL
a	NULL
flow	NULL
rate	NULL
of	NULL
0.5	NULL
ml/min	NULL
.	NULL

Fractions	NULL
(	NULL
0.5	NULL
ml	NULL
)	NULL
were	NULL
collected	NULL
and	NULL
subjected	NULL
to	NULL
Western	NULL
blotting	NULL
with	NULL
antibodies	NULL
specific	NULL
for	NULL
BTK	NULL
and	NULL
STAT5A	NULL
.	NULL

Proteins	NULL
were	NULL
visualized	NULL
using	NULL
ECL	NULL
and	NULL
analyzed	NULL
by	NULL
densitometry	NULL
.	NULL

The	NULL
numbers	NULL
20-34	NULL
correspond	NULL
to	NULL
fractions	NULL
,	NULL
and	NULL
arrows	NULL
below	NULL
the	NULL
blot	NULL
designate	NULL
the	NULL
predicted	NULL
size	NULL
of	NULL
the	NULL
complexes	NULL
based	NULL
upon	NULL
size	NULL
standards	NULL
.	NULL

E	NULL
,	NULL
precipitation	NULL
analysis	NULL
.	NULL

STAT5A	NULL
(	NULL
STAT5A	NULL
IP	NULL
)	NULL
and	NULL
BTK	NULL
immune	NULL
complexes	NULL
(	NULL
BTK	NULL
IP	NULL
)	NULL
as	NULL
well	NULL
as	NULL
whole	NULL
cell	NULL
lysates	NULL
(	NULL
WCL	NULL
)	NULL
were	NULL
subjected	NULL
to	NULL
Western	NULL
blot	NULL
(	NULL
WB	NULL
)	NULL
analyses	NULL
using	NULL
anti-STAT5A	NULL
and	NULL
anti-BTK	NULL
antibodies	NULL
.	NULL

The	NULL
arrowheads	NULL
indicate	NULL
the	NULL
positions	NULL
of	NULL
the	NULL
BTK	NULL
and	NULL
STAT5A	NULL
protein	NULL
bands	NULL
.	NULL

IgM	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

1B.1	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
although	NULL
there	NULL
was	NULL
as	NULL
much	NULL
STAT5A	NULL
in	NULL
these	NULL
immune	NULL
complexes	NULL
as	NULL
in	NULL
those	NULL
prepared	NULL
before	NULL
anti-IgM	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

18.2	NULL
)	NULL
,	NULL
and	NULL
the	NULL
Western	NULL
blot	NULL
analysis	NULL
of	NULL
the	NULL
whole	NULL
cell	NULL
lysates	NULL
with	NULL
the	NULL
same	NULL
anti-BTK	NULL
antibodies	NULL
did	NULL
not	NULL
indicate	NULL
any	NULL
change	NULL
in	NULL
the	NULL
amount	NULL
of	NULL
cellular	NULL
BTK	NULL
(	NULL
Fig	NULL
.	NULL

1B.3	NULL
)	NULL
.	NULL

These	NULL
observations	NULL
are	NULL
reminiscent	NULL
of	NULL
the	NULL
reported	NULL
association	NULL
between	NULL
BTK	NULL
and	NULL
the	NULL
multifunctional	NULL
transcription	NULL
factor	NULL
BAP-135/TFII-I	NULL
in	NULL
unstimulated	NULL
(	NULL
but	NULL
not	NULL
anti-IgM-stimulated	NULL
)	NULL
B	NULL
cells	NULL
(	NULL
17	NULL
)	NULL
.	NULL

We	NULL
performed	NULL
``	NULL
pull-down	NULL
``	NULL
experiments	NULL
with	NULL
full-length	NULL
MBP-BTK-	NULL
(	NULL
1-659	NULL
)	NULL
and	NULL
truncated	NULL
MBP-BTK	NULL
(	NULL
MBP-BTK-	NULL
(	NULL
408-659	NULL
)	NULL
,	NULL
BTK	NULL
kinase	NULL
domain	NULL
;	NULL
MBP-BTK-	NULL
(	NULL
2-137	NULL
)	NULL
,	NULL
BTK	NULL
PH	NULL
domain	NULL
)	NULL
or	NULL
GST-BTK	NULL
fusion	NULL
proteins	NULL
(	NULL
GST-BTK-	NULL
(	NULL
219-268	NULL
)	NULL
,	NULL
BTK	NULL
SH3	NULL
domain	NULL
;	NULL
GST-BTK-	NULL
(	NULL
281-377	NULL
)	NULL
,	NULL
BTK	NULL
SH2	NULL
domain	NULL
)	NULL
corresponding	NULL
to	NULL
different	NULL
domains	NULL
of	NULL
BTK	NULL
in	NULL
an	NULL
attempt	NULL
to	NULL
elucidate	NULL
the	NULL
structural	NULL
requirements	NULL
for	NULL
BTK	NULL
binding	NULL
to	NULL
STAT5A	NULL
.	NULL

Only	NULL
the	NULL
full-length	NULL
BTK	NULL
and	NULL
BTK	NULL
KD	NULL
were	NULL
able	NULL
to	NULL
bind	NULL
and	NULL
pull	NULL
down	NULL
STAT5A	NULL
from	NULL
lysates	NULL
of	NULL
KL2	NULL
human	NULL
Epstein-Barr	NULL
virus-transformed	NULL
B	NULL
lymphoblastoid	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
kinase	NULL
domain	NULL
appears	NULL
to	NULL
mediate	NULL
the	NULL
binding	NULL
of	NULL
BTK	NULL
to	NULL
STAT5A	NULL
.	NULL

We	NULL
next	NULL
set	NULL
out	NULL
to	NULL
examine	NULL
the	NULL
in	NULL
vivo	NULL
interactions	NULL
between	NULL
ectopically	NULL
expressed	NULL
BTK	NULL
and	NULL
STAT5A	NULL
proteins	NULL
in	NULL
a	NULL
heterologous	NULL
expression	NULL
system	NULL
.	NULL

To	NULL
confirm	NULL
that	NULL
a	NULL
physical	NULL
association	NULL
exists	NULL
between	NULL
BTK	NULL
and	NULL
STAT5A	NULL
when	NULL
they	NULL
are	NULL
coexpressed	NULL
in	NULL
Sf21	NULL
cells	NULL
,	NULL
we	NULL
examined	NULL
whether	NULL
BTK	NULL
and	NULL
STAT5A	NULL
are	NULL
present	NULL
as	NULL
native	NULL
complexes	NULL
Sf21	NULL
cells	NULL
cotransfected	NULL
with	NULL
PFB-statdba	NULL
+	NULL
PFB-btk	NULL
.	NULL

Lysates	NULL
of	NULL
Sf21	NULL
cells	NULL
were	NULL
size-fractionated	NULL
by	NULL
fast	NULL
protein	NULL
liquid	NULL
chromatography	NULL
on	NULL
a	NULL
Superdex	NULL
200	NULL
size	NULL
exclu-	NULL
sion	NULL
column	NULL
(	NULL
Amersham	NULL
Pharmacia	NULL
Biotech	NULL
)	NULL
,	NULL
and	NULL
the	NULL
elution	NULL
patterns	NULL
of	NULL
BTK	NULL
and	NULL
STAT5A	NULL
proteins	NULL
were	NULL
examined	NULL
by	NULL
immunoblotting	NULL
with	NULL
antibodies	NULL
recognizing	NULL
the	NULL
individual	NULL
proteins	NULL
.	NULL

The	NULL
relative	NULL
amounts	NULL
of	NULL
each	NULL
protein	NULL
per	NULL
fraction	NULL
were	NULL
determined	NULL
by	NULL
densitometric	NULL
scanning	NULL
.	NULL

More	NULL
than	NULL
90	NULL
%	NULL
of	NULL
the	NULL
BTK	NULL
protein	NULL
eluted	NULL
in	NULL
fractions	NULL
27-29	NULL
,	NULL
corresponding	NULL
to	NULL
apparent	NULL
native	NULL
molecular	NULL
masses	NULL
of	NULL
75-150	NULL
kDa	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
D.1	NULL
and	NULL
D.2	NULL
)	NULL
.	NULL

The	NULL
remainder	NULL
of	NULL
the	NULL
BTK	NULL
protein	NULL
eluted	NULL
in	NULL
fractions	NULL
21-26	NULL
,	NULL
which	NULL
correspond	NULL
to	NULL
apparent	NULL
native	NULL
molecular	NULL
masses	NULL
of	NULL
>	NULL
270	NULL
kDa	NULL
.	NULL

Notably	NULL
,	NULL
these	NULL
fractions	NULL
also	NULL
contained	NULL
STAT5A	NULL
protein	NULL
(	NULL
Fig	NULL
.	NULL

1D	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggested	NULL
the	NULL
existence	NULL
of	NULL
270-350-kDa	NULL
native	NULL
complexes	NULL
containing	NULL
BTK	NULL
and	NULL
STAT5A	NULL
.	NULL

We	NULL
next	NULL
used	NULL
Western	NULL
blot	NULL
analyses	NULL
to	NULL
evaluate	NULL
the	NULL
interaction	NULL
between	NULL
BTK	NULL
and	NULL
STAT5A	NULL
in	NULL
these	NULL
Sf21	NULL
cells	NULL
coexpressing	NULL
both	NULL
BTK	NULL
and	NULL
STAT5A	NULL
.	NULL

BTK	NULL
immune	NULL
complexes	NULL
from	NULL
these	NULL
whole	NULL
cell	NULL
lysates	NULL
contained	NULL
STAT5A	NULL
(	NULL
Fig	NULL
.	NULL

1K.1	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
and	NULL
STAT5A	NULL
immune	NULL
complexes	NULL
from	NULL
these	NULL
whole	NULL
cell	NULL
lysates	NULL
contained	NULL
BTK	NULL
(	NULL
Fig	NULL
.	NULL

15.2	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
initial	NULL
findings	NULL
indicated	NULL
that	NULL
,	NULL
when	NULL
ectopically	NULL
coexpressed	NULL
in	NULL
Sf21	NULL
cells	NULL
,	NULL
BTK	NULL
and	NULL
STAT5A	NULL
proteins	NULL
can	NULL
physically	NULL
associate	NULL
with	NULL
each	NULL
other	NULL
.	NULL

We	NULL
next	NULL
sought	NULL
to	NULL
examine	NULL
the	NULL
ability	NULL
of	NULL
purified	NULL
recombinant	NULL
BTK	NULL
to	NULL
bind	NULL
purified	NULL
recombinant	NULL
STAT5A	NULL
by	NULL
surface	NULL
plasmon	NULL
resonance	NULL
,	NULL
which	NULL
permits	NULL
direct	NULL
measurements	NULL
of	NULL
the	NULL
association	NULL
and	NULL
dissociation	NULL
kinetics	NULL
of	NULL
binding	NULL
interactions	NULL
.	NULL

Fig	NULL
.	NULL

2	NULL
shows	NULL
representative	NULL
BlAcore	NULL
sensorgrams	NULL
of	NULL
concentra-tion-dependent	NULL
solution	NULL
phase	NULL
>	NULL
95	NULL
%	NULL
pure	NULL
STAT5A	NULL
binding	NULL
to	NULL
immobilized	NULL
>	NULL
95	NULL
%	NULL
pure	NULL
BTK	NULL
on	NULL
BlAcore	NULL
sensor	NULL
chips	NULL
.	NULL

The	NULL
binding	NULL
traces	NULL
were	NULL
analyzed	NULL
assuming	NULL
a	NULL
single	NULL
bimolecular	NULL
6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san	NULL
$	NULL
4g	NULL
/310-2q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wou	NULL
;	NULL
papeojumo	NULL
(	NULL
STAT5A	NULL
as	NULL
a	NULL
Substrate	NULL
of	NULL
BTK	NULL
350	NULL
|-	NULL
l	NULL
310	NULL
|	NULL
270	NULL
|	NULL
3	NULL
230	NULL
|	NULL
CC	NULL
o	NULL
199	NULL
)	NULL
BTK	NULL
,	NULL
6.0	NULL
ug	NULL
&	NULL
1so	NULL
2.	NULL
g	NULL
``	NULL
*J	NULL
BTK	NULL
,	NULL
3.0	NULL
ug	NULL
50	NULL
}	NULL
_L	NULL
.	NULL

C	NULL
f	NULL
_	NULL
LLL	NULL
BTK	NULL
,	NULL
1.5	NULL
ug	NULL
30	NULL
}	NULL
are	NULL
t	NULL
TT-R	NULL
-__	NULL
e_	NULL
LLL	NULL
al	NULL
=	NULL
BSA	NULL
+50	NULL
1	NULL
1	NULL
1	NULL
1	NULL
1	NULL
1	NULL
1	NULL
i	NULL
i	NULL
|	NULL
100	NULL
-s0	NULL
_	NULL
40	NULL
110	NULL
i180	NULL
250	NULL
S20	NULL
soo	NULL
460	NULL
530	NULL
-	NULL
600	NULL
Time	NULL
(	NULL
sec	NULL
)	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Solution	NULL
phase	NULL
binding	NULL
interactions	NULL
between	NULL
BTK	NULL
and	NULL
STAT5A	NULL
.	NULL

A	NULL
representative	NULL
BlAcore	NULL
sensorgram	NULL
shows	NULL
the	NULL
binding	NULL
of	NULL
purified	NULL
recombinant	NULL
STAT5A	NULL
to	NULL
the	NULL
purified	NULL
recombinant	NULL
BTK	NULL
protein	NULL
immobilized	NULL
on	NULL
a	NULL
CMS	NULL
sensor	NULL
chip	NULL
.	NULL

STAT5A	NULL
protein	NULL
was	NULL
injected	NULL
at	NULL
time	NULL
0	NULL
and	NULL
exposed	NULL
to	NULL
the	NULL
surface	NULL
for	NULL
300	NULL
s	NULL
(	NULL
association	NULL
phase	NULL
)	NULL
,	NULL
followed	NULL
by	NULL
a	NULL
5-min	NULL
flow	NULL
of	NULL
Hepes-EP	NULL
buffer	NULL
during	NULL
which	NULL
dissociation	NULL
could	NULL
be	NULL
observed	NULL
.	NULL

binding	NULL
equilibrium	NULL
between	NULL
BTK	NULL
and	NULL
STAT5A	NULL
proteins	NULL
.	NULL

The	NULL
maximum	NULL
resonance	NULL
signal	NULL
(	NULL
R	NULL
,	NULL
,	NULL
,	NULL
,	NULL
,	NULL
)	NULL
increased	NULL
in	NULL
a	NULL
concentration-dependent	NULL
fashion	NULL
from	NULL
49.6	NULL
RU	NULL
at	NULL
20	NULL
ug/ml	NULL
STAT5A	NULL
to	NULL
169	NULL
RU	NULL
at	NULL
40	NULL
ug/ml	NULL
STAT5A	NULL
and	NULL
238	NULL
RU	NULL
at	NULL
80	NULL
ug/ml	NULL
STAT5A	NULL
.	NULL

The	NULL
kinetics	NULL
of	NULL
the	NULL
binding	NULL
was	NULL
independent	NULL
of	NULL
the	NULL
STAT5A	NULL
con-centration	NULL
.	NULL

The	NULL
average	NULL
on-rate	NULL
(	NULL
K	NULL
,	NULL
,	NULL
,	NULL
)	NULL
was	NULL
3.0	NULL
+	NULL
0.9	NULL
X	NULL
104	NULL
~	NULL
'	NULL
s	NULL
~*	NULL
,	NULL
the	NULL
average	NULL
off-rate	NULL
(	NULL
Reg	NULL
)	NULL
was	NULL
11.1	NULL
+	NULL
0.3	NULL
%	NULL
10~*	NULL
s~	NULL
'	NULL
,	NULL
and	NULL
the	NULL
average	NULL
affinity	NULL
constant	NULL
(	NULL
KD	NULL
=	NULL
k	NULL
,	NULL
w/k	NULL
,	NULL
,	NULL
)	NULL
was	NULL
44.4	NULL
+	NULL
13.0	NULL
nM	NULL
.	NULL

These	NULL
results	NULL
provide	NULL
unprecedented	NULL
experimental	NULL
evidence	NULL
that	NULL
BTK	NULL
is	NULL
capable	NULL
of	NULL
directly	NULL
binding	NULL
STAT5A	NULL
with	NULL
a	NULL
relatively	NULL
high	NULL
affinity	NULL
.	NULL

Tyrosine	NULL
Phosphorylation	NULL
of	NULL
STAT5A	NULL
by	NULL
BTK-We	NULL
have	NULL
performed	NULL
a	NULL
series	NULL
of	NULL
experiments	NULL
to	NULL
further	NULL
confirm	NULL
and	NULL
extend	NULL
these	NULL
initial	NULL
observations	NULL
.	NULL

Sf21	NULL
cells	NULL
transfected	NULL
with	NULL
PFB-statba	NULL
expressed	NULL
the	NULL
recombinant	NULL
murine	NULL
STAT5A	NULL
protein	NULL
,	NULL
as	NULL
detected	NULL
by	NULL
anti-STAT5A	NULL
immunoblotting	NULL
of	NULL
STAT5A	NULL
immune	NULL
complexes	NULL
from	NULL
whole	NULL
cell	NULL
lysates	NULL
prepared	NULL
48	NULL
h	NULL
after	NULL
transfec-tion	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

By	NULL
comparison	NULL
,	NULL
control	NULL
Sf21	NULL
cells	NULL
transfected	NULL
with	NULL
PFB	NULL
did	NULL
not	NULL
show	NULL
any	NULL
evidence	NULL
of	NULL
STAT5A	NULL
expression	NULL
,	NULL
demonstrating	NULL
that	NULL
the	NULL
anti-STAT5A	NULL
antibody	NULL
used	NULL
for	NULL
immunoblotting	NULL
does	NULL
not	NULL
recognize	NULL
an	NULL
endogenous	NULL
insect	NULL
STAT5A	NULL
protein	NULL
.	NULL

The	NULL
anti-phosphotyrosine	NULL
Western	NULL
blot	NULL
analysis	NULL
of	NULL
the	NULL
STAT5A	NULL
immune	NULL
complexes	NULL
from	NULL
Sf21	NULL
cells	NULL
transfected	NULL
with	NULL
PFB-stat5a	NULL
did	NULL
not	NULL
show	NULL
any	NULL
evidence	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
.	NULL

Thus	NULL
,	NULL
insect	NULL
kinases	NULL
in	NULL
Sf21	NULL
cells	NULL
do	NULL
not	NULL
significantly	NULL
phosphorylate	NULL
recombinant	NULL
STAT5A	NULL
in	NULL
vivo	NULL
.	NULL

We	NULL
next	NULL
sought	NULL
to	NULL
determine	NULL
if	NULL
coexpression	NULL
of	NULL
STAT5A	NULL
with	NULL
BTK	NULL
leads	NULL
to	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT5A	NULL
in	NULL
vivo	NULL
.	NULL

Controls	NULL
included	NULL
Sf21	NULL
cells	NULL
co-transfected	NULL
with	NULL
PFB-statd	NULL
@	NULL
and	NULL
recombinant	NULL
plasmids	NULL
for	NULL
TEC	NULL
or	NULL
JAK3	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3B.1	NULL
(	NULL
first	NULL
lane	NULL
)	NULL
and	NULL
Fig	NULL
.	NULL

3C	NULL
.	NULL

1	NULL
(	NULL
second	NULL
lane	NULL
)	NULL
,	NULL
anti-phosphotyrosine	NULL
Western	NULL
blot	NULL
analysis	NULL
of	NULL
STAT5A	NULL
immune	NULL
complexes	NULL
from	NULL
Sf21	NULL
cells	NULL
cotransfected	NULL
with	NULL
PFB-statd	NULL
@	NULL
+	NULL
PFB-btk	NULL
showed	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT5A	NULL
protein	NULL
.	NULL

The	NULL
level	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT5A	NULL
in	NULL
Sf21	NULL
cells	NULL
coexpressing	NULL
BTK	NULL
was	NULL
similar	NULL
to	NULL
that	NULL
in	NULL
Sf21	NULL
cells	NULL
coexpressing	NULL
JAK3	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
no	NULL
STAT5A	NULL
tyrosine	NULL
phosphorylation	NULL
was	NULL
observed	NULL
in	NULL
Sf21	NULL
cells	NULL
coexpressing	NULL
TEC	NULL
kinase	NULL
(	NULL
Fig	NULL
.	NULL

3B.1	NULL
,	NULL
second	NULL
lane	NULL
,	NULL
and	NULL
Fig	NULL
.	NULL

3C.1	NULL
.	NULL

,	NULL
third	NULL
lane	NULL
)	NULL
.	NULL

STAT5A	NULL
was	NULL
expressed	NULL
at	NULL
similar	NULL
levels	NULL
in	NULL
each	NULL
of	NULL
the	NULL
transfectants	NULL
(	NULL
Fig	NULL
.	NULL

3B.2	NULL
and	NULL
3C.2	NULL
)	NULL
,	NULL
and	NULL
all	NULL
three	NULL
tyrosine	NULL
kinases	NULL
were	NULL
enzymatically	NULL
active	NULL
in	NULL
Sf21	NULL
cells	NULL
,	NULL
as	NULL
shown	NULL
by	NULL
their	NULL
ability	NULL
to	NULL
phosphorylate	NULL
an	NULL
exogenous	NULL
substrate	NULL
(	NULL
GST	NULL
for	NULL
Tec	NULL
family	NULL
members	NULL
and	NULL
B-casein	NULL
for	NULL
JAK3	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

3B.3	NULL
)	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
both	NULL
BTK	NULL
and	NULL
JAK3	NULL
to	NULL
tyrosine-phospho-rylate	NULL
STAT5A	NULL
was	NULL
dependent	NULL
on	NULL
the	NULL
enzymatic	NULL
activity	NULL
of	NULL
31221	NULL
STAT-5A	NULL
IP	NULL
4	NULL
&	NULL
&	NULL
«	NULL
&	NULL
3	NULL
,	NULL
``	NULL
$	NULL
49	NULL
p	NULL
G	NULL
rus	NULL
y	NULL
Ad	NULL
a	NULL
&	NULL
&	NULL
&	NULL
&	NULL
&	NULL
%	NULL
<	NULL
C.1	NULL
€	NULL
@	NULL
C	NULL
(	NULL
Da	NULL
QQ	NULL
QQ	NULL
(	NULL
j	NULL
:	NULL
QQ	NULL
5°	NULL
9	NULL
$	NULL
200-	NULL
kDa	NULL
STATSA	NULL
IP	NULL
96	NULL
wane	NULL
APT	NULL
wB	NULL
97-	NULL
w-	NULL
-	NULL
STAT5A	NULL
69	NULL
46	NULL
:	NULL
a	NULL
C.2	NULL
«	NULL
atms	NULL
sme	NULL
eames	NULL
.	NULL

<	NULL
STATSA	NULL
STATSA	NULL
WB	NULL
__	NULL
APT	NULL
WB	NULL
S0	NULL
eA	NULL
ar	NULL
STAT	NULL
5A	NULL
WB	NULL
69-o	NULL
$	NULL
4	NULL
:	NULL
&	NULL
Sé	NULL
‘	NULL
.	NULL

*y	NULL
¢	NULL
``	NULL
£	NULL
CAA	NULL
$	NULL
$	NULL
&	NULL
&	NULL
&	NULL
&	NULL
&	NULL
+	NULL
gs	NULL
v9	NULL
?	NULL

“	NULL
&	NULL
(	NULL
we	NULL
?	NULL

B.1	NULL
I	NULL
D.1	NULL
V163	NULL
v5	NULL
“	NULL
V159	NULL
:	NULL
«	NULL
pa	NULL
«	NULL
f	NULL
kDa	NULL
&	NULL
F	NULL
F	NULL
6	NULL
$	NULL
kDa	NULL
200-	NULL
97-	NULL
wame	NULL
LJ	NULL
-	NULL
STAT5A	NULL
STAT5A	NULL
IP	NULL
--	NULL
APT	NULL
WB	NULL
STATSA	NULL
IP	NULL
Ret	NULL
we	NULL
``	NULL
--	NULL
-statsa	NULL
--	NULL
D2	NULL
97	NULL
-	NULL
eens	NULL
(	NULL
lip	NULL
weet	NULL
we	NULL
-	NULL
<	NULL
STAT	NULL
SA	NULL
eo-wo	NULL
«	NULL
-a	NULL
w	NULL
»	NULL
|	NULL
a	NULL
un	NULL
ws	NULL
STAT5A	NULL
IP-	NULL
»	NULL
STATSA	NULL
WB	NULL
B.2	NULL
statsa	NULL
i	NULL
»	NULL
|	NULL
07	NULL
-	NULL
eme	NULL
-STAT5A	NULL
STAT5A	NULL
WB	NULL
mass	NULL
sums	NULL
as	NULL
«	NULL
\	NULL
...	NULL
#	NULL
Kinase	NULL
IP	NULL
KA	NULL
'	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

In	NULL
vivo	NULL
phosphorylation	NULL
of	NULL
ectopically	NULL
expressed	NULL
STAT5A	NULL
by	NULL
BTK	NULL
in	NULL
a	NULL
heterologous	NULL
expression	NULL
system	NULL
.	NULL

A	NULL
,	NULL
expression	NULL
of	NULL
STAT5A	NULL
in	NULL
Sf21	NULL
cells	NULL
.	NULL

Sf21	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
PFB	NULL
or	NULL
PFB-stat5a	NULL
.	NULL

After	NULL
48	NULL
h	NULL
,	NULL
cells	NULL
were	NULL
lysed	NULL
,	NULL
lysates	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
anti-STAT5A	NULL
antibodies	NULL
,	NULL
and	NULL
immune	NULL
complexes	NULL
were	NULL
subjected	NULL
to	NULL
Western	NULL
blot	NULL
analysis	NULL
with	NULL
anti-STAT5A	NULL
or	NULL
anti-phosphotyrosine	NULL
(	NULL
APT	NULL
)	NULL
antibodies	NULL
.	NULL

B	NULL
and	NULL
C	NULL
,	NULL
coexpression	NULL
of	NULL
STAT5A	NULL
with	NULL
Tec	NULL
family	NULL
tyrosine	NULL
kinases	NULL
or	NULL
JAK3	NULL
in	NULL
Sf21	NULL
cells	NULL
.	NULL

STAT5A	NULL
was	NULL
co-expressed	NULL
with	NULL
BTK	NULL
,	NULL
TEC	NULL
,	NULL
or	NULL
JAK3	NULL
.	NULL

STAT5A	NULL
was	NULL
immunoprecipitated	NULL
,	NULL
and	NULL
immune	NULL
complexes	NULL
were	NULL
subjected	NULL
to	NULL
Western	NULL
blot	NULL
analysis	NULL
with	NULL
anti-phosphotyrosine	NULL
(	NULL
B	NULL
.	NULL

1	NULL
and	NULL
C.1	NULL
)	NULL
or	NULL
anti-STAT5A	NULL
(	NULL
B.2	NULL
and	NULL
C.2	NULL
)	NULL
antibodies	NULL
.	NULL

The	NULL
enzymatic	NULL
activities	NULL
of	NULL
the	NULL
expressed	NULL
tyrosine	NULL
kinases	NULL
were	NULL
measured	NULL
by	NULL
phosphorylation	NULL
of	NULL
exogenous	NULL
substrates	NULL
(	NULL
GST	NULL
-Iga	NULL
for	NULL
Tec	NULL
family	NULL
members	NULL
and	NULL
B-casein	NULL
for	NULL
JAK3	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
[	NULL
y-*	NULL
``	NULL
P	NULL
]	NULL
JATP	NULL
(	NULL
B.3	NULL
)	NULL
.	NULL

D	NULL
,	NULL
requirement	NULL
for	NULL
an	NULL
active	NULL
kinase	NULL
domain	NULL
for	NULL
BTK-induced	NULL
or	NULL
JAK3-induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT5A	NULL
.	NULL

STAT5A	NULL
was	NULL
coexpressed	NULL
with	NULL
JAK3	NULL
,	NULL
kinase-inactive	NULL
JAK3	NULL
mutant	NULL
,	NULL
BTK	NULL
,	NULL
or	NULL
kinase-inactive	NULL
BTK	NULL
mutant	NULL
.	NULL

STAT5A	NULL
was	NULL
immunoprecipitated	NULL
,	NULL
and	NULL
immune	NULL
complexes	NULL
were	NULL
subjected	NULL
to	NULL
Western	NULL
blot	NULL
analysis	NULL
with	NULL
anti-phospho-	NULL
tyrosine	NULL
(	NULL
D.1	NULL
)	NULL
or	NULL
anti-STAT5A	NULL
(	NULL
D.2	NULL
)	NULL
antibodies	NULL
.	NULL

-	NULL
GST-ige	NULL
:	NULL
-	NULL
B-casain	NULL
their	NULL
respective	NULL
kinase	NULL
domains	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3D	NULL
,	NULL
coexpression	NULL
of	NULL
kinase-dead	NULL
mutants	NULL
of	NULL
BTK	NULL
(	NULL
Y551F	NULL
,	NULL
BTK®*	NULL
``	NULL
``	NULL
*	NULL
``	NULL
)	NULL
or	NULL
JAK3	NULL
(	NULL
K851E	NULL
,	NULL
JAK3*	NULL
``	NULL
*	NULL
``	NULL
)	NULL
did	NULL
not	NULL
result	NULL
in	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STATS5A	NULL
.	NULL

We	NULL
next	NULL
used	NULL
in	NULL
vitro	NULL
kinase	NULL
assays	NULL
to	NULL
determine	NULL
if	NULL
BTK	NULL
can	NULL
phosphorylate	NULL
STAT5A	NULL
.	NULL

BTK	NULL
immune	NULL
complexes	NULL
from	NULL
whole	NULL
cell	NULL
lysates	NULL
of	NULL
Sf21	NULL
cells	NULL
transfected	NULL
with	NULL
PFB-btk	NULL
were	NULL
mixed	NULL
with	NULL
purified	NULL
STAT5A	NULL
(	NULL
10	NULL
ug	NULL
)	NULL
and	NULL
10	NULL
Ci	NULL
of	NULL
[	NULL
y-SZP	NULL
]	NULL
)	NULL
ATP	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
5	NULL
mM	NULL
each	NULL
of	NULL
Mncl	NULL
,	NULL
and	NULL
MgSQO	NULL
,	NULL
.	NULL

TEC	NULL
from	NULL
PFB-tec-transfected	NULL
Sf21	NULL
cells	NULL
and	NULL
JAK3	NULL
from	NULL
PFB-jak3-transfected	NULL
Sf21	NULL
cells	NULL
were	NULL
also	NULL
included	NULL
for	NULL
comparison	NULL
.	NULL

The	NULL
kinase	NULL
reactions	NULL
were	NULL
stopped	NULL
after	NULL
10	NULL
min	NULL
,	NULL
STAT5A	NULL
was	NULL
immunoprecipitated	NULL
,	NULL
and	NULL
its	NULL
phosphorylation	NULL
status	NULL
was	NULL
assessed	NULL
by	NULL
autoradiography	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
BTK	NULL
was	NULL
capable	NULL
of	NULL
phosphorylating	NULL
STAT5A	NULL
.	NULL

The	NULL
phosphorylation	NULL
level	NULL
of	NULL
BTK-treated	NULL
STAT5A	NULL
was	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
JAK3-treated	NULL
STAT5A	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
BTK	NULL
,	NULL
TEC	NULL
did	NULL
not	NULL
phosphorylate	NULL
STAT5A	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
STAT5A	NULL
was	NULL
virtually	NULL
identical	NULL
in	NULL
each	NULL
kinase	NULL
reaction	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
and	NULL
all	NULL
three	NULL
tyrosine	NULL
kinases	NULL
,	NULL
including	NULL
TEC	NULL
,	NULL
were	NULL
enzymatically	NULL
active	NULL
,	NULL
as	NULL
meas-	NULL
6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san	NULL
$	NULL
4g	NULL
/310-2q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wou	NULL
;	NULL
papeojumo	NULL
(	NULL
31222	NULL
&	NULL
/	NULL
&	NULL
a*	NULL
&	NULL
-	NULL
€	NULL
+	NULL
kDa	NULL
<	NULL
6	NULL
“	NULL
&	NULL
y	NULL
A	NULL
U	NULL
%	NULL
R	NULL
_	NULL
©	NULL
-	NULL
-	NULL
>	NULL
C	NULL
WAD	NULL
-sa	NULL
<	NULL
s	NULL
97	NULL
BTK	NULL
»	NULL
»	NULL
-	NULL
wih	NULL
e	NULL
With	NULL
<	NULL
TEC	NULL
L	NULL
can	NULL
d	NULL
«	NULL
meus	NULL
46-o	NULL
.	NULL

69	NULL
'	NULL
+	NULL
PS	NULL
46	NULL
==	NULL
.	NULL

-a	NULL
f	NULL
+oPT	NULL
30	NULL
~	NULL
2+	NULL
-	NULL
<	NULL
a	NULL
.	NULL

e	NULL
PY	NULL
21.5-N	NULL
#	NULL
_	NULL
-	NULL
<	NULL
14.3-yess	NULL
|	NULL
Fon	NULL
|	NULL
os	NULL
[	NULL
sxs	NULL
|	NULL
ta	NULL
Jc	NULL
AA	NULL
-	NULL
A	NULL
A	NULL
_-	NULL
A	NULL
&	NULL
A	NULL
A	NULL
A4	NULL
&	NULL
A	NULL
A	NULL
A	NULL
AAA	NULL
``	NULL
s	NULL
$	NULL
8	NULL
¢	NULL
1	NULL
§	NULL
ts	NULL
€	NULL
R	NULL
2	NULL
Sags	NULL
17	NULL
KD	NULL
STAT5A	NULL
CNBr	NULL
Cleavage	NULL
Map	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

A-C	NULL
,	NULL
in	NULL
vitro	NULL
phosphorylation	NULL
of	NULL
STAT5A	NULL
by	NULL
BTK	NULL
.	NULL

Sf21	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
PFB-btk	NULL
,	NULL
PFB-tec	NULL
,	NULL
or	NULL
PFB-jak3	NULL
.	NULL

A	NULL
,	NULL
cell	NULL
lysates	NULL
from	NULL
various	NULL
transfectants	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
specific	NULL
antibodies	NULL
,	NULL
and	NULL
the	NULL
immune-complexes	NULL
were	NULL
mixed	NULL
with	NULL
purified	NULL
STAT5A	NULL
and	NULL
[	NULL
y-*P	NULL
]	NULL
JATP	NULL
.	NULL

The	NULL
kinase	NULL
reactions	NULL
were	NULL
stopped	NULL
by	NULL
adding	NULL
radioimmune	NULL
precipitation	NULL
buffer	NULL
(	NULL
20	NULL
mM	NULL
MOPS	NULL
,	NULL
pH	NULL
7	NULL
,	NULL
150	NULL
mM	NULL
NaCl	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
1	NULL
%	NULL
sodium	NULL
deoxycholate	NULL
,	NULL
0.1	NULL
%	NULL
SDS	NULL
)	NULL
,	NULL
centrifuged	NULL
at	NULL
12,000	NULL
rpm	NULL
,	NULL
and	NULL
the	NULL
supernatants	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
an	NULL
anti-STAT5A	NULL
antibody	NULL
.	NULL

The	NULL
phosphorylation	NULL
status	NULL
of	NULL
the	NULL
immunoprecipitated	NULL
STAT5A	NULL
was	NULL
determined	NULL
by	NULL
autoradiography	NULL
.	NULL

B	NULL
,	NULL
the	NULL
amount	NULL
of	NULL
STAT5A	NULL
in	NULL
each	NULL
kinase	NULL
reaction	NULL
was	NULL
determined	NULL
by	NULL
STAT5A	NULL
immunoprecipitation	NULL
and	NULL
anti-STAT5A	NULL
immunoblotting	NULL
.	NULL

C	NULL
,	NULL
the	NULL
enzymatic	NULL
activity	NULL
of	NULL
the	NULL
immunoprecipitated	NULL
tyrosine	NULL
kinases	NULL
was	NULL
measured	NULL
by	NULL
autophosphorylation	NULL
in	NULL
immune	NULL
complex	NULL
kinase	NULL
assays	NULL
.	NULL

D-F	NULL
,	NULL
phosphoamino	NULL
acid	NULL
analysis	NULL
(	NULL
PAA	NULL
)	NULL
and	NULL
cyanogen	NULL
bromide	NULL
(	NULL
CNBr	NULL
)	NULL
cleavage	NULL
analysis	NULL
of	NULL
BTK-phosphorylated	NULL
STAT5A	NULL
.	NULL

BTK	NULL
was	NULL
immunoprecipitated	NULL
from	NULL
lysates	NULL
of	NULL
PFB-btk-transfected	NULL
Sf21	NULL
cells	NULL
and	NULL
an	NULL
immune	NULL
complex	NULL
kinase	NULL
assay	NULL
was	NULL
performed	NULL
with	NULL
purified	NULL
STAT5A	NULL
and	NULL
[	NULL
y-*°P	NULL
]	NULL
JATP	NULL
.	NULL

The	NULL
reaction	NULL
was	NULL
stopped	NULL
with	NULL
radicimmune	NULL
precipitation	NULL
.	NULL

buffer	NULL
,	NULL
and	NULL
STAT5A	NULL
was	NULL
immunoprecipitated	NULL
and	NULL
run	NULL
on	NULL
a	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

The	NULL
*°P-labeled	NULL
STAT5A	NULL
band	NULL
was	NULL
isolated	NULL
and	NULL
subjected	NULL
to	NULL
PAA	NULL
(	NULL
shown	NULL
in	NULL
D	NULL
)	NULL
or	NULL
CNBr	NULL
cleavage	NULL
analysis	NULL
(	NULL
shown	NULL
in	NULL
E	NULL
)	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
ninhydrin-stained	NULL
phosphoamino	NULL
acid	NULL
standards	NULL
(	NULL
phospho-serine	NULL
(	NULL
PS	NULL
)	NULL
,	NULL
phosphotyrosine	NULL
(	NULL
PY	NULL
)	NULL
,	NULL
and	NULL
phosphothreonine	NULL
(	NULL
PT	NULL
)	NULL
)	NULL
are	NULL
indicated	NULL
with	NULL
circles	NULL
.	NULL

The	NULL
CNBr	NULL
cleavage	NULL
map	NULL
of	NULL
STAT5A	NULL
is	NULL
depicted	NULL
in	NULL
F	NULL
,	NULL
with	NULL
arrowheads	NULL
pointing	NULL
to	NULL
the	NULL
positions	NULL
of	NULL
methionines	NULL
.	NULL

ured	NULL
by	NULL
autophosphorylation	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4D	NULL
,	NULL
phosphoamino	NULL
acid	NULL
analysis	NULL
of	NULL
the	NULL
BTK-phosphorylated	NULL
STAT5A	NULL
protein	NULL
confirmed	NULL
that	NULL
BTK	NULL
phosphorylates	NULL
STAT5A	NULL
exclusively	NULL
on	NULL
tyrosine	NULL
residues	NULL
.	NULL

CNBr	NULL
cleavage	NULL
of	NULL
BTK-phosphorylated	NULL
STAT5A	NULL
protein	NULL
yielded	NULL
a	NULL
single	NULL
phosphopeptide	NULL
of	NULL
~17	NULL
kDa	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
£	NULL
and	NULL
F	NULL
)	NULL
.	NULL

This	NULL
fragment	NULL
contains	NULL
the	NULL
tyrosine	NULL
STAT5A	NULL
as	NULL
a	NULL
Substrate	NULL
of	NULL
BTK	NULL
residues	NULL
at	NULL
positions	NULL
665	NULL
,	NULL
668	NULL
,	NULL
682	NULL
,	NULL
683	NULL
,	NULL
and	NULL
694	NULL
as	NULL
well	NULL
as	NULL
the	NULL
SH2	NULL
domain	NULL
and	NULL
a	NULL
portion	NULL
of	NULL
the	NULL
SH3	NULL
domain	NULL
.	NULL

Identification	NULL
of	NULL
Tyrosine	NULL
694	NULL
of	NULL
STAT5A	NULL
as	NULL
the	NULL
Target	NULL
Phosphorylation	NULL
Site	NULL
for	NULL
BTK	NULL
Kinase	NULL
Domain-We	NULL
constructed	NULL
a	NULL
molecular	NULL
model	NULL
of	NULL
the	NULL
STATS5A	NULL
structure	NULL
(	NULL
residues	NULL
163-703	NULL
)	NULL
based	NULL
on	NULL
its	NULL
homology	NULL
with	NULL
STAT1	NULL
and	NULL
STAT3	NULL
$	NULL
crystal	NULL
structures	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

A	NULL
flexible	NULL
or	NULL
B-strand-like	NULL
conformation	NULL
is	NULL
a	NULL
desired	NULL
structural	NULL
feature	NULL
for	NULL
effective	NULL
phosphorylation	NULL
of	NULL
protein	NULL
substrates	NULL
by	NULL
protein	NULL
kinases	NULL
.	NULL

Similar	NULL
to	NULL
the	NULL
structural	NULL
conformation	NULL
revealed	NULL
by	NULL
the	NULL
STAT1	NULL
and	NULL
STAT3B	NULL
crystal	NULL
structures	NULL
,	NULL
our	NULL
model	NULL
indicates	NULL
that	NULL
the	NULL
tail	NULL
segment	NULL
of	NULL
STAT5A	NULL
from	NULL
residue	NULL
693	NULL
to	NULL
residue	NULL
703	NULL
(	NULL
694	NULL
included	NULL
)	NULL
adopts	NULL
a	NULL
B-strand-like	NULL
conformation	NULL
,	NULL
which	NULL
is	NULL
therefore	NULL
suitable	NULL
for	NULL
binding	NULL
interactions	NULL
with	NULL
the	NULL
BTK	NULL
kinase	NULL
domain	NULL
.	NULL

Tyr©	NULL
``	NULL
*	NULL
of	NULL
STAT5A	NULL
is	NULL
in	NULL
close	NULL
contact	NULL
with	NULL
the	NULL
BTK	NULL
catalytic	NULL
residues	NULL
including	NULL
Asp	NULL
``	NULL
,	NULL
Arg	NULL
``	NULL
,	NULL
and	NULL
Asn®	NULL
``	NULL
°	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
Gly*	NULL
``	NULL
,	NULL
Val	NULL
``	NULL
,	NULL
and	NULL
Lys®	NULL
``	NULL
of	NULL
STAT5A	NULL
are	NULL
near	NULL
the	NULL
BTK	NULL
residues	NULL
Pro®	NULL
(	NULL
backbone	NULL
)	NULL
,	NULL
Phe	NULL
``	NULL
``	NULL
``	NULL
,	NULL
and	NULL
Lys*	NULL
``	NULL
°	NULL
,	NULL
respectively	NULL
.	NULL

Based	NULL
on	NULL
our	NULL
model	NULL
,	NULL
these	NULL
residues	NULL
interact	NULL
with	NULL
each	NULL
other	NULL
and	NULL
constitute	NULL
the	NULL
binding	NULL
affinity	NULL
between	NULL
STAT5A	NULL
and	NULL
the	NULL
BTK	NULL
kinase	NULL
domain	NULL
.	NULL

Our	NULL
model	NULL
also	NULL
indicates	NULL
that	NULL
the	NULL
SH2	NULL
and	NULL
SH3	NULL
domains	NULL
of	NULL
BTK	NULL
may	NULL
sterically	NULL
clash	NULL
with	NULL
the	NULL
N-terminal	NULL
domain	NULL
of	NULL
STAT5A	NULL
(	NULL
residues	NULL
1-150	NULL
)	NULL
,	NULL
which	NULL
is	NULL
predicted	NULL
to	NULL
reside	NULL
near	NULL
the	NULL
coiled-coil	NULL
domain	NULL
and	NULL
may	NULL
be	NULL
accessible	NULL
by	NULL
the	NULL
less	NULL
bulky	NULL
BTK	NULL
kinase	NULL
domain	NULL
.	NULL

According	NULL
to	NULL
this	NULL
model	NULL
,	NULL
of	NULL
the	NULL
five	NULL
tyrosine	NULL
residues	NULL
in	NULL
the	NULL
SH2	NULL
domain	NULL
and	NULL
tail	NULL
segment	NULL
of	NULL
STAT5A	NULL
,	NULL
only	NULL
Tyr	NULL
is	NULL
fully	NULL
exposed	NULL
to	NULL
the	NULL
solvent	NULL
environment	NULL
and	NULL
therefore	NULL
is	NULL
the	NULL
most	NULL
accessible	NULL
tyrosine	NULL
residue	NULL
for	NULL
phosphorylation	NULL
by	NULL
BTK	NULL
.	NULL

All	NULL
tyrosine	NULL
residues	NULL
except	NULL
for	NULL
Tyr®*	NULL
are	NULL
either	NULL
sterically	NULL
inaccessible	NULL
or	NULL
adopt	NULL
a	NULL
helical	NULL
conformation	NULL
unsuitable	NULL
for	NULL
phosphorylation	NULL
.	NULL

For	NULL
example	NULL
,	NULL
Tyr®®	NULL
``	NULL
is	NULL
surrounded	NULL
by	NULL
His	NULL
``	NULL
,	NULL
Pro	NULL
``	NULL
``	NULL
,	NULL
and	NULL
Lys	NULL
;	NULL
Tyr®®	NULL
``	NULL
is	NULL
surrounded	NULL
by	NULL
Ser	NULL
and	NULL
Lys®	NULL
``	NULL
``	NULL
and	NULL
possibly	NULL
sterically	NULL
occluded	NULL
by	NULL
a	NULL
loop	NULL
formed	NULL
by	NULL
residues	NULL
685-700	NULL
;	NULL
Tyr	NULL
``	NULL
is	NULL
surrounded	NULL
by	NULL
Arg*	NULL
``	NULL
*	NULL
,	NULL
Lys®	NULL
``	NULL
``	NULL
,	NULL
and	NULL
Ie	NULL
``	NULL
;	NULL
and	NULL
Tyr®®	NULL
is	NULL
surrounded	NULL
by	NULL
Pro°®	NULL
``	NULL
*	NULL
,	NULL
Pro°	NULL
``	NULL
,	NULL
and	NULL
Ne	NULL
``	NULL
.	NULL

Both	NULL
and	NULL
Tyr®	NULL
``	NULL
*	NULL
adopt	NULL
a	NULL
helical	NULL
conformation	NULL
that	NULL
is	NULL
not	NULL
suitable	NULL
for	NULL
phosphorylation	NULL
.	NULL

Tyr®*	NULL
``	NULL
is	NULL
the	NULL
only	NULL
tyrosine	NULL
(	NULL
other	NULL
than	NULL
Tyr®*	NULL
)	NULL
that	NULL
may	NULL
be	NULL
eligible	NULL
for	NULL
phosphorylation	NULL
and	NULL
more	NULL
exposed	NULL
than	NULL
the	NULL
aforementioned	NULL
tyrosine	NULL
residues	NULL
.	NULL

However	NULL
,	NULL
Tyr	NULL
``	NULL
is	NULL
located	NULL
on	NULL
a	NULL
B-strand	NULL
as	NULL
a	NULL
part	NULL
of	NULL
a	NULL
B-sheet	NULL
structure	NULL
on	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
.	NULL

Although	NULL
sufficiently	NULL
exposed	NULL
for	NULL
phosphorylation	NULL
,	NULL
Tyr®	NULL
``	NULL
``	NULL
is	NULL
situated	NULL
on	NULL
a	NULL
relatively	NULL
rigid	NULL
B-sheet	NULL
structure	NULL
.	NULL

More	NULL
importantly	NULL
,	NULL
Tyr®	NULL
``	NULL
``	NULL
is	NULL
less	NULL
accessible	NULL
than	NULL
Tyr®*	NULL
because	NULL
it	NULL
is	NULL
close	NULL
to	NULL
the	NULL
N-terminal	NULL
domain	NULL
of	NULL
STAT5A	NULL
according	NULL
to	NULL
the	NULL
full	NULL
model	NULL
of	NULL
the	NULL
STAT1	NULL
protein	NULL
(	NULL
61	NULL
)	NULL
.	NULL

These	NULL
modeling	NULL
studies	NULL
taken	NULL
together	NULL
with	NULL
the	NULL
CNBr	NULL
cleavage	NULL
data	NULL
prompted	NULL
the	NULL
hypothesis	NULL
that	NULL
Tyr®*	NULL
of	NULL
STAT5A	NULL
is	NULL
the	NULL
target	NULL
phosphorylation	NULL
site	NULL
for	NULL
BTK	NULL
.	NULL

In	NULL
order	NULL
to	NULL
determine	NULL
the	NULL
site	NULL
of	NULL
BTK-mediated	NULL
phosphorylation	NULL
in	NULL
STAT5A	NULL
,	NULL
tyrosine	NULL
residues	NULL
present	NULL
in	NULL
the	NULL
18-kDa	NULL
CNBr	NULL
fragment	NULL
at	NULL
positions	NULL
665	NULL
,	NULL
668	NULL
,	NULL
682	NULL
,	NULL
683	NULL
,	NULL
and	NULL
694	NULL
were	NULL
mutated	NULL
to	NULL
phenylalanine	NULL
,	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

In	NULL
addition	NULL
,	NULL
mutations	NULL
were	NULL
also	NULL
made	NULL
in	NULL
the	NULL
SH2	NULL
and	NULL
SH3	NULL
domains	NULL
to	NULL
determine	NULL
the	NULL
role	NULL
of	NULL
these	NULL
domains	NULL
for	NULL
in	NULL
vivo	NULL
recognition	NULL
and	NULL
phosphorylation	NULL
of	NULL
STAT5A	NULL
by	NULL
BTK	NULL
.	NULL

The	NULL
various	NULL
STAT5A	NULL
mutants	NULL
were	NULL
coexpressed	NULL
in	NULL
Sf21	NULL
cells	NULL
with	NULL
wild	NULL
type	NULL
BTK	NULL
.	NULL

Fig	NULL
.	NULL

6A	NULL
shows	NULL
that	NULL
BTK	NULL
tyrosine	NULL
phosphorylates	NULL
the	NULL
Y665F	NULL
,	NULL
Y668F	NULL
,	NULL
and	NULL
Y682F	NULL
,	NULL
Y683F	NULL
mutants	NULL
of	NULL
STAT5A	NULL
but	NULL
not	NULL
the	NULL
Y694F	NULL
mutant	NULL
of	NULL
STAT5A	NULL
.	NULL

Notably	NULL
,	NULL
STAT5A	NULL
mutations	NULL
in	NULL
the	NULL
SH2	NULL
(	NULL
R307K	NULL
)	NULL
and	NULL
SH3	NULL
(	NULL
Y251L	NULL
,	NULL
Y252L	NULL
)	NULL
domains	NULL
did	NULL
not	NULL
alter	NULL
the	NULL
BTK	NULL
phosphorylation	NULL
of	NULL
STAT5A	NULL
.	NULL

STAT5A	NULL
mutants	NULL
were	NULL
expressed	NULL
at	NULL
similar	NULL
levels	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
,	NULL
and	NULL
the	NULL
enzymatic	NULL
activity	NULL
levels	NULL
of	NULL
BTK	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
various	NULL
STAT5A	NULL
proteins	NULL
were	NULL
comparable	NULL
(	NULL
Fig	NULL
.	NULL

6C	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
BTK	NULL
immunoprecipitated	NULL
from	NULL
whole	NULL
cell	NULL
lysates	NULL
of	NULL
PFB-btk-trans-	NULL
6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san	NULL
$	NULL
4g	NULL
/310-2q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wou	NULL
;	NULL
papeojumo	NULL
(	NULL
STAT5A	NULL
as	NULL
a	NULL
Substrate	NULL
of	NULL
BTK	NULL
31223	NULL
668	NULL
0	NULL
/	NULL
og3	NULL
,	NULL
-	NULL
SH2	NULL
Domain	NULL
Linker	NULL
Domain	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

Molecular	NULL
model	NULL
of	NULL
STAT5A	NULL
.	NULL

Molecular	NULL
model	NULL
of	NULL
the	NULL
STAT5A	NULL
structure	NULL
is	NULL
shown	NULL
as	NULL
a	NULL
surface	NULL
representation	NULL
(	NULL
A	NULL
)	NULL
and	NULL
ribbon	NULL
representation	NULL
(	NULL
B	NULL
)	NULL
.	NULL

The	NULL
structure	NULL
of	NULL
STAT5A	NULL
(	NULL
residues	NULL
163-703	NULL
)	NULL
was	NULL
constructed	NULL
based	NULL
on	NULL
its	NULL
homology	NULL
with	NULL
STAT1	NULL
and	NULL
STATS3B	NULL
crystal	NULL
structures	NULL
.	NULL

Different	NULL
domains	NULL
are	NULL
shown	NULL
in	NULL
different	NULL
colors	NULL
:	NULL
the	NULL
coiled-coil	NULL
domain	NULL
in	NULL
red	NULL
,	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
in	NULL
gold	NULL
,	NULL
the	NULL
linker	NULL
domain	NULL
in	NULL
green	NULL
,	NULL
and	NULL
the	NULL
SH2	NULL
domain	NULL
in	NULL
blue	NULL
.	NULL

The	NULL
DNA	NULL
double	NULL
strand	NULL
is	NULL
used	NULL
to	NULL
mark	NULL
the	NULL
DNA	NULL
binding	NULL
location	NULL
and	NULL
is	NULL
shown	NULL
as	NULL
a	NULL
stick	NULL
model	NULL
(	NULL
A	NULL
,	NULL
multicolor	NULL
)	NULL
and	NULL
a	NULL
space-filling	NULL
model	NULL
(	NULL
B	NULL
,	NULL
yellow	NULL
for	NULL
phosphate	NULL
and	NULL
blue	NULL
and	NULL
white	NULL
for	NULL
two	NULL
different	NULL
DNA	NULL
strands	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

All	NULL
five	NULL
tyrosine	NULL
residues	NULL
on	NULL
the	NULL
SH2	NULL
domain	NULL
and	NULL
tail	NULL
segment	NULL
that	NULL
were	NULL
subjected	NULL
to	NULL
phenylalanine	NULL
mutations	NULL
are	NULL
shown	NULL
in	NULL
different	NULL
colors	NULL
and	NULL
labeled	NULL
accordingly	NULL
.	NULL

Among	NULL
them	NULL
,	NULL
only	NULL
Tyr®	NULL
``	NULL
*	NULL
(	NULL
red	NULL
)	NULL
is	NULL
fully	NULL
exposed	NULL
to	NULL
the	NULL
solvent	NULL
environment	NULL
.	NULL

The	NULL
other	NULL
four	NULL
tyrosine	NULL
residues	NULL
are	NULL
at	NULL
least	NULL
half-buried	NULL
,	NULL
consistent	NULL
with	NULL
our	NULL
694	NULL
:	NULL
experimental	NULL
data	NULL
suggesting	NULL
that	NULL
Tyr	NULL
``	NULL
is	NULL
most	NULL
accessible	NULL
to	NULL
BTK	NULL
phosphorylation	NULL
.	NULL

Other	NULL
tyrosine	NULL
residues	NULL
including	NULL
Tyr	NULL
``	NULL
and	NULL
Tyr	NULL
``	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
are	NULL
situated	NULL
on	NULL
a	NULL
helix	NULL
of	NULL
the	NULL
coiled-coil	NULL
domain	NULL
.	NULL

fected	NULL
Sf21	NULL
cells	NULL
phosphorylated	NULL
wild	NULL
type	NULL
STAT5A	NULL
(	NULL
Fig	NULL
.	NULL

6D	NULL
,	NULL
first	NULL
lane	NULL
)	NULL
,	NULL
but	NULL
it	NULL
failed	NULL
to	NULL
phosphorylate	NULL
the	NULL
Y694F	NULL
mutant	NULL
of	NULL
STAT5A	NULL
(	NULL
Fig	NULL
.	NULL

6D	NULL
,	NULL
second	NULL
lane	NULL
)	NULL
,	NULL
although	NULL
the	NULL
amounts	NULL
of	NULL
STAT5A	NULL
proteins	NULL
(	NULL
Fig	NULL
.	NULL

6E	NULL
)	NULL
and	NULL
level	NULL
of	NULL
BTK	NULL
kinase	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

6F	NULL
)	NULL
were	NULL
virtually	NULL
identical	NULL
in	NULL
these	NULL
in	NULL
vitro	NULL
kinase	NULL
reac-tions	NULL
.	NULL

Notably	NULL
,	NULL
mutation	NULL
of	NULL
the	NULL
Phe	NULL
``	NULL
residue	NULL
back	NULL
to	NULL
a	NULL
tyrosine	NULL
residue	NULL
restored	NULL
the	NULL
ability	NULL
of	NULL
BTK	NULL
to	NULL
phosphorylate	NULL
STAT5A	NULL
(	NULL
Fig	NULL
.	NULL

6D	NULL
,	NULL
third	NULL
lane	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
uniquely	NULL
implicate	NULL
Tyr®*	NULL
of	NULL
STAT5A	NULL
as	NULL
the	NULL
BTK	NULL
phosphorylation	NULL
site	NULL
.	NULL

We	NULL
next	NULL
examined	NULL
the	NULL
ability	NULL
of	NULL
BTK	NULL
to	NULL
phosphorylate	NULL
STAT5A	NULL
in	NULL
the	NULL
presence	NULL
and	NULL
absence	NULL
of	NULL
wild	NULL
type	NULL
or	NULL
kinase-inactive	NULL
JAK3	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6G	NULL
,	NULL
both	NULL
BTK	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
and	NULL
JAK3	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
(	NULL
but	NULL
not	NULL
their	NULL
inactive	NULL
kinase	NULL
domain	NULL
mutants	NULL
;	NULL
see	NULL
lanes	NULL
2	NULL
and	NULL
4	NULL
)	NULL
were	NULL
capable	NULL
of	NULL
phosphorylating	NULL
STAT5A	NULL
.	NULL

By	NULL
comparison	NULL
,	NULL
no	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT5A	NULL
was	NULL
evident	NULL
in	NULL
Sf21	NULL
cells	NULL
co-expressing	NULL
kinase	NULL
inactive	NULL
mutants	NULL
of	NULL
BTK	NULL
as	NULL
well	NULL
as	NULL
JAK3	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

Notably	NULL
,	NULL
wild	NULL
type	NULL
BTK	NULL
was	NULL
capable	NULL
of	NULL
phosphorylating	NULL
STAT5A	NULL
even	NULL
when	NULL
co-expressed	NULL
with	NULL
the	NULL
kinase-inactive	NULL
mutant	NULL
of	NULL
JAK3	NULL
(	NULL
lane	NULL
8	NULL
)	NULL
,	NULL
which	NULL
does	NULL
not	NULL
phosphorylate	NULL
STAT5A	NULL
(	NULL
Zane	NULL
2	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
BTK-mediated	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT5A	NULL
can	NULL
not	NULL
be	NULL
attributed	NULL
to	NULL
JAK3	NULL
.	NULL

Similarly	NULL
,	NULL
neither	NULL
the	NULL
wild	NULL
type	NULL
nor	NULL
the	NULL
kinase-inactive	NULL
mutant	NULL
of	NULL
BTK	NULL
affected	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
co-expressed	NULL
wild	NULL
type	NULL
JAK3	NULL
kinase	NULL
to	NULL
phosphorylate	NULL
STAT5A	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
7	NULL
)	NULL
.	NULL

The	NULL
immunoprecipitable	NULL
STAT5A	NULL
protein	NULL
expression	NULL
levels	NULL
for	NULL
the	NULL
various	NULL
Sf21	NULL
cell	NULL
samples	NULL
were	NULL
virtually	NULL
identical	NULL
(	NULL
Fig	NULL
.	NULL

6M	NULL
)	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
co-expressed	NULL
kinase	NULL
proteins	NULL
JAK3	NULL
(	NULL
Fig	NULL
.	NULL

61	NULL
)	NULL
and	NULL
BTK	NULL
(	NULL
Fig	NULL
.	NULL

6J	NULL
)	NULL
was	NULL
confirmed	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
do	NULL
not	NULL
lend	NULL
any	NULL
support	NULL
to	NULL
the	NULL
suggestion	NULL
that	NULL
BTK	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT5A	NULL
indirectly	NULL
by	NULL
first	NULL
transphosphorylating	NULL
and	NULL
activating	NULL
JAK3	NULL
.	NULL

However	NULL
,	NULL
it	NULL
is	NULL
conceivable	NULL
that	NULL
these	NULL
two	NULL
tyrosine	NULL
kinases	NULL
cooperate	NULL
in	NULL
regulation	NULL
of	NULL
the	NULL
STAT5A-linked	NULL
signaling	NULL
pathways	NULL
.	NULL

One	NULL
might	NULL
also	NULL
speculate	NULL
that	NULL
co-expression	NULL
of	NULL
these	NULL
two	NULL
tyrosine	NULL
kinases	NULL
in	NULL
Sf21	NULL
cells	NULL
would	NULL
have	NULL
resulted	NULL
in	NULL
additive	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT5A	NULL
if	NULL
the	NULL
expression	NULL
level	NULL
of	NULL
each	NULL
kinase	NULL
alone	NULL
was	NULL
insufficient	NULL
to	NULL
cause	NULL
optimal	NULL
phosphorylation	NULL
of	NULL
STAT5A	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT5A	NULL
by	NULL
JAK3	NULL
results	NULL
in	NULL
enhanced	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

In	NULL
order	NULL
to	NULL
determine	NULL
if	NULL
the	NULL
BTK-mediated	NULL
tyrosine	NULL
phosphorylation	NULL
also	NULL
augments	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
ectopically	NULL
expressed	NULL
STAT5A	NULL
in	NULL
a	NULL
heterologous	NULL
expression	NULL
system	NULL
,	NULL
we	NULL
performed	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
using	NULL
a	NULL
*P	NULL
-labeled	NULL
oligonucleotide	NULL
representing	NULL
a	NULL
GAS-like	NULL
element	NULL
from	NULL
the	NULL
B-casein	NULL
gene	NULL
promoter	NULL
region	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7A	NULL
,	NULL
extracts	NULL
from	NULL
untransfected	NULL
Sf21	NULL
cells	NULL
(	NULL
Zane	NULL
1	NULL
)	NULL
or	NULL
Sf21	NULL
cells	NULL
transfected	NULL
with	NULL
PFB-stat5a	NULL
alone	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
did	NULL
not	NULL
contain	NULL
any	NULL
proteins	NULL
capable	NULL
of	NULL
binding	NULL
the	NULL
probe	NULL
causing	NULL
a	NULL
mobility	NULL
shift	NULL
.	NULL

By	NULL
comparison	NULL
,	NULL
a	NULL
significant	NULL
mobility	NULL
shift	NULL
of	NULL
the	NULL
°°P-labeled	NULL
oligonucleotide	NULL
probe	NULL
was	NULL
observed	NULL
in	NULL
extracts	NULL
from	NULL
Sf21	NULL
cells	NULL
co-expressing	NULL
wild	NULL
type	NULL
BTK	NULL
and	NULL
STAT5A	NULL
(	NULL
Zane	NULL
5	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
indicate	NULL
that	NULL
BTK-mediated	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
ectopically	NULL
expressed	NULL
STAT5A	NULL
enhances	NULL
its	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

The	NULL
level	NULL
of	NULL
STAT5A	NULL
activation	NULL
in	NULL
these	NULL
extracts	NULL
was	NULL
virtually	NULL
identical	NULL
to	NULL
that	NULL
observed	NULL
in	NULL
extracts	NULL
of	NULL
Sf21	NULL
cells	NULL
co-expressing	NULL
wild	NULL
type	NULL
JAK3	NULL
and	NULL
STAT5A	NULL
(	NULL
compare	NULL
lanes	NULL
5	NULL
and	NULL
10	NULL
)	NULL
.	NULL

The	NULL
observed	NULL
mobility	NULL
shifts	NULL
of	NULL
the	NULL
oligonucleotide	NULL
probe	NULL
were	NULL
not	NULL
caused	NULL
by	NULL
endogenous	NULL
insect	NULL
STAT	NULL
proteins	NULL
,	NULL
because	NULL
no	NULL
mobility	NULL
shifts	NULL
were	NULL
observed	NULL
when	NULL
we	NULL
used	NULL
extracts	NULL
from	NULL
Sf21	NULL
cells	NULL
expressing	NULL
wild	NULL
type	NULL
BTK	NULL
alone	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
or	NULL
wild	NULL
type	NULL
JAK3	NULL
alone	NULL
(	NULL
lane	NULL
9	NULL
)	NULL
.	NULL

BTK-mediated	NULL
activation	NULL
of	NULL
STAT5A	NULL
was	NULL
dependent	NULL
on	NULL
the	NULL
enzymatic	NULL
activity	NULL
of	NULL
BTK	NULL
,	NULL
since	NULL
no	NULL
mobility	NULL
shifts	NULL
were	NULL
observed	NULL
in	NULL
extracts	NULL
of	NULL
Sf21	NULL
cells	NULL
co-expressing	NULL
STAT5A	NULL
and	NULL
a	NULL
kinase-inactive	NULL
mutant	NULL
of	NULL
BTK	NULL
(	NULL
Zane	NULL
6	NULL
)	NULL
.	NULL

In	NULL
accordance	NULL
with	NULL
the	NULL
above	NULL
detailed	NULL
data	NULL
identifying	NULL
Tyr©*	NULL
as	NULL
the	NULL
BTK	NULL
phosphorylation	NULL
site	NULL
of	NULL
STAT5A	NULL
,	NULL
co-expression	NULL
of	NULL
BTK	NULL
was	NULL
unable	NULL
to	NULL
activate	NULL
the	NULL
Y694F	NULL
mutant	NULL
of	NULL
STAT5A	NULL
(	NULL
lane	NULL
8	NULL
)	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
that	NULL
STAT5A	NULL
is	NULL
a	NULL
functional	NULL
target	NULL
for	NULL
BTK	NULL
.	NULL

We	NULL
next	NULL
used	NULL
the	NULL
baculovirus	NULL
expression	NULL
system	NULL
to	NULL
compare	NULL
the	NULL
ability	NULL
of	NULL
mutant	NULL
BTK	NULL
proteins	NULL
with	NULL
point	NULL
mutations	NULL
of	NULL
conserved	NULL
residues	NULL
in	NULL
the	NULL
PH	NULL
(	NULL
R28C	NULL
)	NULL
,	NULL
SH/kinase	NULL
domain	NULL
(	NULL
Y551F	NULL
,	NULL
autophosphorylation	NULL
site	NULL
mutant	NULL
;	NULL
K430E	NULL
,	NULL
ATP	NULL
binding	NULL
site	NULL
mutant	NULL
)	NULL
,	NULL
SH2	NULL
(	NULL
R307K	NULL
)	NULL
,	NULL
and	NULL
SH3	NULL
(	NULL
Y251L	NULL
,	NULL
Y252L	NULL
)	NULL
domains	NULL
to	NULL
phosphorylate	NULL
STAT5A	NULL
in	NULL
vivo	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7B	NULL
,	NULL
recombinant	NULL
BTK	NULL
proteins	NULL
with	NULL
mutant	NULL
PH	NULL
,	NULL
SH2	NULL
,	NULL
or	NULL
SH3	NULL
domains	NULL
were	NULL
capable	NULL
of	NULL
tyrosine	NULL
phosphorylating	NULL
the	NULL
co-expressed	NULL
wild	NULL
6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san	NULL
$	NULL
4g	NULL
/310-2q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wou	NULL
;	NULL
papeojumo	NULL
(	NULL
31224	NULL
STAT5A	NULL
as	NULL
a	NULL
Substrate	NULL
of	NULL
BTK	NULL
&	NULL
€	NULL
+	NULL
a	NULL
*	NULL
4	NULL
5	NULL
}	NULL
le	NULL
}	NULL
x66	NULL
}	NULL
?	NULL

?	NULL

?	NULL

’	NULL
266	NULL
.	NULL

£5	NULL
}	NULL
``	NULL
@	NULL
#	NULL
‘	NULL
igﬂ	NULL
65g	NULL
!	NULL
)	NULL

65g	NULL
A	NULL
“	NULL
?	NULL

?	NULL

?	NULL

«	NULL
é	NULL
‘	NULL
if	NULL
Ahab	NULL
“	NULL
(	NULL
g	NULL
;	NULL
63	NULL
?	NULL

Eff	NULL
}	NULL
?	NULL

J	NULL
F	NULL
J	NULL
JF	NULL
J	NULL
3	NULL
&	NULL
&	NULL
&	NULL
C	NULL
2	NULL
E	NULL
4	NULL
4	NULL
#	NULL
$	NULL
*	NULL
*	NULL
$	NULL
*	NULL
E	NULL
S	NULL
&	NULL
8	NULL
$	NULL
&	NULL
4	NULL
4	NULL
4	NULL
A	NULL
&	NULL
_	NULL
&	NULL
6	NULL
kDa	NULL
D	NULL
¥	NULL
WW	NULL
-statsa	NULL
STATSA	NULL
IP	NULL
_	NULL
97-	NULL
eeaap	NULL
eae	NULL
«	NULL
wo	NULL
ense	NULL
eath	NULL
-ST/T5¢	NULL
{	NULL
B9-	NULL
F	NULL
STAT5A	NULL
IP	NULL
coe	NULL
:	NULL
mme	NULL
cums	NULL
.	NULL

<	NULL
BTK	NULL
STATSA	NULL
bot	NULL
-	NULL
,	NULL
_	NULL
ab	NULL
#	NULL
B	NULL
amo	NULL
aao	NULL
aan	NULL
aah	NULL
-s	NULL
:	NULL
15	NULL
.	NULL

C	NULL
«	NULL
GST-Iga	NULL
97	NULL
BTK	NULL
IP	NULL
KA	NULL
(	NULL
8	NULL
Y	NULL
y	NULL
6	NULL
STATS	NULL
A	NULL
»	NULL
-	NULL
baad	NULL
Game	NULL
STAT5A	NULL
WB	NULL
H	NULL
statsa-	NULL
eam	NULL
can	NULL
cas	NULL
cae	NULL
cae	NULL
cay	NULL
cont	NULL
STAT5A	NULL
IP-	NULL
»	NULL
STATS5A	NULL
WB	NULL
I	NULL
JAK3	NULL
=-	NULL
#	NULL
«	NULL
mum	NULL
woos	NULL
___	NULL
seme	NULL
JAK3	NULL
IP	NULL
--	NULL
JAK3	NULL
WB	NULL
J	NULL
BTk	NULL
»	NULL
UAB	NULL
anth	NULL
ts	NULL
caut	NULL
cms	NULL
tt	NULL
BTK	NULL
IP	NULL
--	NULL
BTK	NULL
WB	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

A-C	NULL
,	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
mutant	NULL
STAT5A	NULL
proteins	NULL
by	NULL
ectopically	NULL
expressed	NULL
wild	NULL
type	NULL
BTK	NULL
in	NULL
a	NULL
heterologous	NULL
expression	NULL
system	NULL
.	NULL

Mutant	NULL
STAT5A	NULL
proteins	NULL
were	NULL
co-expressed	NULL
in	NULL
Sf21	NULL
cells	NULL
with	NULL
wild	NULL
type	NULL
BTK	NULL
.	NULL

STAT5A	NULL
proteins	NULL
were	NULL
immunoprecipitated	NULL
,	NULL
and	NULL
the	NULL
immune	NULL
complexes	NULL
were	NULL
subjected	NULL
to	NULL
Western	NULL
blot	NULL
analysis	NULL
with	NULL
anti-phosphotyrosine	NULL
(	NULL
A4	NULL
)	NULL
or	NULL
anti-STAT5A	NULL
(	NULL
B	NULL
)	NULL
antibodies	NULL
.	NULL

The	NULL
enzymatic	NULL
activity	NULL
of	NULL
the	NULL
expressed	NULL
BTK	NULL
protein	NULL
was	NULL
measured	NULL
by	NULL
examining	NULL
the	NULL
autophosphorylation	NULL
of	NULL
BTK	NULL
in	NULL
the	NULL
anti-BTK	NULL
immunoprecipitates	NULL
from	NULL
the	NULL
Sf21	NULL
lysates	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
[	NULL
y-*P	NULL
]	NULL
JATP	NULL
(	NULL
C	NULL
)	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
BTK	NULL
,	NULL
STAT5A	NULL
,	NULL
and	NULL
prestained	NULL
molecular	NULL
mass	NULL
markers	NULL
(	NULL
in	NULL
kilodaltons	NULL
)	NULL
are	NULL
indicated	NULL
with	NULL
arrowheads	NULL
.	NULL

D-F	NULL
,	NULL
requirement	NULL
for	NULL
an	NULL
intact	NULL
Tyr®*	NULL
residue	NULL
for	NULL
BTK-mediated	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT5A	NULL
.	NULL

D	NULL
,	NULL
Sf21	NULL
cells	NULL
expressing	NULL
wild	NULL
type	NULL
BTK	NULL
were	NULL
lysed	NULL
and	NULL
immunoprecipitated	NULL
,	NULL
and	NULL
the	NULL
BTK	NULL
immune	NULL
complexes	NULL
were	NULL
mixed	NULL
with	NULL
purified	NULL
wild	NULL
type	NULL
STAT5A	NULL
(	NULL
BTK	NULL
+	NULL
STAT5A	NULL
)	NULL
,	NULL
Y694F	NULL
mutant	NULL
of	NULL
STAT5A	NULL
(	NULL
BTKY*	NULL
+	NULL
STAT5A*®*	NULL
``	NULL
)	NULL
,	NULL
or	NULL
Y694F-Y	NULL
mutant	NULL
of	NULL
STAT5SA	NULL
(	NULL
BTK®	NULL
``	NULL
*	NULL
+	NULL
STAT5A****	NULL
``	NULL
-*	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
[	NULL
y-*P	NULL
]	NULL
ATP	NULL
.	NULL

The	NULL
in	NULL
vitro	NULL
kinase	NULL
reactions	NULL
were	NULL
stopped	NULL
by	NULL
adding	NULL
radioimmune	NULL
precipitation	NULL
buffer	NULL
,	NULL
and	NULL
the	NULL
phosphorylated	NULL
STAT5A	NULL
protein	NULL
was	NULL
visualized	NULL
by	NULL
autoradiography	NULL
.	NULL

E	NULL
,	NULL
after	NULL
stopping	NULL
the	NULL
kinase	NULL
reactions	NULL
,	NULL
the	NULL
kinase	NULL
reaction	NULL
mixtures	NULL
were	NULL
centrifuged	NULL
at	NULL
12,000	NULL
rpm	NULL
,	NULL
and	NULL
the	NULL
supernatants	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
an	NULL
anti-STAT5A	NULL
antibody	NULL
.	NULL

The	NULL
immune	NULL
complexes	NULL
were	NULL
subjected	NULL
to	NULL
Western	NULL
blot	NULL
analysis	NULL
with	NULL
the	NULL
anti-STAT5A	NULL
antibody	NULL
.	NULL

F	NULL
,	NULL
the	NULL
enzymatic	NULL
activity	NULL
of	NULL
BTK	NULL
in	NULL
the	NULL
kinase	NULL
reactions	NULL
was	NULL
measured	NULL
by	NULL
examining	NULL
its	NULL
autophosphorylation	NULL
as	NULL
well	NULL
as	NULL
its	NULL
ability	NULL
to	NULL
phosphorylate	NULL
GST-Iga	NULL
in	NULL
immune	NULL
complex	NULL
kinase	NULL
assays	NULL
.	NULL

G-J	NULL
,	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT5A	NULL
by	NULL
ectopically	NULL
expressed	NULL
BTK	NULL
is	NULL
independent	NULL
of	NULL
JAK3	NULL
.	NULL

Wild	NULL
type	NULL
BTK	NULL
,	NULL
JAK3	NULL
and	NULL
their	NULL
kinase-inactive	NULL
mutants	NULL
were	NULL
co-expressed	NULL
with	NULL
STAT5A	NULL
in	NULL
Sf21	NULL
cells	NULL
.	NULL

Cells	NULL
were	NULL
lysed	NULL
after	NULL
48	NULL
h	NULL
of	NULL
incubation	NULL
,	NULL
lysates	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
anti-STAT5A	NULL
(	NULL
G	NULL
and	NULL
H7	NULL
)	NULL
,	NULL
anti-JAK3	NULL
(	NULL
I	NULL
)	NULL
,	NULL
or	NULL
anti-BTK	NULL
(	NULL
J	NULL
)	NULL
antibodies	NULL
and	NULL
subjected	NULL
to	NULL
immunoblotting	NULL
with	NULL
anti-phosphotyrosine	NULL
antibodies	NULL
(	NULL
G	NULL
)	NULL
,	NULL
anti-STAT5A	NULL
antibody	NULL
(	NULL
H	NULL
)	NULL
,	NULL
anti-JAK3	NULL
antibody	NULL
(	NULL
/	NULL
)	NULL
,	NULL
or	NULL
anti-BTK	NULL
antibody	NULL
(	NULL
J	NULL
)	NULL
.	NULL

type	NULL
STAT5A	NULL
protein	NULL
,	NULL
whereas	NULL
recombinant	NULL
BTK	NULL
proteins	NULL
with	NULL
SH1/kinase	NULL
domain	NULL
mutations	NULL
were	NULL
not	NULL
.	NULL

The	NULL
expression	NULL
levels	NULL
of	NULL
STAT5A	NULL
(	NULL
Fig	NULL
.	NULL

7C	NULL
)	NULL
and	NULL
mutant	NULL
BTK	NULL
proteins	NULL
(	NULL
Fig	NULL
.	NULL

7D	NULL
)	NULL
were	NULL
similar	NULL
for	NULL
all	NULL
Sf21	NULL
cells	NULL
co-expressing	NULL
STAT5A	NULL
and	NULL
a	NULL
mutant	NULL
BTK	NULL
protein	NULL
.	NULL

No	NULL
BTK	NULL
kinase	NULL
activity	NULL
was	NULL
detected	NULL
in	NULL
BTK	NULL
immune	NULL
complexes	NULL
from	NULL
Sf21	NULL
cells	NULL
expressing	NULL
the	NULL
kinase	NULL
domain	NULL
mutants	NULL
of	NULL
BTK	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
with	NULL
the	NULL
results	NULL
of	NULL
the	NULL
pull-down	NULL
experiments	NULL
,	NULL
these	NULL
findings	NULL
indicate	NULL
that	NULL
the	NULL
PH	NULL
,	NULL
SH2	NULL
,	NULL
and	NULL
SH3	NULL
domains	NULL
of	NULL
BTK	NULL
do	NULL
not	NULL
significantly	NULL
contribute	NULL
to	NULL
its	NULL
physical	NULL
and	NULL
functional	NULL
interactions	NULL
with	NULL
STAT5A	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
BTK	NULL
to	NULL
phosphorylate	NULL
STAT5A	NULL
requires	NULL
both	NULL
an	NULL
intact	NULL
ATP-binding	NULL
site	NULL
and	NULL
an	NULL
intact	NULL
autophosphorylation	NULL
site	NULL
within	NULL
the	NULL
kinase	NULL
domain	NULL
.	NULL

We	NULL
next	NULL
examined	NULL
the	NULL
ability	NULL
of	NULL
purified	NULL
recombinant	NULL
BTK-KD	NULL
to	NULL
phosphorylate	NULL
purified	NULL
recombinant	NULL
STAT5A	NULL
using	NULL
in	NULL
vitro	NULL
kinase	NULL
assays	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7F.1	NULL
,	NULL
STAT5A	NULL
did	NULL
not	NULL
show	NULL
any	NULL
significant	NULL
level	NULL
of	NULL
phosphorylation	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
BTK-KD	NULL
,	NULL
and	NULL
BTK-KD	NULL
was	NULL
capable	NULL
of	NULL
tyrosine-phosphorylating	NULL
STAT5A	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
other	NULL
proteins	NULL
.	NULL

The	NULL
amounts	NULL
of	NULL
STAT5A	NULL
in	NULL
these	NULL
kinase	NULL
reactions	NULL
were	NULL
virtually	NULL
identical	NULL
(	NULL
Fig	NULL
.	NULL

7F.3	NULL
)	NULL
.	NULL

We	NULL
next	NULL
sought	NULL
to	NULL
determine	NULL
if	NULL
coexpression	NULL
of	NULL
STAT5A	NULL
with	NULL
BTK-KD	NULL
in	NULL
Sf21	NULL
cells	NULL
leads	NULL
to	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT5A	NULL
in	NULL
vivo	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7G	NULL
(	NULL
fourth	NULL
lane	NULL
)	NULL
,	NULL
anti-phosphotyrosine	NULL
Westen	NULL
blot	NULL
analysis	NULL
of	NULL
whole	NULL
cell	NULL
lysates	NULL
of	NULL
Sf21	NULL
cells	NULL
coexpressing	NULL
STAT5A	NULL
and	NULL
BTK-KD	NULL
showed	NULL
two	NULL
major	NULL
tyrosine-phosphorylated	NULL
protein	NULL
bands	NULL
corresponding	NULL
to	NULL
6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san	NULL
$	NULL
4g	NULL
/310-2q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wou	NULL
;	NULL
papeojumo	NULL
(	NULL
STAT5A	NULL
as	NULL
a	NULL
Substrate	NULL
of	NULL
BTK	NULL
-	NULL
&	NULL
y	NULL
y	NULL
gw	NULL
&	NULL
~	NULL
®	NULL
ro	NULL
£	NULL
2	NULL
as*	NULL
CS	NULL
£	NULL
$	NULL
<	NULL
6	NULL
CAPEA	NULL
A	NULL
ALAC	NULL
«	NULL
2°	NULL
¢	NULL
3	NULL
A	NULL
an	NULL
«	NULL
»	NULL
-	NULL
9	NULL
._	NULL
e	NULL
«	NULL
&	NULL
Xév	NULL
is	NULL
)	NULL
<	NULL
0	NULL
?	NULL

49	NULL
22	NULL
:	NULL
6+	NULL
é	NULL
?	NULL

éd	NULL
‘	NULL
F1	NULL
!	NULL

97.4	NULL
-	NULL
``	NULL
he	NULL
emmm	NULL
.	NULL

-	NULL
<	NULL
STATS5A	NULL
66	NULL
46	NULL
«	NULL
eme	NULL
:	NULL
awhile	NULL
_	NULL
-	NULL
<	NULL
BTK-KD	NULL
30	NULL
F2	NULL
3	NULL
#	NULL
B	NULL
-	NULL
@	NULL
--	NULL
<	NULL
o	NULL
F3	NULL
974	NULL
-	NULL
wore	NULL
|	NULL
.	NULL

-a	NULL
STATSA	NULL
66	NULL
&	NULL
#	NULL
#	NULL
4	NULL
»	NULL
4	NULL
&	NULL
£	NULL
£	NULL
£4	NULL
£4	NULL
¥	NULL
28	NULL
ug	NULL
V	NULL
UJ	NULL
C	NULL
C	NULL
C	NULL
©	NULL
~	NULL
&	NULL
&	NULL
&	NULL
&	NULL
&	NULL
B	NULL
STATSA	NULL
IP	NULL
‘	NULL
—_	NULL
<	NULL
STATSA	NULL
APT	NULL
blot	NULL
C	NULL
STAT5A	NULL
IP	NULL
starsa	NULL
vio	NULL
:	NULL
Cet	NULL
eaap	NULL
game	NULL
<	NULL
sta	NULL
15A	NULL
Bucs	NULL
most	NULL
-	NULL
®	NULL
D	NULL
cuses	NULL
cuse	NULL
comes	NULL
-	NULL
<	NULL
BT	NULL
BTK	NULL
IP	NULL
BTK	NULL
blot	NULL
~	NULL
wen	NULL
ne	NULL
E	NULL
BTK	NULL
IP	NULL
KA	NULL
Wei	NULL
eme	NULL
<	NULL
BTK	NULL
a	NULL
€	NULL
«	NULL
&	NULL
<	NULL
ya	NULL
g	NULL
©	NULL
aC	NULL
X	NULL
&	NULL
is	NULL
8	NULL
®	NULL
,	NULL
€©	NULL
p	NULL
£	NULL
®	NULL
ab	NULL
6	NULL
Ma	NULL
A	NULL
2	NULL
$	NULL
s*	NULL
\	NULL
x	NULL
\p	NULL
x	NULL
9	NULL
«	NULL
$	NULL
0	NULL
?	NULL

{	NULL
gov	NULL
«	NULL
i~	NULL
«	NULL
40V	NULL
ko	NULL
é	NULL
&	NULL
C	NULL
&	NULL
a	NULL
G	NULL
220	NULL
-	NULL
®	NULL
97	NULL
-	NULL
caree	NULL
seme	NULL
.	NULL

-a	NULL
STAT5A	NULL
46	NULL
wae	NULL
diy	NULL
=	NULL
-	NULL
<	NULL
ctk	NULL
ko	NULL
30	NULL
Fig	NULL
.	NULL

7	NULL
.	NULL

A	NULL
,	NULL
activation	NULL
of	NULL
STAT5A	NULL
by	NULL
ectopically	NULL
expressed	NULL
BTK	NULL
.	NULL

Wild	NULL
type	NULL
or	NULL
Y694F	NULL
mutant	NULL
STAT5A	NULL
was	NULL
coexpressed	NULL
with	NULL
wild	NULL
type	NULL
or	NULL
kinase-inactive	NULL
mutant	NULL
BTK	NULL
,	NULL
or	NULL
wild	NULL
type	NULL
JAK3	NULL
.	NULL

Control	NULL
Sf21	NULL
cells	NULL
were	NULL
either	NULL
not	NULL
transfected	NULL
or	NULL
transfected	NULL
with	NULL
expression	NULL
plasmids	NULL
for	NULL
STAT5A	NULL
,	NULL
mutant	NULL
STAT5A	NULL
,	NULL
BTK	NULL
,	NULL
mutant	NULL
BTK	NULL
,	NULL
or	NULL
JAK3	NULL
alone	NULL
.	NULL

Whole	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
tested	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
active	NULL
STAT5A	NULL
by	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
using	NULL
an	NULL
annealed	NULL
oligonucleotide	NULL
corresponding	NULL
to	NULL
the	NULL
GAS-like	NULL
STATS5	NULL
binding	NULL
site	NULL
in	NULL
the	NULL
B-casein	NULL
gene	NULL
promoter	NULL
(	NULL
5-AGATTTCTAGGAATTCAAATC-3	NULL
'	NULL
)	NULL
.	NULL

The	NULL
position	NULL
of	NULL
shifted	NULL
complex	NULL
of	NULL
activated	NULL
STAT5A	NULL
is	NULL
indicated	NULL
with	NULL
an	NULL
arrowhead	NULL
.	NULL

B-E	NULL
,	NULL
requirement	NULL
for	NULL
an	NULL
intact	NULL
BTK	NULL
kinase	NULL
domain	NULL
for	NULL
the	NULL
in	NULL
vivo	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT5A	NULL
by	NULL
ectopically	NULL
expressed	NULL
BTK	NULL
.	NULL

STAT5A	NULL
was	NULL
coexpressed	NULL
in	NULL
Sf21	NULL
cells	NULL
with	NULL
the	NULL
indicated	NULL
site-specific	NULL
mutants	NULL
of	NULL
BTK	NULL
.	NULL

STAT5A	NULL
was	NULL
immunoprecipitated	NULL
and	NULL
STAT5A	NULL
immune	NULL
complexes	NULL
were	NULL
subjected	NULL
to	NULL
either	NULL
anti-phosphotyrosine	NULL
(	NULL
B	NULL
)	NULL
or	NULL
anti-STAT5A	NULL
(	NULL
C	NULL
)	NULL
immunoblotting	NULL
.	NULL

BTK	NULL
was	NULL
immunoprecipitated	NULL
,	NULL
and	NULL
BTK	NULL
immune	NULL
complexes	NULL
were	NULL
subjected	NULL
to	NULL
in	NULL
vitro	NULL
kinase	NULL
assays	NULL
with	NULL
[	NULL
y-*P	NULL
]	NULL
ATP	NULL
(	NULL
E	NULL
)	NULL
or	NULL
anti-BTK	NULL
immunoblotting	NULL
(	NULL
D	NULL
)	NULL
.	NULL

F	NULL
and	NULL
G	NULL
,	NULL
recombinant	NULL
BTK	NULL
kinase	NULL
domain	NULL
phosphorylates	NULL
STAT5A	NULL
.	NULL

F	NULL
,	NULL
purified	NULL
BTK-KD	NULL
was	NULL
examined	NULL
for	NULL
its	NULL
ability	NULL
to	NULL
phosphorylate	NULL
purified	NULL
STAT5A	NULL
in	NULL
in	NULL
vitro	NULL
kinase	NULL
assays	NULL
(	NULL
F.1	NULL
)	NULL
.	NULL

Control	NULL
reactions	NULL
contained	NULL
no	NULL
STAT5A	NULL
(	NULL
Zane	NULL
1	NULL
)	NULL
or	NULL
no	NULL
BTK	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

Samples	NULL
were	NULL
examined	NULL
for	NULL
BTK-KD	NULL
content	NULL
(	NULL
F.2	NULL
)	NULL
and	NULL
STAT5A	NULL
content	NULL
(	NULL
F.3	NULL
)	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
.	NULL

G	NULL
,	NULL
BTK-KD	NULL
and	NULL
STAT5A	NULL
were	NULL
coexpressed	NULL
in	NULL
Sf21	NULL
cells	NULL
,	NULL
and	NULL
STAT5A	NULL
immunoprecipitated	NULL
from	NULL
Sf21	NULL
whole	NULL
cell	NULL
lysates	NULL
was	NULL
examined	NULL
for	NULL
tyrosine	NULL
phosphorylation	NULL
by	NULL
anti-phosphotyrosine	NULL
(	NULL
APT	NULL
)	NULL
Western	NULL
blot	NULL
analysis	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
STAT5A	NULL
immunoprecipitates	NULL
(	NULL
IP	NULL
)	NULL
from	NULL
Sf21	NULL
cells	NULL
transfected	NULL
with	NULL
PFB-stat5a	NULL
;	NULL
lane	NULL
2	NULL
,	NULL
STAT5A	NULL
immunoprecipitate	NULL
from	NULL
Sf21	NULL
cells	NULL
transfected	NULL
with	NULL
PFB-stat5a	NULL
plus	NULL
PFB-btk-kd	NULL
;	NULL
lane	NULL
3	NULL
,	NULL
BTK	NULL
immunoprecipitate	NULL
from	NULL
Sf21	NULL
cells	NULL
transfected	NULL
with	NULL
PFB-btk-kd	NULL
;	NULL
lane	NULL
4	NULL
,	NULL
whole	NULL
cell	NULL
lysate	NULL
Sf21	NULL
cells	NULL
transfected	NULL
with	NULL
PFB-stat5a	NULL
plus	NULL
PFB-btk-kd	NULL
.	NULL

STAT5A	NULL
and	NULL
BTK-KD	NULL
.	NULL

STAT5A	NULL
immunoprecipitated	NULL
from	NULL
whole	NULL
cell	NULL
lysates	NULL
of	NULL
Sf21	NULL
cells	NULL
expressing	NULL
STAT5A	NULL
alone	NULL
showed	NULL
no	NULL
tyrosine	NULL
phosphorylation	NULL
(	NULL
Fig	NULL
.	NULL

7G	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

When	NULL
compared	NULL
with	NULL
this	NULL
STAT5A	NULL
protein	NULL
,	NULL
STAT5A	NULL
immunoprecipitated	NULL
from	NULL
whole	NULL
cell	NULL
lysates	NULL
of	NULL
Sf21	NULL
cells	NULL
coexpressing	NULL
STAT5A	NULL
and	NULL
BTK-KD	NULL
showed	NULL
markedly	NULL
enhanced	NULL
tyrosine	NULL
phosphorylation	NULL
(	NULL
Fig	NULL
.	NULL

7G	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
findings	NULL
provided	NULL
direct	NULL
evidence	NULL
that	NULL
the	NULL
KD	NULL
of	NULL
BTK	NULL
is	NULL
capable	NULL
of	NULL
tyrosine-phosphorylating	NULL
STAT5A	NULL
both	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
KD	NULL
of	NULL
BTK	NULL
is	NULL
sufficient	NULL
for	NULL
the	NULL
functional	NULL
interactions	NULL
between	NULL
BTK	NULL
and	NULL
STAT5A	NULL
.	NULL

Activation	NULL
of	NULL
a	NULL
BTK-dependent	NULL
and	NULL
JAK3-independent	NULL
Mechanism	NULL
of	NULL
STAT5A	NULL
Tyrosine	NULL
Phosphorylation	NULL
in	NULL
B	NULL
Cells	NULL
after	NULL
Engagement	NULL
of	NULL
the	NULL
B	NULL
Cell	NULL
Antigen	NULL
Receptor-B	NULL
cells	NULL
abundantly	NULL
express	NULL
STAT5	NULL
,	NULL
and	NULL
engagement	NULL
of	NULL
the	NULL
B	NULL
cell	NULL
antigen-receptor	NULL
results	NULL
in	NULL
activation	NULL
of	NULL
STATS	NULL
(	NULL
31	NULL
)	NULL
.	NULL

We	NULL
first	NULL
sought	NULL
to	NULL
confirm	NULL
these	NULL
results	NULL
by	NULL
examining	NULL
the	NULL
phosphorylation	NULL
status	NULL
of	NULL
anti-STAT5A	NULL
immunoreactive	NULL
protein	NULL
(	NULL
presumed	NULL
chicken	NULL
STAT5	NULL
)	NULL
in	NULL
DT4O	NULL
chicken	NULL
B	NULL
cells	NULL
after	NULL
stimulation	NULL
with	NULL
the	NULL
anti-chicken	NULL
IgM	NULL
antibody	NULL
M4	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

8A	NULL
,	NULL
M4	NULL
stimulation	NULL
resulted	NULL
in	NULL
enhanced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STATS	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

Notably	NULL
,	NULL
pretreatment	NULL
of	NULL
DT4O	NULL
cells	NULL
with	NULL
the	NULL
BTK	NULL
inhibitor	NULL
6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san	NULL
$	NULL
4g	NULL
/310-2q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wou	NULL
;	NULL
papeojumo	NULL
(	NULL
31226	NULL
STAT5A	NULL
as	NULL
a	NULL
Substrate	NULL
of	NULL
BTK	NULL
algM	NULL
$	NULL
®	NULL
a	NULL
®	NULL
@	NULL
A	NULL
o	NULL
eﬁﬁﬁb	NULL
$	NULL
3	NULL
?	NULL

kOn	NULL
STATSA	NULL
IP	NULL
57	NULL
.	NULL

P	NULL
-l	NULL
<	NULL
STAT5A	NULL
APT	NULL
blot	NULL
60-	NULL
«	NULL
4	NULL
B	NULL
STATSA	NULL
IP	NULL
o7-	NULL
ame	NULL
mall	NULL
LstarsA	NULL
STATSA	NULL
blot	NULL
#	NULL
o-algM	NULL
algM	NULL
G	NULL
WT	NULL
L	NULL
C	NULL
ipa	NULL
0	NULL
5000	NULL
30	NULL
60°	NULL
C	NULL
'	NULL
``	NULL
o	NULL
s	NULL
10	NULL
so	NULL
ao	NULL
&	NULL
10°	NULL
``	NULL
0	NULL
ag	NULL
95	NULL
``	NULL
sTaTsA	NULL
IP	NULL
**	NULL
P	NULL
m	NULL
<	NULL
BTK	NULL
AFTHlct	NULL
:	NULL
#	NULL
-	NULL
STAT	NULL
5A	NULL
so-	NULL
P	NULL
so-BTK	NULL
IAEA	NULL
BTK	NULL
IP+APT	NULL
blot	NULL
STATSA	NULL
IP	NULL
in	NULL
D	NULL
kDa	NULL
D	NULL
'	NULL
STATSA	NULL
blot	NULL
-	NULL
97-	NULL
amas	NULL
-	NULL
maak	NULL
-	NULL
<	NULL
STAT	NULL
5A	NULL
ar-wsas	NULL
cue	NULL
cus	NULL
ame	NULL
cue	NULL
ind	NULL
69	NULL
-	NULL
BTK	NULL
IP-	NULL
>	NULL
BTK	NULL
blot	NULL
BTK	NULL
IP-+	NULL
BTK	NULL
blot	NULL
aight	NULL
H	NULL
__WT	NULL
__	NULL
E	NULL
kDa	NULL
E	NULL
'	NULL
``	NULL
o	NULL
10°	NULL
``	NULL
0	NULL
10	NULL
``	NULL
ar	NULL
sone	NULL
seam	NULL
-	NULL
STATSA	NULL
h	NULL
%	NULL
&	NULL
``	NULL
statsain-	NULL
pour	NULL
*	NULL
STATSA	NULL
IP	NULL
STATsA	NULL
IP+APT	NULL
blot	NULL
STATSA	NULL
IP	NULL
--	NULL
APT	NULL
blot	NULL
APT	NULL
blot	NULL
ar-	NULL
+	NULL
WB	NULL
<	NULL
STAT	NULL
5A	NULL
F	NULL
kDa	NULL
1	NULL
bal	NULL
97-	NULL
cue	NULL
cme	NULL
cee	NULL
ques	NULL
eme	NULL
dome	NULL
mos	NULL
mos	NULL
mmm	NULL
gett	NULL
<	NULL
STAT	NULL
5A	NULL
STAT5A	NULL
IP	NULL
.	NULL

ll.-STATSA	NULL
IP~+STATS	NULL
blot	NULL
STATSA	NULL
IP+STATS	NULL
blot	NULL
STAT5A	NULL
blot	NULL
-	NULL
97-	NULL
)	NULL
«	NULL
STAT	NULL
5A	NULL
BTK	NULL
,	NULL
rBTK®	NULL
``	NULL
BTK	NULL
,	NULL
rBTK®®	NULL
Fig	NULL
.	NULL

8	NULL
.	NULL

A	NULL
and	NULL
B	NULL
,	NULL
pretreatment	NULL
of	NULL
chicken	NULL
B	NULL
cells	NULL
with	NULL
the	NULL
BTK	NULL
inhibitor	NULL
LFM-A13	NULL
prevents	NULL
anti-IgM-induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT5A	NULL
.	NULL

Cells	NULL
were	NULL
stimulated	NULL
with	NULL
anti-IgM	NULL
(	NULL
M4	NULL
)	NULL
antibody	NULL
(	NULL
10	NULL
ug/10	NULL
x	NULL
10°	NULL
cells/ml	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
100	NULL
uM	NULL
LFM-A13	NULL
(	NULL
a	NULL
BTK	NULL
inhibitor	NULL
that	NULL
does	NULL
not	NULL
inhibit	NULL
JAK3	NULL
)	NULL
or	NULL
100	NULL
um	NULL
HI-P131	NULL
(	NULL
a	NULL
JAK3	NULL
inhibitor	NULL
that	NULL
does	NULL
not	NULL
inhibit	NULL
BTK	NULL
)	NULL
for	NULL
30	NULL
min	NULL
.	NULL

Cells	NULL
were	NULL
lysed	NULL
and	NULL
immunoprecipitated	NULL
with	NULL
STAT5A	NULL
,	NULL
and	NULL
STAT5A	NULL
immune	NULL
complexes	NULL
were	NULL
subjected	NULL
to	NULL
Western	NULL
blot	NULL
analyses	NULL
with	NULL
anti-phosphotyrosine	NULL
(	NULL
A	NULL
)	NULL
or	NULL
anti-STAT5A	NULL
(	NULL
B	NULL
)	NULL
antibodies	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
BTK	NULL
and	NULL
STAT5A	NULL
are	NULL
marked	NULL
with	NULL
arrowheads	NULL
.	NULL

C-F	NULL
,	NULL
requirement	NULL
for	NULL
an	NULL
active	NULL
BTK	NULL
for	NULL
the	NULL
anti-IgM-induced	NULL
in	NULL
vivo	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT5A	NULL
.	NULL

BTK-deficient	NULL
DT40	NULL
chicken	NULL
B	NULL
cells	NULL
reconstituted	NULL
with	NULL
wild	NULL
type	NULL
human	NULL
BTK	NULL
(	NULL
C-F	NULL
)	NULL
and	NULL
BTK-deficient	NULL
DT4O	NULL
chicken	NULL
B	NULL
cells	NULL
reconstituted	NULL
with	NULL
inactive	NULL
kinase	NULL
domain-mutant	NULL
human	NULL
BTK	NULL
(	NULL
C'-F	NULL
``	NULL
)	NULL
were	NULL
stimulated	NULL
with	NULL
M-4	NULL
anti-chicken	NULL
IgM	NULL
antibody	NULL
(	NULL
20	NULL
ug	NULL
of	NULL
M-4/m1/10	NULL
x	NULL
10°	NULL
cells	NULL
)	NULL
and	NULL
lysed	NULL
at	NULL
the	NULL
indicated	NULL
times	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
anti-BTK	NULL
(	NULL
C	NULL
,	NULL
D	NULL
,	NULL
C	NULL
'	NULL
,	NULL
and	NULL
D	NULL
'	NULL
)	NULL
or	NULL
anti-STAT	NULL
antibodies	NULL
(	NULL
E	NULL
,	NULL
F	NULL
,	NULL
E	NULL
'	NULL
,	NULL
and	NULL
F	NULL
``	NULL
)	NULL
and	NULL
immunoblotted	NULL
with	NULL
anti-phosphotyrosine	NULL
(	NULL
C	NULL
,	NULL
£	NULL
,	NULL
C	NULL
'	NULL
,	NULL
and	NULL
E	NULL
``	NULL
)	NULL
,	NULL
anti-BTK	NULL
(	NULL
D	NULL
and	NULL
D	NULL
'	NULL
)	NULL
,	NULL
or	NULL
anti-STAT5A	NULL
antibodies	NULL
(	NULL
F	NULL
and	NULL
F	NULL
``	NULL
)	NULL
as	NULL
indicated	NULL
.	NULL

G	NULL
and	NULL
H	NULL
,	NULL
B	NULL
cell	NULL
antigen	NULL
receptor-mediated	NULL
versus	NULL
IL-2	NULL
receptor-mediated	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT5A	NULL
in	NULL
B	NULL
cells	NULL
from	NULL
wild	NULL
type	NULL
,	NULL
XID	NULL
,	NULL
and	NULL
JAK3	NULL
knockout	NULL
mice	NULL
.	NULL

Splenocytes	NULL
from	NULL
normal	NULL
and	NULL
XID	NULL
mice	NULL
(	NULL
G	NULL
)	NULL
and	NULL
normal	NULL
and	NULL
JAK3	NULL
knockout	NULL
mice	NULL
(	NULL
)	NULL
were	NULL
stimulated	NULL
with	NULL
an	NULL
anti-mouse	NULL
IgM	NULL
antibody	NULL
(	NULL
10	NULL
ug/10	NULL
x	NULL
10°	NULL
cells/ml	NULL
)	NULL
or	NULL
recombinant	NULL
IL-2	NULL
(	NULL
20	NULL
ng/10	NULL
x	NULL
10°	NULL
cells/ml	NULL
)	NULL
for	NULL
10	NULL
min	NULL
.	NULL

Cells	NULL
were	NULL
lysed	NULL
and	NULL
immunoprecipitated	NULL
with	NULL
an	NULL
anti-STAT5A	NULL
antibody	NULL
,	NULL
and	NULL
the	NULL
STAT5A	NULL
immune	NULL
complexes	NULL
were	NULL
subjected	NULL
to	NULL
immunoblotting	NULL
with	NULL
anti-phospho-	NULL
tyrosine	NULL
(	NULL
G	NULL
and	NULL
H	NULL
,	NULL
upper	NULL
panels	NULL
)	NULL
or	NULL
anti-STAT5A	NULL
(	NULL
G	NULL
and	NULL
H	NULL
,	NULL
lower	NULL
panels	NULL
)	NULL
antibodies	NULL
.	NULL

LEFM-A13	NULL
,	NULL
which	NULL
does	NULL
not	NULL
inhibit	NULL
JAK3	NULL
(	NULL
5	NULL
)	NULL
abrogated	NULL
the	NULL
M4-induced	NULL
STAT5	NULL
phosphorylation	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

By	NULL
comparison	NULL
,	NULL
the	NULL
JAK3	NULL
inhibitor	NULL
HI-P131	NULL
,	NULL
which	NULL
does	NULL
not	NULL
inhibit	NULL
BTK	NULL
(	NULL
40	NULL
)	NULL
,	NULL
did	NULL
not	NULL
prevent	NULL
the	NULL
M4-induced	NULL
STAT5	NULL
phosphorylation	NULL
in	NULL
DT4O0	NULL
cells	NULL
(	NULL
Zane	NULL
4	NULL
)	NULL
.	NULL

Anti-STAT5A	NULL
immunoblotting	NULL
confirmed	NULL
that	NULL
the	NULL
amounts	NULL
of	NULL
immunoprecipitated	NULL
STAT5A	NULL
in	NULL
these	NULL
samples	NULL
were	NULL
comparable	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
provided	NULL
circumstantial	NULL
evidence	NULL
that	NULL
BTK	NULL
(	NULL
but	NULL
not	NULL
JAK3	NULL
)	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
STAT5	NULL
tyrosine	NULL
phosphorylation	NULL
after	NULL
B	NULL
cell	NULL
antigen	NULL
receptor	NULL
ligation	NULL
.	NULL

We	NULL
next	NULL
studied	NULL
the	NULL
role	NULL
of	NULL
BTK	NULL
in	NULL
B	NULL
cell	NULL
antigen	NULL
receptor-mediated	NULL
STATS5	NULL
phosphorylation	NULL
by	NULL
comparing	NULL
the	NULL
STATS	NULL
tyrosine	NULL
phosphorylation	NULL
levels	NULL
after	NULL
M4	NULL
antibody	NULL
stimulation	NULL
in	NULL
BTK-deficient	NULL
DT4O	NULL
cells	NULL
reconstituted	NULL
with	NULL
wild	NULL
type	NULL
human	NULL
BTK	NULL
versus	NULL
BTK-deficient	NULL
DT4O	NULL
cells	NULL
reconstituted	NULL
with	NULL
kinase-inactive	NULL
mutant	NULL
BTK	NULL
.	NULL

Notably	NULL
,	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
BTK	NULL
(	NULL
Fig	NULL
.	NULL

8C	NULL
)	NULL
preceded	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT5A	NULL
(	NULL
Fig	NULL
.	NULL

8E	NULL
)	NULL
in	NULL
BTK-deficient	NULL
DT4O	NULL
cells	NULL
reconstituted	NULL
with	NULL
wild	NULL
type	NULL
human	NULL
BTK	NULL
.	NULL

By	NULL
comparison	NULL
,	NULL
B	NULL
cell	NULL
antigen	NULL
receptor	NULL
ligation	NULL
failed	NULL
to	NULL
trigger	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
BTK	NULL
(	NULL
Fig	NULL
.	NULL

8C	NULL
``	NULL
)	NULL
or	NULL
STATS	NULL
(	NULL
Fig	NULL
.	NULL

8FE	NULL
'	NULL
)	NULL
in	NULL
BTK-deficient	NULL
DT4O	NULL
cells	NULL
reconstituted	NULL
with	NULL
kinase-inactive	NULL
mutant	NULL
BTK	NULL
.	NULL

Immunoblotting	NULL
with	NULL
anti-BTK	NULL
and	NULL
anti-STATS5	NULL
antibodies	NULL
confirmed	NULL
that	NULL
the	NULL
samples	NULL
corresponding	NULL
to	NULL
the	NULL
different	NULL
time	NULL
points	NULL
after	NULL
M4	NULL
stimulation	NULL
contained	NULL
comparable	NULL
levels	NULL
of	NULL
BTK	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
,	NULL
D	NULL
and	NULL
D	NULL
'	NULL
)	NULL
and	NULL
STATS	NULL
(	NULL
Fig	NULL
.	NULL

8F	NULL
and	NULL
F	NULL
'	NULL
)	NULL
proteins	NULL
.	NULL

We	NULL
next	NULL
examined	NULL
the	NULL
effects	NULL
of	NULL
anti-IgM	NULL
stimulation	NULL
on	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
status	NULL
of	NULL
STAT5A	NULL
in	NULL
murine	NULL
B	NULL
cells	NULL
from	NULL
BTK-competent	NULL
wild	NULL
type	NULL
mice	NULL
versus	NULL
functionally	NULL
BTK-deficient	NULL
XID	NULL
mice	NULL
.	NULL

Whereas	NULL
the	NULL
anti-IgM	NULL
stimulation	NULL
resulted	NULL
in	NULL
enhanced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT5A	NULL
in	NULL
BTK-competent	NULL
B	NULL
cells	NULL
from	NULL
wild	NULL
type	NULL
mice	NULL
(	NULL
Fig	NULL
.	NULL

8G	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
;	NULL
Fig	NULL
.	NULL

8H	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
,	NULL
no	NULL
STAT5A	NULL
phosphorylation	NULL
was	NULL
induced	NULL
in	NULL
BTK-deficient	NULL
B	NULL
cells	NULL
from	NULL
XID	NULL
mice	NULL
(	NULL
Fig	NULL
.	NULL

8G	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
provide	NULL
experimental	NULL
evidence	NULL
that	NULL
BTK	NULL
plays	NULL
a	NULL
pivotal	NULL
role	NULL
in	NULL
B	NULL
cell	NULL
antigen	NULL
receptor-mediated	NULL
STAT5A	NULL
phosphorylation	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
B	NULL
cells	NULL
from	NULL
XID	NULL
mice	NULL
,	NULL
B	NULL
cells	NULL
from	NULL
JAK3	NULL
knockout	NULL
mice	NULL
showed	NULL
a	NULL
normal	NULL
STAT5A	NULL
phosphorylation	NULL
response	NULL
to	NULL
anti-IgM	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

8H	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
JAK3	NULL
is	NULL
not	NULL
required	NULL
for	NULL
the	NULL
B	NULL
cell	NULL
antigen	NULL
receptor-mediated	NULL
STAT5A	NULL
phosphorylation	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

BTK	NULL
is	NULL
essential	NULL
for	NULL
the	NULL
physiologic	NULL
B	NULL
cell	NULL
responses	NULL
to	NULL
stimulation	NULL
of	NULL
the	NULL
B	NULL
cell	NULL
antigen	NULL
receptor	NULL
(	NULL
1-6	NULL
)	NULL
and	NULL
is	NULL
required	NULL
for	NULL
normal	NULL
B	NULL
cell	NULL
development	NULL
,	NULL
since	NULL
defects	NULL
in	NULL
BTK	NULL
lead	NULL
to	NULL
XID	NULL
in	NULL
mice	NULL
and	NULL
XLA	NULL
in	NULL
humans	NULL
(	NULL
7	NULL
,	NULL
8	NULL
)	NULL
.	NULL

Recent	NULL
observations	NULL
suggest	NULL
the	NULL
involvement	NULL
of	NULL
BTK	NULL
in	NULL
signal	NULL
transduction	NULL
pathways	NULL
affecting	NULL
gene	NULL
transcription	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Recent	NULL
studies	NULL
have	NULL
further	NULL
revealed	NULL
a	NULL
nucleocytoplasmic	NULL
shuttling	NULL
system	NULL
for	NULL
BTK	NULL
that	NULL
has	NULL
implications	NULL
regarding	NULL
potential	NULL
targets	NULL
inside	NULL
the	NULL
nucleus	NULL
,	NULL
which	NULL
may	NULL
be	NULL
critical	NULL
in	NULL
gene	NULL
regulation	NULL
during	NULL
B	NULL
cell	NULL
development	NULL
and	NULL
differentiation	NULL
(	NULL
14	NULL
)	NULL
.	NULL

An	NULL
unresolved	NULL
question	NULL
in	NULL
B	NULL
cell	NULL
immunology	NULL
is	NULL
the	NULL
nature	NULL
of	NULL
the	NULL
molecular	NULL
coupling	NULL
mechanisms	NULL
that	NULL
link	NULL
the	NULL
proximal	NULL
signals	NULL
that	NULL
are	NULL
triggered	NULL
by	NULL
the	NULL
engagement	NULL
of	NULL
the	NULL
B	NULL
cell	NULL
antigen	NULL
receptor	NULL
to	NULL
downstream	NULL
signal	NULL
transduction	NULL
pathways	NULL
affecting	NULL
gene	NULL
transcription	NULL
.	NULL

The	NULL
recognition	NULL
of	NULL
an	NULL
antigen	NULL
by	NULL
the	NULL
B	NULL
cell	NULL
antigen	NULL
receptor	NULL
triggers	NULL
a	NULL
6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san	NULL
$	NULL
4g	NULL
/310-2q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wou	NULL
;	NULL
papeojumo	NULL
(	NULL
STAT5A	NULL
as	NULL
a	NULL
Substrate	NULL
of	NULL
BTK	NULL
signal	NULL
transduction	NULL
cascade	NULL
that	NULL
culminates	NULL
in	NULL
activation	NULL
of	NULL
multiple	NULL
genes	NULL
controlling	NULL
activation	NULL
,	NULL
proliferation	NULL
,	NULL
differentiation	NULL
,	NULL
and	NULL
survival	NULL
of	NULL
B	NULL
cells	NULL
.	NULL

BCR	NULL
stimulation	NULL
leads	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
transcription	NULL
factor	NULL
NF-kB	NULL
,	NULL
which	NULL
in	NULL
turn	NULL
regulates	NULL
genes	NULL
controlling	NULL
B	NULL
cell	NULL
growth	NULL
.	NULL

BTK	NULL
is	NULL
essential	NULL
for	NULL
activation	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
kB/Rel	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
via	NULL
the	NULL
B	NULL
cell	NULL
antigen	NULL
receptor	NULL
(	NULL
15	NULL
,	NULL
49	NULL
)	NULL
.	NULL

BTK	NULL
has	NULL
also	NULL
been	NULL
shown	NULL
to	NULL
regulate	NULL
the	NULL
nuclear	NULL
localization	NULL
and	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
multifunctional	NULL
transcription	NULL
factor	NULL
BAP-	NULL
135/TFII-I	NULL
(	NULL
17	NULL
)	NULL
.	NULL

BAP-135/TFII-I	NULL
is	NULL
a	NULL
ubiquitously	NULL
expressed	NULL
multifunctional	NULL
transcription	NULL
initiation	NULL
factor	NULL
capable	NULL
of	NULL
binding	NULL
to	NULL
several	NULL
promoter	NULL
elements	NULL
,	NULL
including	NULL
initiator	NULL
(	NULL
Inr	NULL
)	NULL
elements	NULL
(	NULL
50-52	NULL
)	NULL
that	NULL
is	NULL
tyrosine	NULL
phosphorylated	NULL
in	NULL
B	NULL
cells	NULL
after	NULL
engagement	NULL
of	NULL
the	NULL
B	NULL
cell	NULL
antigen	NULL
receptor	NULL
(	NULL
12	NULL
)	NULL
.	NULL

TFII-I	NULL
can	NULL
function	NULL
both	NULL
as	NULL
a	NULL
basal	NULL
factor	NULL
through	NULL
the	NULL
Inr	NULL
element	NULL
(	NULL
50-53	NULL
)	NULL
and	NULL
as	NULL
an	NULL
activator	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
a	NULL
functional	NULL
Inr	NULL
element	NULL
(	NULL
53-55	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
TFII-I	NULL
is	NULL
likely	NULL
to	NULL
participate	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
transcription	NULL
of	NULL
several	NULL
genes	NULL
in	NULL
B	NULL
cells	NULL
(	NULL
50-55	NULL
)	NULL
.	NULL

TFII-I	NULL
might	NULL
establish	NULL
an	NULL
additional	NULL
link	NULL
between	NULL
Btk-mediated	NULL
signaling	NULL
and	NULL
transcription	NULL
because	NULL
TFII-I	NULL
possesses	NULL
Inr-dependent	NULL
transcription	NULL
properties	NULL
and	NULL
because	NULL
many	NULL
of	NULL
the	NULL
genes	NULL
that	NULL
are	NULL
important	NULL
for	NULL
normal	NULL
B	NULL
cell	NULL
development	NULL
are	NULL
Inr-containing	NULL
genes	NULL
(	NULL
e.g	NULL
.	NULL

VpreB	NULL
,	NULL
TdT	NULL
,	NULL
and	NULL
possibly	NULL
RAG	NULL
,	NULL
CD5	NULL
,	NULL
Bel-2	NULL
,	NULL
and	NULL
Bcl-xL	NULL
)	NULL
;	NULL
a	NULL
subset	NULL
of	NULL
these	NULL
might	NULL
be	NULL
potentially	NULL
TFII-I-respon-sive	NULL
.	NULL

Interference	NULL
with	NULL
this	NULL
coupling	NULL
mechanism	NULL
may	NULL
contribute	NULL
to	NULL
the	NULL
B	NULL
cell	NULL
deficiencies	NULL
observed	NULL
in	NULL
XLA	NULL
patients	NULL
or	NULL
XID	NULL
mice	NULL
.	NULL

Here	NULL
we	NULL
now	NULL
show	NULL
that	NULL
BTK	NULL
couples	NULL
the	NULL
STAT	NULL
signaling	NULL
pathway	NULL
to	NULL
the	NULL
B	NULL
cell	NULL
antigen	NULL
receptor	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
STAT5A	NULL
links	NULL
BTK-mediated	NULL
signaling	NULL
events	NULL
to	NULL
downstream	NULL
gene	NULL
activation	NULL
.	NULL

A	NULL
compromised	NULL
coupling	NULL
between	NULL
BTK	NULL
and	NULL
STAT5A	NULL
might	NULL
lead	NULL
to	NULL
aberrant	NULL
expression	NULL
of	NULL
the	NULL
STAT5A-responsive	NULL
genes	NULL
and	NULL
might	NULL
contribute	NULL
to	NULL
the	NULL
XLA	NULL
and	NULL
XID	NULL
phenotypes	NULL
.	NULL

BTK	NULL
belongs	NULL
to	NULL
the	NULL
Tec	NULL
family	NULL
of	NULL
nonreceptor	NULL
tyrosine	NULL
kinases	NULL
that	NULL
includes	NULL
Tecl	NULL
,	NULL
Tecll	NULL
,	NULL
Itk	NULL
,	NULL
Bmx/Etk	NULL
,	NULL
and	NULL
DSrc28C	NULL
(	NULL
found	NULL
in	NULL
Drosophila	NULL
)	NULL
(	NULL
56	NULL
)	NULL
.	NULL

Members	NULL
of	NULL
this	NULL
family	NULL
contain	NULL
SH1	NULL
,	NULL
SH2	NULL
,	NULL
and	NULL
SH3	NULL
domains	NULL
but	NULL
lack	NULL
the	NULL
typical	NULL
myristoylation	NULL
site	NULL
and	NULL
negative	NULL
regulatory	NULL
tyrosine	NULL
of	NULL
Sre	NULL
family	NULL
members	NULL
.	NULL

A	NULL
distinctive	NULL
feature	NULL
of	NULL
these	NULL
kinases	NULL
is	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
PH	NULL
domain	NULL
in	NULL
the	NULL
N-terminal	NULL
region	NULL
,	NULL
followed	NULL
by	NULL
a	NULL
unique	NULL
Tec	NULL
homology	NULL
domain	NULL
.	NULL

PH	NULL
domains	NULL
are	NULL
involved	NULL
in	NULL
membrane	NULL
lo-calization	NULL
,	NULL
signal	NULL
transduction	NULL
,	NULL
and	NULL
cytoskeletal	NULL
structure	NULL
of	NULL
several	NULL
proteins	NULL
(	NULL
57-59	NULL
)	NULL
.	NULL

The	NULL
BTK	NULL
PH	NULL
domain	NULL
has	NULL
also	NULL
been	NULL
implicated	NULL
as	NULL
a	NULL
protein	NULL
interaction	NULL
domain	NULL
(	NULL
9	NULL
,	NULL
60	NULL
)	NULL
.	NULL

Yang	NULL
and	NULL
Desiderio	NULL
(	NULL
12	NULL
)	NULL
provided	NULL
evidence	NULL
that	NULL
the	NULL
PH	NULL
domain	NULL
participates	NULL
in	NULL
the	NULL
association	NULL
of	NULL
Btk	NULL
and	NULL
BAP-135/TFII-I	NULL
.	NULL

The	NULL
PH	NULL
domain	NULL
of	NULL
Btk	NULL
is	NULL
primarily	NULL
responsible	NULL
for	NULL
its	NULL
physical	NULL
interaction	NULL
with	NULL
TFII-I	NULL
,	NULL
but	NULL
an	NULL
intact	NULL
kinase	NULL
domain	NULL
of	NULL
BTK	NULL
is	NULL
also	NULL
required	NULL
to	NULL
enhance	NULL
transcriptional	NULL
activity	NULL
of	NULL
TFII-I	NULL
in	NULL
the	NULL
nucleus	NULL
.	NULL

By	NULL
comparison	NULL
,	NULL
our	NULL
data	NULL
presented	NULL
herein	NULL
indicate	NULL
that	NULL
only	NULL
the	NULL
kinase	NULL
domain	NULL
of	NULL
BTK	NULL
appears	NULL
to	NULL
be	NULL
essential	NULL
for	NULL
its	NULL
physical	NULL
and	NULL
functional	NULL
interactions	NULL
with	NULL
STAT5A	NULL
.	NULL

Co-immunoprecipitation	NULL
experiments	NULL
presented	NULL
herein	NULL
indicated	NULL
that	NULL
BTK	NULL
is	NULL
associated	NULL
with	NULL
STAT5A	NULL
in	NULL
unstimulated	NULL
B	NULL
cells	NULL
but	NULL
that	NULL
association	NULL
is	NULL
reduced	NULL
after	NULL
anti-IgM	NULL
stimulation	NULL
.	NULL

These	NULL
results	NULL
are	NULL
reminiscent	NULL
of	NULL
the	NULL
reported	NULL
interactions	NULL
between	NULL
BTK	NULL
and	NULL
TFII-I	NULL
(	NULL
17	NULL
)	NULL
.	NULL

The	NULL
physical	NULL
association	NULL
of	NULL
BTK	NULL
with	NULL
TFII-I	NULL
in	NULL
B	NULL
cells	NULL
is	NULL
reduced	NULL
4-fold	NULL
after	NULL
engagement	NULL
of	NULL
the	NULL
B	NULL
cell	NULL
antigen	NULL
receptor	NULL
(	NULL
17	NULL
)	NULL
.	NULL

It	NULL
has	NULL
been	NULL
proposed	NULL
that	NULL
after	NULL
anti-IgM	NULL
stimulation	NULL
,	NULL
activated	NULL
BTK	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
TFII-I	NULL
,	NULL
which	NULL
in	NULL
turn	NULL
reduces	NULL
the	NULL
constitutive	NULL
association	NULL
of	NULL
BTK	NULL
and	NULL
TFII-I	NULL
and	NULL
allows	NULL
dissociated	NULL
TFII-I	NULL
to	NULL
translocate	NULL
to	NULL
the	NULL
nucleus	NULL
in	NULL
active	NULL
tyrosine-phosphorylated	NULL
form	NULL
(	NULL
17	NULL
)	NULL
.	NULL

It	NULL
is	NULL
conceivable	NULL
that	NULL
a	NULL
similar	NULL
molecular	NULL
mechanism	NULL
governs	NULL
the	NULL
BTK-STAT5A	NULL
interactions	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
our	NULL
results	NULL
demonstrate	NULL
a	NULL
functional	NULL
interac-	NULL
31227	NULL
tion	NULL
between	NULL
the	NULL
transcription	NULL
factor	NULL
STAT5A	NULL
and	NULL
BTK	NULL
.	NULL

BTK	NULL
is	NULL
the	NULL
first	NULL
cytoplasmic	NULL
non-Janus	NULL
kinase	NULL
to	NULL
be	NULL
identified	NULL
as	NULL
a	NULL
positive	NULL
regulator	NULL
of	NULL
STAT5A	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

Our	NULL
findings	NULL
point	NULL
to	NULL
a	NULL
novel	NULL
pathway	NULL
through	NULL
which	NULL
B	NULL
cell-specific	NULL
signals	NULL
mediated	NULL
by	NULL
BTK	NULL
might	NULL
communicate	NULL
with	NULL
target	NULL
genes	NULL
via	NULL
STAT5A	NULL
.	NULL

Thus	NULL
,	NULL
mutations	NULL
in	NULL
the	NULL
BTK	NULL
kinase	NULL
domain	NULL
impairing	NULL
the	NULL
physical	NULL
and/or	NULL
functional	NULL
association	NULL
between	NULL
STAT5A	NULL
and	NULL
BTK	NULL
may	NULL
result	NULL
in	NULL
diminished	NULL
STAT5A-dependent	NULL
transcription	NULL
and	NULL
contribute	NULL
to	NULL
defective	NULL
B	NULL
cell	NULL
development	NULL
and/or	NULL
function	NULL
.	NULL

Our	NULL
findings	NULL
prompt	NULL
the	NULL
hypothesis	NULL
that	NULL
STAT5A	NULL
links	NULL
BTK-mediated	NULL
signaling	NULL
events	NULL
that	NULL
follow	NULL
the	NULL
engagement	NULL
of	NULL
the	NULL
B	NULL
cell	NULL
antigen	NULL
receptor	NULL
to	NULL
downstream	NULL
gene	NULL
activation	NULL
.	NULL

A	NULL
compromised	NULL
coupling	NULL
between	NULL
BTK	NULL
and	NULL
STAT5A	NULL
might	NULL
lead	NULL
to	NULL
aberrant	NULL
expression	NULL
of	NULL
the	NULL
STAT5A-responsive	NULL
genes	NULL
and	NULL
might	NULL
contribute	NULL
to	NULL
the	NULL
XLA	NULL
and	NULL
XID	NULL
phenotypes	NULL
.	NULL

Similarly	NULL
,	NULL
the	NULL
B	NULL
cell	NULL
precursor	NULL
defects	NULL
observed	NULL
in	NULL
STAT5SA/5B-deficient	NULL
mice	NULL
may	NULL
in	NULL
part	NULL
be	NULL
due	NULL
to	NULL
impaired	NULL
coupling	NULL
of	NULL
BTK-mediated	NULL
proximal	NULL
signals	NULL
to	NULL
downstream	NULL
transcription	NULL
programs	NULL
controlling	NULL
the	NULL
orderly	NULL
expansion	NULL
of	NULL
B	NULL
cell	NULL
precursors	NULL
.	NULL

However	NULL
,	NULL
the	NULL
absence	NULL
of	NULL
significant	NULL
defects	NULL
in	NULL
antigen	NULL
receptor-mediated	NULL
mature	NULL
B	NULL
cell	NULL
responses	NULL
of	NULL
STAT5A/5B-deficient	NULL
mice	NULL
indicates	NULL
that	NULL
alternative	NULL
pathways	NULL
can	NULL
develop	NULL
and	NULL
almost	NULL
completely	NULL
compensate	NULL
for	NULL
STAT5	NULL
deficiency	NULL
when	NULL
B	NULL
cells	NULL
are	NULL
forced	NULL
to	NULL
develop	NULL
and	NULL
function	NULL
without	NULL
STAT5	NULL
expression	NULL
.	NULL

Our	NULL
results	NULL
corroborate	NULL
the	NULL
growing	NULL
evidence	NULL
that	NULL
multiple	NULL
coun-terregulatory	NULL
mechanisms	NULL
exist	NULL
in	NULL
B	NULL
cells	NULL
and	NULL
operate	NULL
to	NULL
preserve	NULL
cell	NULL
survival	NULL
and	NULL
growth	NULL
,	NULL
thereby	NULL
ensuring	NULL
their	NULL
orderly	NULL
development	NULL
and	NULL
differentiation	NULL
.	NULL

To	NULL
our	NULL
knowledge	NULL
,	NULL
STAT5A	NULL
deficiency	NULL
has	NULL
not	NULL
been	NULL
linked	NULL
to	NULL
a	NULL
human	NULL
immunodeficiency	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
physiologic	NULL
significance	NULL
of	NULL
our	NULL
findings	NULL
should	NULL
be	NULL
interpreted	NULL
with	NULL
due	NULL
caution	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Rawlings	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
and	NULL
Witte	NULL
,	NULL
O.	NULL
N.	NULL
(	NULL
1994	NULL
)	NULL
Immunol	NULL
.	NULL

Rev	NULL
.	NULL

188	NULL
,	NULL
105-119	NULL
2	NULL
.	NULL

Kurosaki	NULL
T.	NULL
(	NULL
1997	NULL
)	NULL
Curr	NULL
.	NULL

Opin	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

9	NULL
,	NULL
309-318	NULL
3	NULL
.	NULL

Uckun	NULL
,	NULL
F.	NULL
M.	NULL
(	NULL
1998	NULL
)	NULL
Biochem	NULL
.	NULL

Pharmacol	NULL
56	NULL
,	NULL
683-691	NULL
4	NULL
.	NULL

Vassilev	NULL
,	NULL
A.	NULL
,	NULL
Ozer	NULL
,	NULL
Z.	NULL
,	NULL
Navara	NULL
,	NULL
C.	NULL
,	NULL
Mahajan	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Uckun	NULL
,	NULL
F.	NULL
M.	NULL
(	NULL
1999	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

274	NULL
,	NULL
1646-1656	NULL
5	NULL
.	NULL

Mahajan	NULL
,	NULL
S.	NULL
,	NULL
Ghosh	NULL
,	NULL
S.	NULL
,	NULL
Sudbeck	NULL
,	NULL
E.	NULL
A	NULL
,	NULL
Zheng	NULL
,	NULL
Y.	NULL
,	NULL
Downs	NULL
,	NULL
S.	NULL
,	NULL
Hupke	NULL
,	NULL
M.	NULL
,	NULL
Uckun	NULL
,	NULL
F.	NULL
M.	NULL
(	NULL
1999	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

274	NULL
,	NULL
9587-9599	NULL
6	NULL
.	NULL

Tsukada	NULL
,	NULL
S.	NULL
,	NULL
Saffran	NULL
,	NULL
D.	NULL
C.	NULL
,	NULL
Rawlings	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Parolini	NULL
,	NULL
O.	NULL
,	NULL
Allen	NULL
,	NULL
R.	NULL
C.	NULL
,	NULL
Klisak	NULL
,	NULL
T.	NULL
,	NULL
Sparkes	NULL
,	NULL
R.	NULL
S.	NULL
,	NULL
Kubagawa	NULL
,	NULL
H.	NULL
,	NULL
Mohandas	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Quan	NULL
,	NULL
S.	NULL
(	NULL
1993	NULL
)	NULL
Cell	NULL
72	NULL
,	NULL
279-290	NULL
7	NULL
.	NULL

Vetrie	NULL
,	NULL
D.	NULL
,	NULL
Vorechovsky	NULL
,	NULL
I.	NULL
,	NULL
Sideras	NULL
,	NULL
P.	NULL
,	NULL
Holland	NULL
,	NULL
J.	NULL
,	NULL
Davies	NULL
,	NULL
A.	NULL
,	NULL
Flinter	NULL
,	NULL
F.	NULL
,	NULL
Hammarstrom	NULL
,	NULL
L.	NULL
,	NULL
Kinnon	NULL
,	NULL
C.	NULL
,	NULL
Levinsky	NULL
,	NULL
R.	NULL
,	NULL
Bobrow	NULL
,	NULL
M.	NULL
,	NULL
Smith	NULL
,	NULL
C.	NULL
I.	NULL
E.	NULL
,	NULL
and	NULL
Bentley	NULL
,	NULL
D.	NULL
R.	NULL
(	NULL
1993	NULL
)	NULL
Nature	NULL
861	NULL
,	NULL
226-233	NULL
8	NULL
.	NULL

Rawlings	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Saffran	NULL
,	NULL
D.	NULL
C.	NULL
,	NULL
Tsukada	NULL
,	NULL
S.	NULL
,	NULL
Largaespada	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
Grimaldi	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
Cohen	NULL
,	NULL
L.	NULL
,	NULL
Mohr	NULL
,	NULL
R.	NULL
N.	NULL
,	NULL
Bazan	NULL
,	NULL
J.	NULL
F.	NULL
,	NULL
Howard	NULL
,	NULL
M.	NULL
,	NULL
Copeland	NULL
,	NULL
N.	NULL
G.	NULL
,	NULL
Jenkins	NULL
,	NULL
N.	NULL
A.	NULL
,	NULL
and	NULL
Witte	NULL
,	NULL
O.	NULL
N.	NULL
(	NULL
1993	NULL
)	NULL
Science	NULL
261	NULL
,	NULL
358-361	NULL
9	NULL
.	NULL

Tsukada	NULL
,	NULL
S.	NULL
,	NULL
Simon	NULL
,	NULL
M.	NULL
I.	NULL
,	NULL
Witte	NULL
,	NULL
O.	NULL
N.	NULL
,	NULL
and	NULL
Katz	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

91	NULL
,	NULL
11256-11260	NULL
10	NULL
.	NULL

Vihinen	NULL
,	NULL
M.	NULL
,	NULL
Kwan	NULL
,	NULL
S.	NULL
P.	NULL
,	NULL
Lester	NULL
,	NULL
T.	NULL
,	NULL
Ochs	NULL
,	NULL
H.	NULL
D.	NULL
,	NULL
Resnick	NULL
,	NULL
I.	NULL
,	NULL
Valiaho	NULL
,	NULL
J.	NULL
,	NULL
Conley	NULL
,	NULL
M.	NULL
E.	NULL
,	NULL
and	NULL
Smith	NULL
,	NULL
C.	NULL
I	NULL
.	NULL

(	NULL
1999	NULL
)	NULL
Hum	NULL
.	NULL

Mutat	NULL
.	NULL

18	NULL
,	NULL
280-285	NULL
11	NULL
.	NULL

Kerner	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Appleby	NULL
,	NULL
M.	NULL
W.	NULL
,	NULL
Mohr	NULL
,	NULL
R.	NULL
N.	NULL
,	NULL
Chien	NULL
,	NULL
S.	NULL
,	NULL
Rawlings	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Maliazewski	NULL
,	NULL
C.	NULL
R.	NULL
,	NULL
Witte	NULL
,	NULL
O.	NULL
N.	NULL
,	NULL
and	NULL
Perlmutter	NULL
,	NULL
R.	NULL
M.	NULL
(	NULL
1995	NULL
)	NULL
Immunity	NULL
3	NULL
,	NULL
301-312	NULL
12	NULL
.	NULL

Yang	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
Desiderio	NULL
,	NULL
S.	NULL
(	NULL
1997	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

94	NULL
,	NULL
604-609	NULL
13	NULL
.	NULL

Hata	NULL
,	NULL
D.	NULL
,	NULL
Kitaura	NULL
,	NULL
J.	NULL
,	NULL
Hartman	NULL
,	NULL
S.	NULL
E.	NULL
,	NULL
Kawakami	NULL
,	NULL
Y.	NULL
,	NULL
Yokota	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Kawakami	NULL
,	NULL
T.	NULL
(	NULL
1998	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

278	NULL
,	NULL
10979-10987	NULL
14	NULL
.	NULL

Mohamed	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
Vargas	NULL
,	NULL
L.	NULL
,	NULL
Nore	NULL
,	NULL
B.	NULL
F.	NULL
,	NULL
Backesjo	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
Christensson	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Smith	NULL
,	NULL
C.	NULL
I	NULL
.	NULL

(	NULL
2000	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

275	NULL
,	NULL
40614-40619	NULL
15	NULL
.	NULL

Petro	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
,	NULL
Rahman	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
and	NULL
Khan	NULL
,	NULL
W.	NULL
N.	NULL
(	NULL
2000	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

191	NULL
,	NULL
1744-1754	NULL
16	NULL
.	NULL

Petro	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
,	NULL
and	NULL
Kahn	NULL
,	NULL
W.	NULL
N.	NULL
(	NULL
2001	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

276	NULL
,	NULL
1715-1719	NULL
17	NULL
.	NULL

Novina	NULL
,	NULL
C.	NULL
D.	NULL
,	NULL
Kumar	NULL
,	NULL
S.	NULL
,	NULL
Bajpai	NULL
,	NULL
U.	NULL
,	NULL
Cheriyath	NULL
,	NULL
V.	NULL
,	NULL
Zhang	NULL
,	NULL
K.	NULL
,	NULL
Pillai	NULL
,	NULL
S.	NULL
,	NULL
Wortis	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Roy	NULL
,	NULL
A.	NULL
L.	NULL
(	NULL
1999	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

19	NULL
,	NULL
5014-5024	NULL
18	NULL
.	NULL

Fukada	NULL
,	NULL
T.	NULL
,	NULL
Hibi	NULL
,	NULL
M.	NULL
,	NULL
Yamanaka	NULL
,	NULL
Y.	NULL
,	NULL
Takahashi-Tezuka	NULL
,	NULL
M.	NULL
,	NULL
Fujitani	NULL
,	NULL
Y.	NULL
,	NULL
Yamaguchi	NULL
,	NULL
T.	NULL
,	NULL
Nakajima	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Hirano	NULL
,	NULL
T.	NULL
(	NULL
1996	NULL
)	NULL
Immunity	NULL
5	NULL
,	NULL
449-460	NULL
19	NULL
.	NULL

Leonard	NULL
,	NULL
W.	NULL
J	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Nat	NULL
.	NULL

Med	NULL
.	NULL

2	NULL
,	NULL
968-969	NULL
20	NULL
.	NULL

Levy	NULL
,	NULL
D.	NULL
E.	NULL
(	NULL
1997	NULL
)	NULL
Cytokine	NULL
Growth	NULL
Factor	NULL
Rev	NULL
.	NULL

8	NULL
,	NULL
81-90	NULL
21	NULL
.	NULL

Kaneko	NULL
,	NULL
S.	NULL
,	NULL
Suzuki	NULL
,	NULL
N.	NULL
,	NULL
Koizumi	NULL
,	NULL
H.	NULL
,	NULL
Yamamoto	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Sakane	NULL
,	NULL
T.	NULL
(	NULL
1997	NULL
)	NULL
Clin	NULL
.	NULL

Exp	NULL
.	NULL

Immun	NULL
.	NULL

109	NULL
,	NULL
185-193	NULL
22	NULL
.	NULL

Lichtenstein	NULL
,	NULL
A.	NULL
,	NULL
Tu	NULL
,	NULL
Y.	NULL
,	NULL
Fady	NULL
,	NULL
C.	NULL
,	NULL
Vescio	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Berenson	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Cell	NULL
.	NULL

Immunol	NULL
.	NULL

162	NULL
,	NULL
248-255	NULL
23	NULL
.	NULL

Liu	NULL
,	NULL
J.	NULL
,	NULL
Li	NULL
,	NULL
H.	NULL
,	NULL
de	NULL
Tribolet	NULL
,	NULL
N.	NULL
,	NULL
Jaufeerally	NULL
,	NULL
R.	NULL
,	NULL
Hamou	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
and	NULL
Van	NULL
Meir	NULL
.	NULL

E.	NULL
G.	NULL
(	NULL
1994	NULL
)	NULL
Cell	NULL
.	NULL

Immunol	NULL
.	NULL

155	NULL
,	NULL
428-435	NULL
24	NULL
.	NULL

Heim	NULL
,	NULL
M.	NULL
H.	NULL
,	NULL
Kerr	NULL
,	NULL
I.	NULL
M.	NULL
,	NULL
Stark	NULL
,	NULL
G.	NULL
R.	NULL
,	NULL
and	NULL
Darnell	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Jr.	NULL
(	NULL
1995	NULL
)	NULL
Science	NULL
267	NULL
,	NULL
1347-1349	NULL
25	NULL
.	NULL

Levy	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Kvist	NULL
,	NULL
S.	NULL
(	NULL
1990	NULL
)	NULL
Int	NULL
.	NULL

Immunol	NULL
.	NULL

2	NULL
,	NULL
995-1002	NULL
26	NULL
.	NULL

Reddy	NULL
,	NULL
E.	NULL
P.	NULL
,	NULL
Korapati	NULL
,	NULL
A.	NULL
,	NULL
Chaturvedi	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Rane	NULL
,	NULL
S.	NULL
(	NULL
2000	NULL
)	NULL
Oncogene	NULL
19	NULL
,	NULL
2532-2547	NULL
6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san	NULL
$	NULL
4g	NULL
/310-2q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wou	NULL
;	NULL
papeojumo	NULL
(	NULL
31228	NULL
27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

Takata	NULL
,	NULL
M.	NULL
,	NULL
Sabe	NULL
,	NULL
H.	NULL
,	NULL
Hata	NULL
,	NULL
A.	NULL
,	NULL
Inazu	NULL
,	NULL
T.	NULL
,	NULL
Homma	NULL
,	NULL
Y.	NULL
,	NULL
Nukada	NULL
,	NULL
T.	NULL
,	NULL
Yamamura	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Kurosaki	NULL
,	NULL
T.	NULL
(	NULL
1994	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

13	NULL
,	NULL
1341-1349	NULL
Wen	NULL
,	NULL
Z.	NULL
,	NULL
Zhong	NULL
,	NULL
Z.	NULL
,	NULL
and	NULL
Darnell	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Jr.	NULL
(	NULL
1995	NULL
)	NULL
Cell	NULL
82	NULL
,	NULL
241-250	NULL
Jurlander	NULL
,	NULL
J.	NULL
,	NULL
Lai	NULL
,	NULL
C.	NULL
F.	NULL
,	NULL
Tan	NULL
,	NULL
J.	NULL
,	NULL
Chou	NULL
,	NULL
C.	NULL
C.	NULL
,	NULL
Geisler	NULL
,	NULL
C.	NULL
H.	NULL
,	NULL
Schriber	NULL
,	NULL
J.	NULL
,	NULL
Blumenson	NULL
,	NULL
L.	NULL
E.	NULL
,	NULL
Narula	NULL
,	NULL
S.	NULL
K.	NULL
,	NULL
Baumann	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Caligiuri	NULL
,	NULL
M.	NULL
A	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Blood	NULL
89	NULL
,	NULL
4146-4152	NULL
Nosaka	NULL
,	NULL
T.	NULL
,	NULL
Kawashima	NULL
,	NULL
T.	NULL
,	NULL
Misawa	NULL
,	NULL
K.	NULL
,	NULL
Ikuta	NULL
,	NULL
K.	NULL
,	NULL
Mui	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
and	NULL
Kitamura	NULL
,	NULL
T.	NULL
(	NULL
1999	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

18	NULL
,	NULL
4754-4765	NULL
Karras	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
Wang	NULL
,	NULL
Z.	NULL
,	NULL
Coniglio	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
Frank	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
Rothstein	NULL
,	NULL
T.	NULL
L.	NULL
(	NULL
1996	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

157	NULL
,	NULL
39-47	NULL
Pericle	NULL
,	NULL
F.	NULL
,	NULL
Kirken	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
Bronte	NULL
,	NULL
V.	NULL
,	NULL
Sconocchia	NULL
,	NULL
G.	NULL
,	NULL
DaSilva	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Segal	NULL
,	NULL
D.	NULL
M.	NULL
(	NULL
1997	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

159	NULL
,	NULL
2580-2585	NULL
Nakajima	NULL
,	NULL
H.	NULL
,	NULL
Liu	NULL
,	NULL
X.	NULL
W.	NULL
,	NULL
Wynshaw-Boris	NULL
,	NULL
A.	NULL
,	NULL
Rosenthal	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
Imada	NULL
,	NULL
K.	NULL
,	NULL
Finbloom	NULL
,	NULL
D.	NULL
S.	NULL
,	NULL
Hennighausen	NULL
,	NULL
L.	NULL
,	NULL
Leonard	NULL
,	NULL
W.	NULL
J	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Immunity	NULL
7	NULL
,	NULL
691-701	NULL
Teglund	NULL
,	NULL
S.	NULL
,	NULL
McKay	NULL
,	NULL
C.	NULL
,	NULL
Schuetz	NULL
,	NULL
E.	NULL
,	NULL
van	NULL
Deursen	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Stravopodis	NULL
,	NULL
D.	NULL
,	NULL
Wang	NULL
,	NULL
D.	NULL
,	NULL
Brown	NULL
,	NULL
M.	NULL
,	NULL
Bodner	NULL
,	NULL
S.	NULL
,	NULL
Grosveld	NULL
,	NULL
G.	NULL
,	NULL
Thile	NULL
,	NULL
J.	NULL
N.	NULL
(	NULL
1998	NULL
)	NULL
Cell	NULL
98	NULL
,	NULL
841-850	NULL
Sexl	NULL
,	NULL
V.	NULL
,	NULL
Piekorz	NULL
,	NULL
R.	NULL
,	NULL
Moriggl	NULL
,	NULL
R.	NULL
,	NULL
Rohrer	NULL
,	NULL
J.	NULL
,	NULL
Brown	NULL
,	NULL
M.	NULL
P.	NULL
,	NULL
Bunting	NULL
,	NULL
K.	NULL
D.	NULL
,	NULL
Rothammer	NULL
,	NULL
K.	NULL
,	NULL
Roussel	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
and	NULL
Thile	NULL
,	NULL
J.	NULL
N.	NULL
(	NULL
2000	NULL
)	NULL
Blood	NULL
96	NULL
,	NULL
2277-2283	NULL
Saharinen	NULL
,	NULL
P.	NULL
,	NULL
Ekman	NULL
,	NULL
N.	NULL
,	NULL
Sarvas	NULL
,	NULL
K.	NULL
,	NULL
Parker	NULL
,	NULL
P.	NULL
,	NULL
Alitalo	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Silvennoinen	NULL
,	NULL
O	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Blood	NULL
90	NULL
,	NULL
4341-4353	NULL
Tsai	NULL
,	NULL
Y.	NULL
T.	NULL
,	NULL
Su	NULL
,	NULL
Y.	NULL
H.	NULL
,	NULL
Fang	NULL
,	NULL
S.	NULL
S.	NULL
,	NULL
Huang	NULL
,	NULL
T.	NULL
N.	NULL
,	NULL
Qiu	NULL
,	NULL
Y.	NULL
,	NULL
Jou	NULL
,	NULL
Y.	NULL
S.	NULL
,	NULL
Shih	NULL
,	NULL
H.	NULL
M.	NULL
,	NULL
Kung	NULL
,	NULL
H.	NULL
J.	NULL
,	NULL
Chen	NULL
,	NULL
R.	NULL
H.	NULL
(	NULL
2000	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

20	NULL
,	NULL
2043-2054	NULL
Uckun	NULL
,	NULL
F.	NULL
M.	NULL
,	NULL
Waddick	NULL
,	NULL
K.	NULL
G.	NULL
,	NULL
Mahajan	NULL
,	NULL
S.	NULL
,	NULL
Jun	NULL
,	NULL
X.	NULL
,	NULL
Takata	NULL
,	NULL
M.	NULL
,	NULL
Bolen	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Kurosaki	NULL
,	NULL
T.	NULL
(	NULL
1996	NULL
)	NULL
Science	NULL
2783	NULL
,	NULL
1096-1100	NULL
Mahajan	NULL
,	NULL
S.	NULL
,	NULL
Fargnoli	NULL
,	NULL
J.	NULL
,	NULL
Burkhardt	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
Kut	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
Saouaf	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
and	NULL
Bolen	NULL
,	NULL
J	NULL
.	NULL

B	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
,	NULL
5304-5311	NULL
Sudbeck	NULL
,	NULL
E.	NULL
,	NULL
Liu	NULL
,	NULL
X-P.	NULL
,	NULL
Narla	NULL
,	NULL
R.	NULL
K.	NULL
,	NULL
Mahajan	NULL
,	NULL
S.	NULL
,	NULL
Ghosh	NULL
,	NULL
S.	NULL
,	NULL
Mao	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Uckun	NULL
,	NULL
F.	NULL
M.	NULL
(	NULL
1999	NULL
)	NULL
Clin	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

5	NULL
,	NULL
1569-1582	NULL
Uckun	NULL
,	NULL
F.	NULL
M.	NULL
,	NULL
Tuel-Ahigren	NULL
,	NULL
L.	NULL
,	NULL
Waddick	NULL
,	NULL
K.	NULL
G.	NULL
,	NULL
Jun	NULL
,	NULL
X.	NULL
,	NULL
Jin	NULL
,	NULL
J.	NULL
,	NULL
Myers	NULL
,	NULL
D.	NULL
E.	NULL
,	NULL
Rowley	NULL
,	NULL
R.	NULL
B.	NULL
,	NULL
Burkhardt	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
and	NULL
Bolen	NULL
,	NULL
J	NULL
.	NULL

B	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271	NULL
,	NULL
6389-6397	NULL
42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

STAT5A	NULL
as	NULL
a	NULL
Substrate	NULL
of	NULL
BTK	NULL
Luo	NULL
,	NULL
K.	NULL
X.	NULL
,	NULL
Hurley	NULL
,	NULL
T.	NULL
R.	NULL
,	NULL
and	NULL
Sefton	NULL
,	NULL
B.	NULL
M.	NULL
(	NULL
1991	NULL
)	NULL
Methods	NULL
Enzymol	NULL
.	NULL

201	NULL
,	NULL
149-152	NULL
Schreiber	NULL
,	NULL
E.	NULL
,	NULL
Matthias	NULL
,	NULL
P.	NULL
,	NULL
Muller	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
and	NULL
Schaffner	NULL
,	NULL
W.	NULL
(	NULL
1989	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17	NULL
,	NULL
6419	NULL
Williams	NULL
,	NULL
M.	NULL
D.	NULL
,	NULL
Rostovtsev	NULL
,	NULL
A.	NULL
,	NULL
Narla	NULL
,	NULL
R.	NULL
K.	NULL
,	NULL
and	NULL
Uckun	NULL
,	NULL
F.	NULL
M.	NULL
(	NULL
1998	NULL
)	NULL
Protein	NULL
Expression	NULL
Purif	NULL
.	NULL

18	NULL
,	NULL
210-221	NULL
Guex	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Peitsch	NULL
,	NULL
M.	NULL
C.	NULL
(	NULL
1997	NULL
)	NULL
Electrophoresis	NULL
18	NULL
,	NULL
2714-2723	NULL
Sack	NULL
,	NULL
J.	NULL
S.	NULL
(	NULL
1988	NULL
)	NULL
J.	NULL
Mol	NULL
.	NULL

Graphics	NULL
6	NULL
,	NULL
244-245	NULL
Rajamohan	NULL
,	NULL
F.	NULL
,	NULL
Pugmire	NULL
,	NULL
M.	NULL
,	NULL
Kurinov	NULL
,	NULL
I.	NULL
,	NULL
and	NULL
Uckun	NULL
,	NULL
F.	NULL
M.	NULL
(	NULL
2000	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

275	NULL
,	NULL
3382-3390	NULL
Leonard	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
and	NULL
O'Shea	NULL
,	NULL
J.	NULL
J	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

16	NULL
,	NULL
293-322	NULL
Bajpai	NULL
,	NULL
U.	NULL
D.	NULL
,	NULL
Zhang	NULL
,	NULL
K.	NULL
,	NULL
Teutsch	NULL
,	NULL
M.	NULL
,	NULL
Sen	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Wortis	NULL
,	NULL
H.	NULL
H.	NULL
(	NULL
2000	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

191	NULL
,	NULL
1735-1744	NULL
Roy	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
Meisterernst	NULL
,	NULL
M.	NULL
,	NULL
Pognonec	NULL
,	NULL
P.	NULL
,	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1991	NULL
)	NULL
Nature	NULL
854	NULL
,	NULL
245-248	NULL
Roy	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
Malik	NULL
,	NULL
S.	NULL
,	NULL
Meisterernst	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1993	NULL
)	NULL
Nature	NULL
365	NULL
,	NULL
355-359	NULL
Roy	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
Carruthers	NULL
,	NULL
C.	NULL
,	NULL
Gutjahr	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1993	NULL
)	NULL
Nature	NULL
365	NULL
,	NULL
359-361	NULL
Roy	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
Du	NULL
,	NULL
H.	NULL
,	NULL
Gregor	NULL
,	NULL
P.	NULL
D.	NULL
,	NULL
Novina	NULL
,	NULL
C.	NULL
D.	NULL
,	NULL
Martinez	NULL
,	NULL
E.	NULL
,	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1997	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

16	NULL
,	NULL
7091-7104	NULL
Grueneberg	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
Henry	NULL
,	NULL
R.	NULL
W.	NULL
,	NULL
Brauer	NULL
,	NULL
A.	NULL
,	NULL
Novina	NULL
,	NULL
C.	NULL
D.	NULL
,	NULL
Cheriyath	NULL
,	NULL
V.	NULL
,	NULL
Roy	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
Gilman	NULL
,	NULL
M.	NULL
(	NULL
1997	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

11	NULL
,	NULL
2482-2493	NULL
Kim	NULL
,	NULL
D-W.	NULL
,	NULL
Cheriyath	NULL
,	NULL
V.	NULL
,	NULL
Roy	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
Cochran	NULL
,	NULL
B.	NULL
H.	NULL
(	NULL
1998	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
3310-3320	NULL
Mano	NULL
,	NULL
H.	NULL
(	NULL
1999	NULL
)	NULL
Int	NULL
.	NULL

J.	NULL
Hematol	NULL
.	NULL

69	NULL
,	NULL
6-12	NULL
Hemmings	NULL
,	NULL
B	NULL
.	NULL

A	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Science	NULL
275	NULL
,	NULL
1899	NULL
Hyvonen	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Saraste	NULL
,	NULL
M.	NULL
(	NULL
1997	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

16	NULL
,	NULL
3396-3404	NULL
Lemmon	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Ferguson	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
Schlessinger	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Cell	NULL
85	NULL
,	NULL
621-624	NULL
Yao	NULL
,	NULL
L.	NULL
,	NULL
Kawakami	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Kawakami	NULL
,	NULL
T.	NULL
(	NULL
1994	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

91	NULL
,	NULL
9175-9179	NULL
Chen	NULL
,	NULL
X.	NULL
,	NULL
Vinkemeier	NULL
,	NULL
U.	NULL
,	NULL
Zhao	NULL
,	NULL
Y.	NULL
,	NULL
Jeruzalmi	NULL
,	NULL
D.	NULL
,	NULL
Darnell	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
and	NULL
Kuriyan	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
Cell	NULL
98	NULL
,	NULL
827-839	NULL
6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san	NULL
$	NULL
4g	NULL
/310-2q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wou	NULL
;	NULL
papeojumo	NULL
(	NULL
Transcription	NULL
Factor	NULL
STATSA	NULL
Is	NULL
a	NULL
Substrate	NULL
of	NULL
Bruton	NULL
's	NULL
Tyrosine	NULL
Kinase	NULL
in	NULL
B	NULL
Cells	NULL
Sandeep	NULL
Mahajan	NULL
,	NULL
Alexei	NULL
Vassilev	NULL
,	NULL
Nancy	NULL
Sun	NULL
,	NULL
Zahide	NULL
Ozer	NULL
,	NULL
Chen	NULL
Mao	NULL
and	NULL
Fatih	NULL
M.	NULL
Uckun	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

2001	NULL
,	NULL
276:31216-31228.	NULL
doi	NULL
:	NULL
10.1074/jbc.M104874200	NULL
originally	NULL
published	NULL
online	NULL
June	NULL
18	NULL
,	NULL
2001	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
doi	NULL
:	NULL
10.1074/jbe.M104874200	NULL
Alerts	NULL
:	NULL
*When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
*	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
61	NULL
references	NULL
,	NULL
29	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www.jbe.org/content/276/33/31216.full.html	NULL
#	NULL
ref-list-1	NULL
6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san	NULL
$	NULL
4g	NULL
/310-2q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wou	NULL
;	NULL
papeojumo	NULL
(	NULL

